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S i nce the earl iest recorded descri pti on of herpeti c  l es i ons by the 
1 Roman phys i cian  Herodo�us , the herpes fami ly of vi ruses has been a ssoc-
iated wi th a myri ad of cl i n i cal mani festati ons in man . By the end of the 
1800 ' s ,  Astruc had descri bed the geni tal l es i ons of herpesvi rus eti ol ogy2 
and V ida l  had shown the v irus to be i nfectious and communi cab l e . 3 Much 
of our know ledge of the pathogenesi s of herpesvi ruses began wi th Gruter , 
who , i n  1912 , transmi tted the d i sease to rabbi ts usi ng vesi cul ar fl ui d 
. 4 from a human l eslon .  Goodpasture , in the 1920 ' s , demonstrated that 
herpes s impl ex virus (HSV )  was capab l e  of i nduc i ng a pri mary i nfecti on 
in rabbi ts and hypothes i zed sequenti al neural transport and estab l i sh­
ment of a l a tent state wi thi n  the nerve cel l s  whi ch cou l d  then be reacti ­
vated l a ter to produce recurrent l esi ons .5 By 1971 , Goodpasture ' s  theo­
ries were demonstrated to be correct by the recovery of i nfecti ous HSV 
from sensory gang l i a  of l atentl y i nfected ani mal s and from humans wi th a 
h· f h ·  1 ·  6 lstory 0 recurrent erpetlc eSlons . The herpesvi ruses have subse-
quently been shown to be ubi qui tous in nature and capabl e of i nfecti ng  
ti ssues derived from primi tive ectoderm : ski n ,  mucous membrane , eyes 
and nervous ti ssue . In humans , HSV , al so cal l ed Herpes homin i s , has 
been associ ated wi th gi ngi vostomati ti s ,  recurrent herpes l ab i al i s ,  herpes 
progen i tal i s , ocu l ar keratoconjuncti v i ti s ,  encephal i ti s , and most re­
centl y ,  a possi b l e  rol e i n  carci noma . 
CLASSIF ICATION 
The Herpetov ir idae are a l arge fami ly  of doub l e  stranded deoxyri bo­
nucl eic  acid ( DNA) v iruses that have an i cosahedral caps i d  composed of 
-2-
1 62 capsomeres surrounded by a lipid soluble envelope. The virions contain 
a linear genome of approximately 100 million daltons molecular weight. 
Their ubiquity in nature is demonstrated by the fact that herpesviruses 
can infect over 30 different vertebrate species and some invertebrate 
species.7 In man, Epstein Barr virus, Cytomegalovirus, Varicella-Zoster 
virus, Herpes virus B, as well as HSV, can produce disease. 
On the basis of antigenic, molecular and pathologic properties, HSV 
can be subdivided into two distinct types: type 1 (HSV-1), commonly 
associated with oral and facial lesions, and type 2 (HSV-2), associated 
with genital infections. r�an is the only known host and exclusive reser-
voir for HSV-1 and HSV-2. Although less than 1% of the population has a 
history of clinically evident HSV-1 primary gingivostomatitis, 40 to 90% 
show serologic evidence of previous exposure.8 The genital lesions of 
HSV-2 etiology rank second to gonorrhea in prevalence as a venereal dis-
9 
ease. These two virus types have different biological and biochemical 
properties. HSV-2 produces a larger pock on chick allantoic membranes 
than HSV-1. The buoyant densities of the viral DNAs in cesium chloride 
3 3 
are different: 1. 726 gm/cm and 1.728 gm/cm for HSV-1 DNA and HSV-2 
. 10, 11 DNA, respectlvely. These respective densities correspond to a 
guanine and cytosine content of 67% for HSV-1 and 69% for HSV-2. There 
is more than a 50% genome homology between HSV-1 and HSV-2 as determined 
12 
by DNA-DNA hybridization. This degree of homology is reflected by 
anti gens that produce cross-reacti ng as �/e 11 as type-specifi c anti bodi es 
13 
in man. Other differences between HSV-1 and HSV-2 include: host 
range susceptibility, variation in plaque size, and yield of infectious 
virions after exposure to elevated temperature, ultraviolet (UV) light 
14, 15, 16 
or acid pH. 
-3-
PHYSICAL AND CHEM ICAL PROPERTIES 
Neither of the two-subtypes of HSV are particularly stable under 
various environmental conditions and thus their infectious properties 
can be inactivated. HSV is thermolabile and storage of the virus for 
long periods of time is difficult. Short-term storage necessitates a 
temperature of -70oC; at warmer temperatures, infectivity is quickly 
lost. The half-life of viral infectivity at 3fc is approximately three 
17 
• 
hours. Maintenance of pH is very important in achieving optimal infec-
tivity; for example, a pH of 7.0 - 7.6 results in maximal virus replica-
18 
tion. The virus can also be inactivated by exposure to x-radiation 
or UV light. Infectivity is halved following 7 seconds of UV exposure 
2 17 
at 42 ergs/cm Is. The viral envelope, which is obtained by budding from 
the nuclear membrance of the host cell, is easily disrupted following 
exposure to urea, sodium dodecyl sulfate, and lipid solvents such as 
ethyl ether. Since this envelope is necessary for adsorption to the 
host cell, exposure to these agents can greatly decrease infectivity. 
For example, a 30 minute exposure to ethyl ether completely eliminates 
7 
the infectious capacity of HSV. 
HERPES SIMPLEX VIRUS - HOST CELL INTERACTIONS 
REPLICATION OF HSV IN VITRO 
The replicative cycle of HSV has been well documented. Initially, 
the virions attach to the host cell by an electrostatic interaction 
between the viral envelope and specific receptors on the cellular mem­
brane. Following attachment, the virion is internalized into the cell 
by fusion or by phagocytosis. Uncoating of the virion is followed by 
migration of the viral DNA into the nucleus. There, transcription of 
-4-
the viral DNA into viral RNA takes place via a host DNA dependent RNA 
polymerase. The viral transcript is then processed by capping, cleavage 
and adenylation. After leaving the nucleus, the mRNA is translated into 
proteins on polyribosomes. The viral proteins can be subcategorized into 
various groupings: (i) viral structural or non-structural proteins; 
(ii) early or late proteins (synthesis occurring before or after viral 
19 
DNA synthesis) ; and (iii) the coordinately controlled alpha, beta, gamma 
20 
protein groups (alpha proteins induce the synthesis of beta proteins, 
beta proteins induce the synthesis of gamma proteins and repress the syn­
thesis of alpha proteins, etc.). Thus, within a few hours postinfection, 
host cell protein synthesis is shut down in favor of viral mRNA trans­
lation. The early viral proteins are required in order to initiate syn-
thesis of viral DNA which commonly occurs around six hours postinfection. 
The majority of HSV structural proteins are synthesized as earl y proteins. 
The remaining late proteins are then synthesized bringing the total of 
viral induced proteins to more than 50 , with molecular weights ranging 
20 
from 1 5 ,000 to 280 ,000 daltons. Proteins are cleaved, phosphoryl ated 
and associated with cell lipids. Structural proteins are transported 
into the nucleus \�here assembly takes pl ace. Accumulations of viral pro­
. 21 ducts within the nucleus are called Cowdry type A inclusion bodles. 
Other proteins are glycosylated and inserted into the nuclear and cyto-
plasmic membranes. Within these areas, the assembled nucleocapsid exits 
the nucleus and acquires its envelope. Newly assembled virions are seen 
within the cell between 7 and 12 hours postinfection, and are released 
17 , 22 , 23 
from the host cell about 8 hours later. The virions leave the 
cell by lysis of the host cell, by transport through the endoplasmic 
13 ,  24 
reticulum system, or by spreading directly to an adjacent cell. 
-5-
Although the yield of infectious virus depends upon the cell type and 
growth conditions, HSV replication is generally quite inefficient. Less 
than 20% of the viral DNA is encapsulated and excess viral proteins are 
25 
produced. Many errors in assembly occur which result in unenveloped 
nucleocapsids and hollow envelopes. Some authors state that only between 
one and five percent of the total virus particles are infectious.
22, 25 
Cytologically, HSV infected cells in culture first demonstrate a 
rounding up phenomenon associated with an increase in refractility. 
�Iithin the nucleus, peripheral clumping of chromatin and Cowdry type A 
inclusion bodies can be seen. Some strains of HSV cause fusion of cell 
membranes between adjacent cells forming a syncytium. Ultimately, how-
ever, the host cells undergo lysis and cell death. 
HSV INFECTIONS IN VIVO 
In man, HSV-l and HSV-2 induce a spectrum of diseases ranging from 
gingivostomatitis, recurrent herpes labialis or genital herpetic lesions, 
to fatal herpetic encephalitis. Biopsies of patients with herpetic infec­
tions show characteristic microscopic lesions. These include ballooning 
degeneration of the nuclei, Cowdry type A intranuclear inclusion bodies 
and formation of multinucleated giant cells. The primary site of HSV 
infection is stratified squamous epithelium. Within this epitheli um, 
acantholysis of the spinous cell layer results in suprabasilar vesicles. 
Tzanck cells within the vesicles demonstrate cytologic abnormalities. 
Inflammatory cells infiltrate the underlying fibrous connective tissue. 
HSV can disseminate by viremia or along neurogani� pathways. Internal 
organs as well as the central nervous system can become infected. Histo-
logic findings at these distal sites include coagulation necrosis and peri-
- 6-
vascular cuffing by lymphocytes and plasma cells. With enchephalitis, 
. 26 inclusion bodies are seen in neurons and ollgodendrocytes. Patients 
can succumb to disseminated herpes or encephalitis. 
Numerous animal models have been developed to better elucidate the 
pathogenesis of HSV . Corneal infection of rabbits and foot pad inocula­
tions of guinea pigs were utilized by early investigators to study neural 
transmission. More recently, mice have been infected by different routes 
to study pathogenesis: intracranial, intradermal, intraperitoneal or 
intravaginal. A murine lip model has been described previously and was 
27 
utilized throughout the research described in this dissertation. The 
histopathologic and virus isolation data from this model has documented 
the neurogenic spread of HSV from the lip into the central nervous system 
as follows: lip, day 1; ipsilateral trigeminal ganglion, day 2 ;  contra-
27 
lateral trigeminal ganglion, day 4; and cerebrum and cerebellum, day 5 .  
Fatal encephalitis occurs within 8-12 days after infection and is dose-, 
as we 11 as, age-dependent. Younger mi ce and 1 a rger doses of HSV yi e 1 d 
greater percentages of fatal encephalitis. Mice surviving HSV infection 
develop HSV specific neutralizing antibodies and their regional ganglia 
characteristically demonstrate latent infection. 
LATENT HSV INFECTION 
One of the most intriguing aspects of HSV infection is the phenomenon 
termed latency. Latency involves the potential for recurrent active 
lesions caused by endogenous HSV . After the primary infection in a host 
that is seronegative, the virus becomes sequestered and when conditions 
permit, the virus reappears to cause a recurrent lesion. Goodpasture 
theorized that the trigeminal ganglia serve as resevoirs from which HSV 
-7-
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is reactivated to cause oral and facial lesions. Charlton later reported 
that patients suffered recurrent oral herpetic infections following surgi­
cal manipulation of the trigeminal ganglion.
28 Human, as well as latently 
infected animal ganglia are reactivated and shed infectious virus when 
explanted onto indicator cells.6, 2
9 
However, no reliable.il2. vivo model 
of reactivation that parallels the latent human condition exists. Nesburn 
used surgical stimulation of latently infected rabbit trigeminal ganglia 
30 
to demonstrate peripheral release of infectious HSV from tear drops. 
T\·/o other accounts document HSV reactivation in mice using large quanti-
31, 32 
ties of cyclophosphamides and corticosteroids. The mechanism of 
latency at the molecular level is unknown. However, two major theories 
are offered, the dynamic theory and the static state theory. 
The dynamic theory of latency states that the infected tissues 
(ganglia, skin, or salivary glands) continually produce low levels of 
infectious virus. Recrudescence of clinical lesions is allowed only 
when specific systemic or local conditions exist. Proponents have docu-
men ted that patients, who are clinically free of lesions, shed infectious 
33 
viral particles in body secretions. About 0 .5% of the general popula-
tion excrete HSV in genital secretions, whereas 5% shed HSV from oral 
secretions.34 Also, Galloway, using in situ hybridization, has recently 
35 
detected HSV mRNA in latently infected ganglion cells. These results 
imply that some latent HSV DNA is transcribed. Finally, evidence from 
.i!l vitro studies has sho�m that prostaglandins enhance cell to cell 
36 
spread of HSV. This implies that local immune and inflammatory prereq-
uisites al low infectious virus to replicate and cause clin ical disease. 
Alternatively, the static state theory proposes that virus persists 
in the ganglia in a non-replicating state. This theory explains why it 
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has been so difficult to isolate infectious virus from latently infected 
ganglia and skin. Several lines of evidence support the static state 
theory of latency. First, viral DNA has been detected �lithin neurons by 
� situ hybridization; however, extensive searches for viral antigens or 
virus particles utilizing immunofluorescence and electron microscopy have 
37 
been inconclusive. Secondly, assays utilizing renaturation kinetics 
have determined that only 0. 1 1  ± 0 . 03 genome equivalents of viral DNA are 
38 
present per latently infected ganglia cell. Lastly, temperature-sensi-· 
tive mutants of HSV have been shown capable of establishing latency, sug­
gesting that viral DNA replication is not necessary for the establishment 
39 
of latency. 
In the final analysis, it seems that latent HSV could harbor itself 
within the ganglia in the form of free nucleic acid or nucleic acid inte-
grated into the host's DNA. The virus could then reinitiate clinical dis-
ease according to either the dynamic theory, the static theory, or a com-
bination. It seems that today's technol ogy lacks extreme sensitivity and 
is incapabl e of delineating which form of latent virus or theory of activa-
tion is most correct. 
HERPESVIRUSES AND ONCOGENICITY 
If known malignancies in non-human species existed which were analo-
gous to human oral or genital squamous cell carcinomas, and these were 
found to be virally induced, then the arguments for a role of HSV in onco­
genesis would be strengthened. However, no analogous tumors are known 
to exist. There is ample evidence that members of Herpetoviridae other 
than HSV can and do induce malignancies. A neurolymphomatosis in chick-
ens, known as �\arek's disease, is caused by a herpesvirus. Significantly, 
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a vaccine has been developed against the disease; the first vaccine capa­
ble of controlling a neoplastic process.40 Evidence exists that herpes 
41 
induced lymphomas occur in monkeys, rabbits and guinea pigs. Lucke's 
42 
tumor, an adenocarcinoma of frogs, is caused by a herpesvirus. In man, 
definite association exists bet�leen Epstein-Barr virus and three human 
diseases: infectious mononucleosis, nasopharyngeal carcinoma, and 
43, 44 
African Burkitt's lymphoma. The latter two diseases are malignancies 
capable of killing their human hosts. In summary, guilt by association is 
frequently given as one piece of evidence linking HSV to the etiology of 
human squamous cell carcinomas. 
HSV AND HU�1AN CANCER 
Attempts to implicate HSV as an oncogenic agent began soon after 
epidemiologic studies indicated a correlation between previous HSV-2 geni-
. 45 tal infection in women and the development of uterine cervical carClnoma. 
About the same time, a British physician reported six cases of squamous 
cell carcinoma of the lip in locations that had suffered from recurrent 
46 
herpes labialis. Since these beginnings, many avenues of research have 
been followed investigating the oncogenic potential of HSV-1 and HSV-2. 
Early epidemiologic evidence showed an increased risk of developing 
cervical carcinoma in females with a history of coitus at an early age 
and multiple sex partners. These data led epidemiologists to theorize 
that venereally transmitted factors were involved in the development of 
41 
cervical carcinoma. Because herpes genitalis is a venereally transmitted 
disease and shows increased incidence in patients with histories of sexual 
promiscuity, HSV-2 was soon implicated as an etiologic agent. Neutralizing 
antibodies to HSV-2, assayed by either the kinetics of neutralization or 
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by neutralization titers, are significantly higher in women with cervical 
47 
cancer as opposed to an age matched control group. More impressive 
differences exist for the occurence of antibodies to viral induced non-
structural antigens. Three examples include Aurelian's AG-4 antigen, 
41 
Hollinshead's HSV-TAA, and Anzai 's VP134. Similar seroepidemiologic 
evidence exists linking HSV-1 to the etiology of squamous cell carcinomas 
of the head and neck. Measurements of antibody levels to HSV non-virion 
41, 48, antigens have been made in cancer as well as non-cancer patients. 
49, 50 
Antibodies were observed in 90% of the laryngeal cancer cases, 91% 
of the head and neck squamous cell cancer cases, 11% of the non-squamous 
cell cancer cases (melanoma, breast, salivary gland, etc. ), and 4% of nor-
48, 51 
mal subjects. Hith both HSV-1 and HSV-2, antibodies to type specific 
antigens could simply denote repeated expOSUY'e of persons to viral anti­
gens through recurrence and/or reinfection ; however, the majority of re-
searchers feel that the observed distribution of the antibodies in experi­
mental cases as opposed to controls heavily favors an etiologic role for 
HSV in the devel opment of genital and oral squamous cell carcinomas. To 
the contrary, it must be noted that not all patients with herpes infections 
develop cancer and that cancer can occur in patients with no serologic 
34 
evidence of HSV infection. 
Numerous studies have attempted to detect the presence of HSV-1 and/ 
or HSV-2 specific markers (antigens, RNA, DNA, or virions) in human tumors. 
The unequivocal existence of viral antigens in cervical cancer cells has 
not yet been firmly established. Although Aurelian reported success 
utilizing immunofluorescence and specific antisera directed against HSV-2 
antigens in staining neoplastic cells exfoliated from a cervical lesion, 
numerous other researchers have been unable to find specific herpes 
- 11-
41 
antigens in thei r bi opsies . Attempts are now in progress wi thi n our 
department to detect HSV-2 anti gens i n  cervi cal  carc i noma biops ies  uti l i z­
i ng the immunoperoxi dase sta in  ( Dr .  G. Cabra l , personal communi cati on ) . 
Hybridi zation techni ques have been uti l i zed to detect vi ral nuc l e i c  acids  
in  human tumors . Frenkel was the first to report the detection of HSV-2 
specif ic  DNA fragments and RNA transcripts i n  human cervi cal carc i noma 
52 
ti ssue.  She concl uded that each tumor cel l  contai ned 3 . 5  copies of a 
segment of DNA representi ng 39% of the HSV-2 genome . Recently , Jones re­
ported detection of HSV-2 mRNA in 5 of 8 human cervi cal bi ops i es by � 
53 
si tu hybrid i zati on .  U nfortunately , studies performed by other workers 
have been unsuccessful in detecti ng HSV DtJA in thei r bi opsy material  from 
4 1  
cervi cal  carci nomas . Besi des HSV anti gens and nuc l e i c  aci ds , enti re 
vi rions have been found in tumors . A case from the Ita l i an l i terature i n-
vol ved a carci noma wh i ch arose i n  a l ocati on on the l i p wh i ch had suffered 
recurrent HSV l es i ons . V i rus was i sol ated from thi s  tumor and character-
54 
i zed as  HSV-1 .  F i nal l y ,  one report exi sts i n  wh i ch herpesvi rus were 
observed wi thi n a squamous cel l carc i noma of the uri nary bl adder by el ec-
55 
tron mi croscopy.  Thu s ,  many anecdotal accounts document the presence 
of herpeti c anti gens , nuc le i c acids , o� i nfecti ous v i ri ons wi thi n squamous 
cel l carc i nomas from the oral cavi ty ,  the uterine cervi x and the b ladde r ;  
however , the bu l k  of the mol ecul ar evi dence has fa i l ed to provi de unequ i v-
ocal �v i dence for herpecti c sequences wi thi n carcinomas . 
I n  man ,  carci noma has devel oped at the si te of recurrent herpes 
lab ia l i s  i n  a number of cases . Kvasni cka reported on a etiol ogi c study 
of l ower l i p  carci noma i n  wh i ch 20% of the patients sai d that the i r  carc i -
56 
noma was a di rect conti nuati on of recurrent herpes l a bi al i s . Later , he 
reported on f ive cases of carci noma (four on the l i ps ) that arose at the 
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s i te of recurrent HSV i nfection .  A l ocal i zation s i te analys i s  of 283 
1 ip carc inomas and 320 herpeti c  l esi ons by the same author revealed : "in 
the perioral reg ion , both i n  men and women , cancer i s  frequent where the 
occurrence of herpes s imp l ex i s  frequent and rarer at s i tes where the 
occurrence of herpes s impl ex i s  rarer . "58 An i mportant observati on i n  
these cases i s  that the locati on o f  herpes l abi al i s  and l i p  carci noma i s  
frequentl y that area whi ch recei ves most of the solar  radi ati on , i .e .  the 
sk i n  surface of the upper l i p  and the vermi l l i on porti on of the l ower l i p .  
�larshal l ,  s tudyi ng a group of l ong-term i mmunosuppressed pati ents , noted 
an i ncreased inc idence of HSV i nfecti on and squamous cel l carci noma . 59 
One case , a 14 year ol d boy \<Ii th renal  transp l ants ,  i nvol ved a l i p  carci ­
noma ari s i ng in the s i te of pers i s tent herpes l ab ia l i s .  L ip  carci noma i n  
a pati ent of thi s age i s  rare . 
ONCOGENIC TRANSFORMATION BY HSV 
Attempts to i nduce tumors i n  anima l s  uti l i z i ng HSV-1  or HSV-2 have 
been unsucces sful . Nahmi as i nocul ated newborn hamsters wi th i nfectious 
HSV-2 and with UV- i rradi ated HSV-2 .  Of the animal s recei v ing i nfecti ou s  
HSV-2 , only 2-3% developed sarcomas whi l e  1 %  o f  the control animal s de-
4 1  
vel oped mal i gnancies .  r�ost  researchers feel that the l yti c nature o f  
HSV must be i n  some way inacti vated before the vi rus can become oncogeni c .  
Al ternative l y ,  recurrent exposure o f  the host cel l to HSV , i nstead o f  a 
s i ngl e appl i cation , may be necessary to in i ti ate the neoplasti c  process . 
In studyi ng the i n i ti al stages, of tumor i nducti on by vi ruses , many 
researchers uti l i ze the techn i que of � vi tro v iral  transformati on of 
cul tured cel l s .  I n  order to di sti ngui sh v i rual l y  transformed cel l s  from 
spontaneously ari s i ng vari ants , i t  i s  necess ary to show the presence of 
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spec i fi c  v i ral  markers as wel l  as  to demonstrate .i!!. v i vo o ncogen i c i ty .  
One proplem with studyi ng transformati on by HSV i s  that there are few 
cel l l i nes which are non-permiss i ve for HSV . Consequentl y ,  the l yti c 
capabi l i ty of HSV must be destroyed to prevent death of the host cel l .  
The v i ru s  must  be treated i n  a manner wh i ch e l i mi nates v i ral infecti v i ty 
wi thout affecti ng i ts transforming capabi l i ty .  Ori g inal l y ,  Duff and Rapp 
uti l i zed UV- i rrad i ation to i nacti vate the l yt ic  functions of HSV-2 a nd 
60 
i nduce the transformati on of hamster embryo fi b rob l asts (HEF ) .  S i nce 
the i r  description in  197 1 ,  numerous accounts documenti ng oncogeni c ,  as 
wel l  a s  b iochemi cal transformation of human , rat ,  hamster and mouse cel l s , 
61 , 62 
have appeared for both HSV1 and HSV-2 . 
Hhen UV- i rradi ated HSV was used to transform HEF ce l l s ,  7 of 15 HSV-2 
i sol a tes vlere descri bed by Rapp and Duff as  havi ng transformi ng potenti al , 
4 1  
as we l l  as  2 of 1 2  HSV-1  stra ins . However , i n  most instances , the 
eff ic i ency of transformati on i s  l ow and not more than one or two trans-
6 
formed foci appear for every 5 x 10 cel l s  infected at a mul ti p l i ci ty of 
41 
infection ( MO!) of 1 .  T\�o types of foci are n oted: f ibroblasti c and 
epi thel i o i d .  \�hen tes ted for oncogen i c i ty i n  newborn hamsters , the fi bro­
bl asti c type foci  induce fibrosarcomas ; whereas ,  the ep ithe l i oi d  foci 
produce adenocarci nomas . I nfecti ous vi rus coul d  not be i sol ated from 
ei ther the transformed cel l s  or the i nduced tumors . S i gni fi cantly , the 
sel'a from the tumor beari ng animal s demonstrate neutra l i zi ng anti bodi es 
aga i nst HSV . Furthermore , immunofl uorescence techniques usi ng anti sera 
aga i nst  HSV shov: the presence of vi ral anti gens i n  transformed cel l s  
4 2 ,  63 ,  64 , 65  
( 333-8-9 l i ne ) .  Another method of des troyi ng HSV lytic 
functi ons i nvol ves inacti vation by photodynami c exposure of  neutral red 
treated HSV i nfected cel l s . Photodynami c inacti vati on resul ts in trans-
- 14-
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formed cel l l i nes that are oncogenic when tested i n  newborn hamsters .  
Other techni ques to i nh i b it  the l yt ic  gene functi ons o f  HSV .and encourage 
transformati on i nc l ude :  i ncubation of i nfected cel l s  a t  subopti mal ( 200C )  
66 . 
b . . 1 67 temperatures , l ncu atl on at supraoptl ma temperatures , and i nfecti on 
with temperature sensi ti ve mutants .
62 ,  68 
Nucl ei c  acid hybridi zati on has been used to detect the presence of 
HSV mRNA and DNA in  transformed cel l l i nes . Transformed cel l l i nes  con-
tai n  about 10- 1 3% of the mRNA present in lyti cal ly  i nfected cel l s  and 
4 1 ,  69  
8-21%  of the complete vira l  genome . Thus , only a smal l porti on 
of the compl ete v iral genome appears to be present and acti vely tran­
scri bed i n  transformed ce l l s .  A recent report has documented that bi o-
chemi cal transformation of mouse cel l s  i s  poss i b l e  us i ng restri cti on 
70 
endonucl ease fragments of HSV DNA. 
Duff and Rapp al so observed that endogenous type C RNA tumor v irus  
was rel eased after several passages from 3T3 cel l s  transformed \�i th UV-
71 
i rradiated HSV . The possi bi l i ty thus exi sts that oncogen i c  transforma-
tion by HSV invol ves the activation of an RNA tumor v i rus . 
B IOCHEMICAL TRANSFORMATION BY HSV 
S i nce the proof of oncogen i c  transformati on i nvol ves steps that i n ­
cl ude the subcl oning of foci , col ony formati on i n  soft agar , and tumor 
formati on i n  suscepti b l e  animal s ,  many researchers have attempted to de­
vi se a convenient bi ochemi cal assay to detect HSV trans formati on . To 
date , two assays have been reported . The mos t  wi del y reported assay i n­
vol ves the conversion  of thymi d ine k i nase negati ve (TK- ) mouse or human 
cel l s  to the thymi dine ki nase pos i ti ve (TK+ ) phenotype . The HSV-l and 
HSV-2 thymidi ne k i nases  can be d ist ingui shed from one another and from 
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the thymid i ne k inase found i n  eukaryoti c cytopl asm a nd mi tochondri a .  T h i s  
a ssay measures the transfer of HSV thymi di ne k i nase t o  the mouse or human 
T� cel l s  and the ir  se l ection by growth in HAT ( Hypoxanth i ne , Ami nopteri n ,  
Thymid ine )  med ia . Bi ochemica l  transformati on as measured by convers i on 
to TK+ phenotype has been reported wi th UV inacti vated HSV- 1 , UV i nacti vated 
4 1  
HSV-2 , temperature sens i ti ve mutants of HSV and. fragMents o f  HSV DNA .  
Recentl y ,  another bi ochemi cal transformati on assay has been reported wh i c h  
i nvol ves the detection o f  pl asmi nogen acti vator uti l i zi ng a fibri n  overl ay 
method .
72  
S ince many transformed ma l i gnant cel l s  have been shown to pro­
duce the enzyme plasmi nogen acti vator , thi s report suggests that i ts pres­
ence prov i des a rapid  detecti on of HSV speci fi c cel l transformati on . 
Other b i ochemi cal evidence exi sts �!h i ch al so argues i n  favor of a 
rol e for HSV in transformation .  Deoxyri bonucl eases i nduced by HSV have 
73 
both exonucl ease and endonucl ease acti vi ty .  These enzymes al l ow HSV 
74 
to i nduce chromatid  breaks and di srupt host DNA .  Repai r o f  DNA breaks 
75 
and i ncreased DNA synthes i s  have been reported in HSV infected cel l s .  
Host DNA breakage and repai r cou l d  exp l a i n  vi ral i nserti on mechani sms 
and mutati onal events , ei ther al one or as a cofactor wi th known carci no-
gens . 
HSV AND COCARC INOGENESI S 
Joi nt  action of HSV wi th known carc inogens has been reported � 
vivo and � v i tro . Tanaka reported a greater i nc idence of ski n papi l l o­
mas i nduced by 3-methyl cho 1 anthrene ( 3-t1C ) app 1 i ca ti on when HSV was i n­
jected i ntradermal ly i n  the same area .
76 
Later he reported that the 
intraperiotoneal i njection of HSV on the thi rd day after 3-f1C appl i cati on 
to the s k i n  more than doubled the i ncidence of s k i n  paPi l l omas .77 Al so , 
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the rate of mal i gnant conversi on from papi l l omas to carcinomas was more 
frequent among mice gi ven HSV . Howett reported enhanced bi ochemi cal 
transformation of T� mouse ce l l s  by UV-i rradi ated HSV fol l owing ni tro­
somethyl urea treatment as compared to that seen wi th v i rus or chemi cal 
78 
a lone .  Recently ,  photodye therapy ( l i ght exposure fol l owing neutral 
red appl i cation ) of geni tal  herpeti c l es i ons was he l d  respons i b l e  for the 
79 
devel opment of three cases of i ntraepi dermal carc inomas of the peni s .  
I n  summary , many l i nes of evi dence exist  assoc i at i ng HSV wi th carc i -
noma development. Many o f  these l i nes are wel l  proven , but a greater 
number are i ncompl ete i n  thei r documentati on .  Experimental  studi es i n ­
cl ude : � v i tro transformat ion o f  human and non-human cel l s ,  i nducti on 
of cerv i cal  carcinoma in mi ce and non-human primates , and vi rus s ti mu l a-
43 
tion of host DNA al terations and synthes i s .  The data emanating from 
studies  wi th humans i ncl ude: seroepi demi ol ogy ,  retro specti ve studies 
of venereal vi ral di seases , and vi rus markers ( protei ns, RNA , or DNA ) in 
80 
human squamous cel l carci noma s . Important theoreti cal di fferences 
exi st  between associ ati on , correl ati on and eti ol ogy .  N o  evi dence i mp lyi ng 
assoc iation  or correl ati on of HSV wi th sq uamous cel l carc i noma deve l opment 
can be i n terpreted as defin i te evi dence of  a cause and effect rel ati on-
sh i p .  A puri s t  cou l d  argue that the avi a lable  i nformati on t o  date re­
fl ects merely as assoc i ation of HSV wi th neop l a s i a  due to the preferenti al 
. growth of the v i rus i n  tumor cel l s .  Al though the speci fi c ro l e  of HSV 
in the i nduction of tumors i n  man has not been establi shed wi th any de-
gree of certai nty ,  the many findings that HSV i n fecti ons contribute i n  
a pos i ti ve way t o  the carcinogen i c  processes i n  several experimental 
systems i ndi cates HSV ' s  importance to the fi nal outcome . 
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TWO-STAGE CARCI NOGENES IS  
INTRODUCTION 
The b i ol og i c  processes l eadi ng to mal ignant neopl asms i n  general are 
mu l ti factorial  in terms of et.i ol ogy and mul ti stepped in terms of evol uti on , 
rather than simple "one-h it" mutagenesi s .  Furthermore , the sequenti a l  
nature in  the i nduction of  neop l a s i a  can  be cri t i cal ly  modi fied by  exog-
eneous as  we l l  as endogenous factors . The i nteracti on of mul ti p l e  envi ron­
mental factors may i ncrease the i nci dence of cancer more than the exposure 
to a si ngl e  carci nogen and ga ins  tremendous importance from a pub l i c  heal th 
standpo i n t .  I n  the broadest sense , then , the devel opment of tumors can 
be thought of as a series of cocarci nogen i c  events . 
Hany of the current concepts concern ing  the natura l h i s tory of the 
neoplastic  process in v ivo stem from the pi oneeri ng studies of Berenbl um 
8 1  
i n  194 1 .  H e  successful ly  demonstrated \1hat has now become a c l assi cal 
mouse sk i n tumori genes i s  model . The deve l opmen t of neopl as i a  in thi s 
model i s  d i v i ded into two s tages . The first stage , termed i n i ti ation , 
fol l ows the appl i cation of a si ngl e subthresho ld  dose of a chemi cal car-
ci nogen . Then compounds , termed promoters ,  are admi n i s tered repeatedly 
to the same s i te .  �1os t of  thi s earl y work emp l oyed polycycl i c  aromatic  
hydrocarbons as the i n i ti ati ng agents and  Croton oi l as the promoti ng 
agent. Tumori genes i s  i s  un,i formly i nduced by repeated appl i cati on of the 
promoter to mouse s k i n  treated previ ously wi th a si ng l e  app l i cati on of 
carci nogen . The first tumors arose 30-70 days afte r the begi nning  of pro-
82 
moter treatments . S i gni f i cantl y ,  if the order of the treatments i s  
reversed , no tumors are i nduced . Al so , i f  the promoter i s  given by i t-
sel f repeatedly or if the carci nogen i s  g i ven al one , no tumors emerge . 
-18-
The process of initiation is irreversible; by beginning promoter exposure 
as long as one year after the application of the initiator, tumorigenesis 
is still possible. Thus, a type of permanent but unexpressed damage is 
done during the process of initiation . This damage requires promotion 
in order to express itself as a clinical neoplasm. The following figure 
demonstrates the scheme for two-stage epidermal carcinogenesis in mice 
83 
and underscores the importance of the sequence of treatments. 
Time � 
1 .  X No tumors 
2 .  X .� � * � Tumors 
3 .  X � ! � ! Tumors 
4 .  * � � � X No tumors 
5 .  � � t ! No tumors 
X = Application of Initiator 
� = Application of Promoter 
Considerable interest and importance is now attached to the two-stage 
carcinogenesis model . .  Recent demonstrations exist of similar sequences 
in carcinogenesis of tissues other than skin. In every instance, the 
carcinogen is delivered in minute amounts and the promoter, lacking its 
own carcinogenicity, is subsequently and repeatedly administered. Repre­
sentative systems of initiation-promotion are listed in the following 
table: 
Ti ssue 
Mouse epi derlT!i s  
Rat epi dermis  
Rat b l adder 
Rat l i ver 
Rat mammary g l and 
Mouse l i ver 
r'10use l ung 
�louse embryo fi bro­
b l a sts i n  cul ture 
Mouse stomach 
- 19-
Ini ti ator 
3 Methyl chol anthrene 
Benzopyrene 
N i trosoguan id i ne 
UV-Irradi ati on 
Beta rad i ati on 
Methyl ni trosourea 
Dimethyl ni trosamine 
Dimethyl benzathracene 
Dimethy l ni trosamine 
Dimethyl ni trosami ne 
U rethan 
3 �1ethyl chol anthrene 
UV-Irradiation 
D imethyl benzanthracene 
Promoter 
Tetradecanoyl -Phor­
bo l -Acetate (TPA) 
TPA 
Croton oi 1 
Croton oi 1 
C i garette smoke 
condensate 
Sacchari n 








Thus , i ni ti ati on-promotion sequenci ng and tumori genes i s  can be demonstrated 
84, 85 
� vivo in var ious animal systems as wel l  as � v i tro . 
TUHOR PROMOTING AGENTS AND TETRADECANOYL-PHORBOL-ACETATE 
Agents capab le  of promotion i n  two-s tage carci nogenesi s ,  comprise  
a wi de variety of  chemi cal agents . Phorbol este rs , detergents , i odoaceti c 
acid , p henobarbi tal , arti fi cal sweeteners , and numerous other chemi cal s 
are impl icated �s exogenous promoti ng  agents . Endogenous ly ,  hormones may 
act as promo ters . r�uch of the research i s  centered around the phorbol 
esters , derivi ti ves of Croton oi l .  The seed o i l  of Croton tegl i um ,  a 
l eafy shrub of the fami ly Euphorbi acea e ,  i s  the source o f  the phorbol 
ester s .86 These macrocycl i c di terpene esters were i sol ated and character-
8? 
i zed by Hec ker .  Tetradecanoyl -phorbol -acetate ( TPA ) is the component 
-20-
of Croton o i l  acti ve as  a promoter.  
TPA , sometimes al so cal l ed phorbol -myri s tate-acetate ( P�A) , i s  the 
1 2 ,  13 d iester of phorbol wi th tetradecanoi c and aceti c aci ds as s i de 
groups . The agent has a mel t i ng po int  of 7�C and i s  usual l y  obta ined i n  
crystal l i ne form . TPA i s  sol ub le  i n  organ i c  sol vents i ncl uding  acetone 
and d i methy l su lfoxi de ( D�lS0 ) .  TPA i s  h i gh ly  i rri tati ng and i s  the strong­
est tumor promoter known on mouse ski n .88 After i ni ti ati on wi th d i methy l ­
benzathracene (DMBA) , repeated app l i cati on ( twi ce week ly , 0 .02  umo le  TPAj 
app l i cat ion )  onto mouse sk in  produces a l arge number of papi l l omas and 
11 . 
88 
h ·  f . f squamous ce carC l noma s .  The mec amsm 0 actl on 0 TPA i s  not known , 
but extensive  mol ecul ar research i s  ongoi n g .  I n  the p a s t ,  the preponder-
ance of experimental effort i nvestigati ng the mode of acti on has been 
performed on mouse ski n .  However , i n  that system i t  i s  di ffi cult  to 
i dentify , from an array of b ioc hemi cal al terati ons , that one whi ch i s  
l i nked wi th promoti on . Hany of these .ill vi vo observati ons may be p l ei otrophi c 
responses to cel l d iv i s i on . These i n  v i vo al terati ons wi l l  be briefly 
d i scussed before the more recent .ill vi tro i nves ti gati ons are exami ned . 
TPA app l i cation causes certai n  hi stol ogi c effects on mouse ski n .  
These i ncl ude edema , erythema , l eu kocyte i nfi l tration and , eventual l y ,  
hyperpl a s i a .  Ra ick  demonstrated that fo l l owi ng a s i ngl e exposure to TPA , 
mouse epi derm i s  shi fts to an acti ve gro�/th s tate . The mi toti c i ndex i n -
crea ses  as  we l l  a s  the rate o f  precursor i ncorporati on i nto protei n ,  RNA 
89 
and DNA. Maximum synthesi s of RNA occurs at 6 hours , protei n at 12 
hours and DNA at 18 hours . There i s  an enlargement of nucl eol i ,  as we l l  
as  an i n creased number of polysomes . There i s  al tered morphol ogy of the 
spi nous cel l s  taki ng on the appearance of basal cel l s .  Rapi d  s ti mu la­
t ion  of  phosphol i p i d  synthes i s  i s  noted . I n  addi t ion , al terati on i n  
-21-
membrane permeabi l i ty and structure , reduction i n  epi dermal hi stidase 
acti v i ty ,  as  wel l as an increase in orn i th ine  decarboxyl ase (ODC ) 
acti v i ty have been reported . Si gni f icantly , Bal ma i n  has documented rap i d  
h i s tone phosphoryl ation and sugges ted that th i s  mi ght b e  respons i b l e  for 
90 
. the i ncreased synthes i s  of DNA and RNA. Trol l has reported detecting  
a tryps i n- l i ke protease as early as  30  mi nutes a fter TPA appl i cati on onto 
mouse s k i n .  This  protease may modify o r  remove h i s tones thereby acti vat-
9 1  
i ng a spec i f i c  regi on  of the genome . Al ternati vel y ,  thi s  protease may 
activate DNA in a manner simi l ar to that observed i n  sex hormone acti va-
92 
ti o n ;  Sl aga has reported that TPA bi nds to a cytosol receptor prote i n .  
Other i n teresting i n  v ivo  observations i ncl ude those o f  VanDuuren , who 
reported that mi nor changes in the mol ecul�r  structure of TPA resul t i n  
8 2  
d imi n i s hed , or comp l ete loss  of , tumor promoting acti v i ty o n  mouse ski n .  
Tumor promoting activ i ty i s  al so i nhi bi ted by pri or appl i cation o f  exoge­
nous agents , i ncl ud ing fl uoc i nol one aceton ide (a steroidal anti - infl amma-
93 94 
tory agent ) or reti no ids  (V i tamin  A deri vi ti ves ) . ' Many of the a spects 
of the b i o log ic  nature of tumor promoti on by TPA a re characteri zed ; however , 
the mol ecu lar events that take pl ace duri ng promoti on rema i n  uncl ear . 
Attention to th i s  prob l em has nO�1 turned to .i!!. v i tro eva l uati on of promo­
tion by TPA .  
i�any .i!!. vi tro i nvesti gati ons have focused on the stage of  promoti on 
i n  the deve l o �ment of the neopl ast ic  state . An i n i ti a l  observati on showed 
TPA to be effective in enhanci ng the outgrowth of Swi ss 3T3 cel l s  trans-
fonned by SV40 virus . Good correl ations exi st  bebleen various promoti ng 
agents i n  that system and the cl ass i ca l  .i!!. vivo  mouse ski n assays . 9 5  
Other cel l cul t�re sys tems , uti l i z i ng v�ri ous i n i tiators and promoters , 
are al so s imi l ar to .i!!. v ivo two-state carc inogenes i s ;  cel l s  exposed to 
-22 -
subtransform i ng doses of carc i nogens and phorbol esters produce transformed 
foci . Transformed foci are not produced by treatment wi th carc i nogen or 
phorbol esters a lone .  r40ndal reported transformation of a mouse fi brob last  
cel l  l i ne using  phorbol esters as promoters and aromati c hydrocarbons or 
96 
UV 1 ight as  i n i ti ators . TPA causes a t\'iO to three" fol d enhancement i n  
transformati on o f  rat embryo cel l s  infected wi th a temperature sensi ti ve 
mutant of adenovi rus type 5 .  I n  the presence o f  TPA , these transformed 
foci appeared earl ier and were s ign if icantly l arger i n  di ameter.
97 
Thus , 
a two-stage protocol uti l i z ing  polycycl i c  hydrocarbons , UV l i gh t ,  or 
v irus a s  i n i tiators and phorbol esters as promoters can resul t in in­
creased effic iency of transformati on of cel l s  � vi tro and an enhanced 
abi l i ty of these cel l s  to grow i n  soft agar .  The effect of  phorbol esters 
al one has been i nvesti gated wi th i n  these � v i tro systems and three gen­
eral areas of acti v i ty �li l l  be di scussed : the effect on cel l di fferenti a­
tion , cel l membrane al teration , and the effect on cel l ul ar enzymol ogy . 
�1any effects by TPA upon cel l ul ar di fferentiati on have recently 
been reported . r10st of the evi dence documents a dramati c i nhi bi tory 
effect.  U nder the i nfl uence of TPA , chi cken myob l asts do not enter GO 
phase a t  the same frequency as normal cel l s ,  do not synthes i ze normal 
myos in  cha i ns " and do not exh i b i t  normal fus i on of myotubules . Bes i des 
i ts mi togeni c effect on chi cken chrondrobl asts , TPA transforms these 
cel l s  from sess i le  polygonal cel l s  i n to mobi l e  fi brobl asti c cel l s  that 
form mu l ti l ayers . These chondrobl asts cease to synthes ize tI'iO macro-
98 
mol ecu l es needed in mature carti l age . TPA a l s o  decreases col l agen 
synthes i s  in chi cken fi brob l asts . Thi s effect is revers i b l e  and is not 
the resu l t  of permanent transformation nor the se lection of a popu l at ion 
subset. 99 Expl anted rat tracheal epi the l i um shows an increased rate of 
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cellular division and capacity to grow out in primary cultures in the 
presence of TPA . Significantly , these cells are nontumorigenic when inoc-
100 
ulated into immunosuppressed hosts . Other examples of the inhibitory 
effect on cellular differentiation by TPA include erythroid conversion of 
Friend erythroleukemic cells , adipose conversion of lipogenic mouse cells 
101, 102 
and neurite conversion of mouse neuroblastoma cells. Two general-
ities that have been noted are: (i)  positive correlation exists between 
tumor promoting activity � vivo on mouse skin and a promoter ' s  ability 
to inhibit differentiation of cells � vitro ; (ii) upon removal of the 
95 
promoter the � vitro effects of  the phorbol esters are reversible. 
Rovera reported that TPA has more than an inhibitory effect on cellular 
differentiation. TPA can induce a differentiation of HL-6 human promye-
locytic leukemic cells to become adherent to plastic and to undergo a 
morphologic change into a monocytic cell . He concluded that TPA can have 
at least three different effects upon cellular differentiation : (i )  stim-
ulation of the normal pathway ; ( ii )  inhibition of normal differentiation ; 
and (iii ) induction of an alternate pathway of differentiation. Furthermore , 
he bel i eved the effect of tumor promoti ng agents may depend upon the target 
103 
cell (unipotent vs . multipotent). 
A critical target for tumor promotion by the phorbol esters may be 
the cell membrane . TPA can bind to membranes due to its lipophilic-hydro-
h . l . 104 p 1 lC nature. Examples of TPA ' s  effect upon the cytoplasmi c membrane 
include: ( i) reduction of electrophoretic mobility ; (ii)  blockage of 
stimulation by isoproterenol of epidermal cAMP; ( iii) increased agglutin-
ability of 3T3 cells by concanavalin A ;  (iv )  release of 3T3 cells from 
contact inhibition ; ( v )  synergism with phytohemagglutinin or concanavalin 
A in stimulating lymphocyte DNA systhesis;  and (vi)  various effects on 
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l ysosome di sruption , mi crotub u l e  assembly and cytopl asmi c membrane perme-
84 , 95  
abi l i ty .  C hi cken embryo fi brob lasts in  the presence of  TPA demon-
strate a decrease i n  mean cel l u l ar vol ume , a change in cel l ular  morphol -
ogy , and the l oss of a l arge external transformation sensi ti ve glycopro­
tein ( lETSP ) . 105 TPA al so i nh i b i ts epi dermal growth factor ( EGF ) from 
106 
bi nd i ng to ce l l  membrane receptors on Hela cel l s .  Al though TPA and 
EGF have d i s s imi l ar chemi cal structures , both can i n�uce simi lar  phenom­
ena in Hela cel l s ,  namely : ( i ) increase the synthesi s  of pl asmi nogen 
activator ; ( i i ) stimul ate growth ; ( i i i ) i ncrease sugar transport ; 
( i v ) increase the synthesi s of ODC and prostag l and ins ; and (v ) act as  
107 
a promoter in mouse s k� n  carci nogenesi s .  Thu s ,  TPA may mimic the 
na tura 1 effect of EGF .  
84 
Simi l ar l y ,  TPA may act l i ke a chal one . 
l i s ts of enzymatic  al terations that are secondary to .iD. vi tro expo-
84 , 95 
sure of cel l s to TPA are found in recent revi e\�s . SOl'le i ncl ude : 
( i ) stimul ation of enzymes for h i s tone phosphorylati on ;  ( i i ) stimul ation 
of epidermal cAl>l P ,  cGI�P , and ATPase ; and ( i i i ) i nduct i on of ODC and pl a sm in-
ogen activa tor .  P lasmi nogen acti vator is  a seri ne  protease that cl eaves 
pl asmi nogen to plasmi n ,  but i ts si gni fi cance to promoti on rema i ns uncl ear . 
ODC i nduction  has been noted i n  mouse ski n .iD. v ivo ,  and i n  mouse epi dermal 
86 , 95 , 108 , 109 , 1 10 
cel l s and h.amster embryo cel l s .iD. vi tro . The decar-
boxyl ation of orn i th ine by ODC to form putresc ine is the f irst and rate­
l im i t i ng step in po lyamine b iosynthes i s .  El evated putrescine and spermi d i ne 
concentrations are present i n  transformed chi ck embryo cel l s ,  mouse l euke­
mic cel l s  a nd many neop lasti c  ti ssues . A posi ti ve correlati on exi sts be­
tween a prol'loter '  s abi l i ty to i nduce ODC .iD. v i tro and i ts abi l  i ty to pro-
11 1  
mote tumori genesi s .iD. v i vo .  S i nce metabol i sm of TPA does not occur 
1 1 2  
wi th i n  cel l s ,  al terations observed cannot be due t o  degradati on of TPA . 
- 25-
Numerous theories for the acti on of promoti n g  agents have been offered . 
Boutwel l  proposed that TPA acts as a gene acti vator and derepresses segments 
83 
of the genome wh i ch otherwi se wou l d  rema i n  dormant.  Another theory sug-
gests that TPA i nterferes wi th DNA repa i r  thereby i ncreasi ng the poss i bi l i ty 
of error.  Suppressi on by TPA of host i mmune responsi veness and survei l l ance 
is another theory . Fi nal l y ,  phorbol es ters may i nteract \�i th speci f i c  re-
ceptors on the cel l surface and , anal ogous to hormonal -receptor i nter-
83 
acti ons , i nfl uence the metabol i sm of the affected cel l .  
IN ITIATING AGENTS AND D IMETHYLBENZANTHRACEtlE 
In 1775 , Pott theori zed that chi mney soot i s  a cause of s k i n  cancer 
. 1 13 l n  man .  By 1922 , Passey demonstrated the experimental production of 
1 14  
sk i n  cancer in  laboratory an imal s by the appl i cation of  extracts of soot. 
F i nal l y ,  Kennaway i sol ated and c haracteri zed polycycl i c  hydrocarbons as  
115  
the factors i nvol ved in  carci nogenesi s .  The recent concl usi on of epi-
demiologi sts that 61)-Q'lr of human cancers are env i ronmental in  eti ol ogy 
underscores the importance of c hemi cal carci nogens , i n  general , and 
1 16  
polycycl ic  hydrocarbons , speci fi cal l y .  
Pol ycyc l i c  hydrocarbons are re l ative ly  s t;;t b l e  compounds wh i ch are 
eas i l y  formed by combustion of organ ic  matter. Consequently ,  they are 
found in a i r , soi l and water as products of smoke and combusti on . 
Exampl es i ncl ude ci garette smoke , automobi l e  exhaust and barbequed food 
products . Various polycycl i c  hydrocarbons are carci nogen i c  i n  mode l s  
uti l i zi ng mi ce , rats and hamsters . Thi s  thes i s  wi l l  l imi t i ts attenti on 
to one of the pol ycycl Lc �ydrocarbons , namely Dt1BA. 
DMBA has a col orl ess , crystal l i ne s tructure wh i ch is sol uble i n  
organ ic  sol vents . DMBA has a mol ecul ar wei ght of 258,  a mel ting poi nt of 
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160oC .  a boi l i ng poi nt of 4000C and the fol l owi ng chemi cal structure : 1 17  
DMBA has been studies extens i vely as  a carci nogen . The locati on and 
route of appl i cation are i mportant in determi ni ng the h i stol og i c  type of 
mal i gnancy that arises . Intravenous adm in i stration i nto rats can yi e l d  
tumors o f  the pi l osebaceous un i t  and i n  femal es can produce mammary carc i -
1 1 8 .  1 1 9  1 19 
nomas . Subcutaneous i njecti on yi e l d s  fibrosarcomas . I ntragas-
tric deposi tion of DMBA fol l owed by the repeated admi n i s trati on of TPA 
85 
produces carci nomas of the forestomach . DHBA can produce squamous cel l 
carc i nomas when appl i ed to the sk in  or mucous membranes of l aboratory 
120 . 121 
a nima l  S ·. Sal l ey showed that or1BA was capabl e of i nduc i n g  ora l 
122 . 123 , 124 
squamous cel l carci nomas of the cheek pouch of Syr i an hamsters . 
Wal l en ius  produced pal atal and buccal mucosal squamous carcinomas by ora l 
125 
gavage wi th DMBA. Recentl y .  squamous cel l carci nomas of the tongue 
126 
have been produced by the repeated app 1 i ca  ti on  of or�BA. Only one a t-
tempt at i nduci ng carci nomas of the l i p i s  i n  the l i terature and i n  this 
127 
i nstance . a singl e pa i nti ng of DMBA produced no tumors . 
-27-
Investi gati ons of i n i ti at ing agents reveal ed that the i r  chemi cal 
natures vary and bare no rel at ionshi p to one �nother.  I n  1950 , Boyl and 
suggested that polycycl i c  hydrocarbons underwent b i otransformati on i n  
128 
t i s sues to become act ive carci nogen s .  Gel boyn showed that the cel l ul ar 
microsomal fracti on i s  the s i te of b i otransformation i nto hydoxylated 
129 
der ivat ives . The mi crosomal mi xed functi on oxi dase sys tems are l ocated 
h d 1 . . 1 
83 k ' . o n  t e en op asm l C  retl cu urn. These enzyme sys tems ta e l nactl ve 
pol ycyc l i c  hydrocarbons through an epoxi de i ntermedi ate step to a d i hydro-
130 
d io l . Many c hemi cal carc i n ogens are act ive only after th i s  conversi on .  
A key mi xed function oxi dase i s  aryl hydrocarbon hydroxyl ase ( AHH ) . 
Thi s enZYMe i s  present i n  human l ung , human l ymphocytes , and ski n from 
1 3 1 ,  132 
m ice , rats and humans . AHH may determi ne suscepti bi l i ty to 
po l ycycl i c  hydrocarbon carc inogenesi s .  Thi s enzyme ' s  degree of i nduc i bi l i ty 
i n  man and mouse i s  geneti cal ly determi ned . The h i gher the degree of i nduc­
i b i l  i ty ,  the greater the suscepti bi l i ty to pol ycys l i c  hydrocarbon carci no-
133 
genes i s .  
Chemical  carc i nogens have strong el ectroph i l i c  reg iOns .
116 
These 
regi ons can react wi th nuc l eoph i l i c  areas , rel ati ve ly  abundant i n  DNA , RNA 
and protei ns . Al though the nature by wh i ch chemi cal carci nogens i ni ti ate 
transformation i s  unknown , i t  may be that bi ndi ng to DNA l eads to the i r  
interca l ati on i nto the hel i cal structure . Thi s i nserti on , i f  mai nta i ned , 
can pl'oduce "frame s h i ft" mutati ons . Chemi cal carci nogens can b i nd to 
nuc l e ic  acids i n  cel l s  � vi tro causi ng trans formati on . These transformed 
134 
cel l s  produce carc i nomas when i njected i nto l aboratory anima l s .  A 
posi tive correl ati on ex i s ts between the DNA b ind ing capabi l i ty of vari ous 
1 1 ·  h d b d th . . . t '  . 135 po ycyc l C  y rocar ons an , e l  r oncogem C l  y l!l V l  vo.  Two observa-
tions support a geneti c mechan i sm of acti on : ( i )  i ni ti ati on .:!D.. vi vo i s  
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irrever s i b l e  and permanen t ;  and ( i i ) i n i ti at ion � vi tro requi res at l east 
84 
one round of cel l d iv i  s i on after the carc inogen treatment. HO�/ever , an 
ep igenetic mechani sm of acti on proposes that the act i ve carci nogen b i nds 
1 16 
wi th RNA or protei ns to control the i r  express i on .  
U l  TRAV IOlET L IGHT AND CARCI NOGENESIS 
The e l ectromagneti c spectrum extends from cosmi c rays to radi o waves . 
Near the center of the spectrum l ies the vi s i b l e  fi e l d  of l i ght .  Wi thi n 
the v i s i b l e  spectrum , the shortest wave l engths percei vabl e  are v io let  and 
the l onges t are red . The nei ghbor ing i n vi s i b l e  reg i ons are the UV and 
i nfrared regi ons . The UV spectrum consi sts of shorter wave l engths and 
hi gher energy photons than vio l et l i gh t .  The UV spectrum has 200 to 400 
nm wave l engths and i s  subdivi ded i nto three porti ons ( UV-A , UV- B ,  and 
136 
UV-C in  order of decreasing  wave l engths . ) 
Both procaryoti c  and eucaryoti c  cel l s  show mol ecu lar damage fol l ow­
ing  UV exposure . Cel l ul ar  damage may be oxygen dependent or oxygen i nde­
pendent. Oxygen dependent damage is med i ated by free-rad i cal s and i ncl udes 
si ng l e  s trand DNA breaks or DNA-protei n  cross- l i nks . Oxygen i ndependent 
damage l eads to the format ion of pyrimi d i ne di mers and thymi ne g lycol s .  
Dimers can be formed petween thymine-thymine , cytosi ne-cytos i ne ,  or cyto­
si ne-thym i n e .  Al l types of d imers have been i sol ated from i n  vi vo UV- i rra-
137 
d iated gu i nea pi g and mouse sk i n .  Evi dence exi sts that these d i mers 
138 
can g i ve r i se to tumors . 
Fol l owi ng UV induced damage to the ce l l , parti cularly the DNA, repai r  
must be compl eted before normal cel l u l ar rep l i cati on and functi ons can re­
sume . A number of d ifferent DNA repa i r  mechan i sms are known , name ly :  
photoreacti vat ion , exci s ion  rep a i r  and pos trep l i cati on repa i r . 136 I n  the 
-29-
a bsence of normal repa i r , ce l l u l ar al terations and pos s i bl y  death wi l l  
fol l ow .  The human di sease , xeroderma pi gmentosum i s  an examp le . Thi s 
di sease i s  geneti cal ly transm i tted . I t  shows an i ncreased i ncidence i n  
139  
s k i n  cancers fol l owi ng UV  damage due  to  defecti ve DNA repai r  mechani sms . 
Evi dence exi sts that imp l i cates UV- i rradi ati on as a cause i n  the deve l -
opment of some human cancers , parti cularly squamous cel l carc i noma , basal 
cel l carci noma and mel anoma . This  evi dence can be summari zed as fol l ows : 
( i )  superf i c i al s k i n  cancers occur most frequently on surfaces chroni cal ly  
exposed to sunl ight ; ( i i ) protection from UV  damage exists among dark pi g­
mented races ; ( i i i )  persons in occupati ons ,  such  as fi s h i ng and farmi n g ,  
wi th i ncreased sun exposure time have a greater i nc idence o f  ski n cancer ; 
( i v )  near the equator where sun exposure i s  greate r ,  an i ncreased preva­
l ence of ski n cancer exi sts ; ( v )  geneti c di seases (a l bi n ism ,  xeroderma 
pi gmentosum ) that show photosens i t i v i ty are associ ated wi th i ncreased 
ski n cancer devel opment ;  and ( v i ) ski n cancer can be produced in animal s 
136 , 140 
by repeated exposures of UV radi ation .  Ski n tumors have been i n-
141 , 142 , 
duced i n  Swi ss , Hairl ess , C3Hf , and T-cel l defi cient Nude mi ce .  
143 , 144 , 145 
The major concl usi ons of these � v i vo studi es can be 
summari zed as  fol lows : ( i )  \"ave lengths between 280 and 320 nm are the 
most  effect ive in produc i ng s k i n  cancer ; ( i i ) ski n  pi gmentati on and h a i r  
protect aga inst  U V  induced tumori genes i s ;  ( i i i )  U V  i nduction i s  a cumula­
tive process ; ( iv )  the l atent period is  i nversely rel ated to  the dose of 
UV rad i ati on ; and ( v )  the i nduced carc inomas are of the squamous ce l l  
146 
type.  
Several chemical s can potenti ate UV induced transformation � vi tro 
and i n  vivo . B i ngham demonstrated a cocarci nogeni c effect usi ng n-paraffi ns  
147 
in  combi nati on wi th UV l i ght .  Eps te i n  reported tumor formati on on mouse 
-30-
ski n subjected to UV l i ght and bi -week ly  appl i cations of Croton oi l .  UV 
exposure or Croton oil app l i cation al one produced no tumors after 18 months 
of observati on . 148 Croton oi l i s  the promoter whi l e  UV l i ght acts as  an 
i n i ti ator.  Mondal demonstrated the i n  vi tro transformati on of mouse embryo 
fi brobl asts usi ng UV-i rrad i ati on whi l e  a phorbol es ter was present in the 
med i a .  UV- i rradi ation al one causes no transformed foci ; howeve r ,  
- 3  
transformation frequencies o f  1 . 3  - 37 . 0  x 10 resul t when TPA is added 
96 
to the medi a  48 to 96 hours posti rradi ati on .  Thus , TPA potenti ates the 
effect of subthreshol d doses of UV l i ght i n  v i tro . 
Al though sun exposure i s  recogni zed as a common reason gi ven by 
pati ents for recurring herpes l ab ia l i s ,  few studies combi ni ng UV l i ght and 
HSV are documented . Most of these studies are i nvol ved wi th the UV treat-
ment of HSV prior to � vi tro transformati on assays ( d i scussed under Onco­
genic Transformation by HSV ) .  Harbour showed that UV exposure two days 
before HSV i nfection of mouse ski n ,  has no effect on the vi ral ti ter in  
the ti ssue three days posti nfecti o n .  However , UV exoosure , t�!O days after 
149 
HSV i nfection , enhances the v ira l  ti ter in  the ti ssues . Coppey noted 
that human skin  cul tures exposed to UV l i ght  before i nfecti on wi th HSV-1 
150 
show impa i red v iral production . F i nal ly , Hamoar demons trated that i n-
fection of nontransformed mouse cel l s  wi th UV i nacti vated HSV res u l ts i n  
1 5 1  
rel ease of type C v i rus . 
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r/ATERIALS 'AND METHODS* 
EXPER IMENTAL ANH1ALS 
F ive  to nine week ol d ma l e  BALB/c or Swi ss  ICR mi ce were obtained 
from Laboratory Supply  Company ( I ndi anapo l i s , Indiana ) , S imonson Labora­
tories  (San Diego , Cal i forni a )  or F low Laboratories ( Dubl i n ,  V i rgini a ) . 
M ice were housed at a maximum of 10/cage and s up p l i ed tap water and Puri na 
Lab Rodent C how ad l i bi tum. Ani ma l s  were accl i mated for fi ve to seven days 
prior to experimental mani pul ations . HSV infected and un infected mi ce 
were housed i n  separate bi ohazard faci l i ties ; carcinogen treated ani ma l s  
were housed i n  a thi rd b iohazard l ocati on . 
The LSH stra i n  of gol den Syr ian hamsters ( Charles  R i ver Laboratories ) 
was used for hamster embryo fi brob l ast  producti on , anti sera producti on , 
and oncogen i c  determination of cel l s  transformed � vi tro . Hamsters were 
housed i n  bi ohazard faci l i ties . Ne\� Zeal and I'lh i te rabb i ts were used for 
anti sera production and were housed i n  the central an imal faci l i ti es . 
V IRUS 
Two s tra i ns of HSV were u sed . The Patton stra i n  of HSV- 1 and the 333 
stra i n  of HSV-2 ( 333)  or igi nal ly  i sol ated from human les ions , \�ere ob­
tai ned from Dr.  " B .  K. Murray , Medi cal Col l ege of V i rgi n i a .  V i rus stocks 
were prepared by i nfecting monolayers of HEp-2 cel l s  (HOI  = 0 . 1 ) and 
harvesti ng when  80% of the cel l s showed HSV induced cytopathi c effects . 
The cel l associ ated vi rus was obtai ned by lys i ng the i nfected cel l s  i n  
d i s ti l l ed water ( 2  ml /T-75 flask for 3 0  minutes ) and s ubsequent sonication 
for 30 seconds . Supernatant fl u i ds were cl arified by l ow speed certri fu­
gati on . Al i quots of vi rus pool s were stored at -70oC .  Vi rus i n fect ivi ty 
*Refer to Appendix  I for the suppl i er of each reagent or chemical . 
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was a ssayed on green monkey k idney cel l s  and expressed as  p l aque form i ng 
un i ts per ml ( PFU/m ) .  
CELLS AND MED IA 
Several cel l l i nes were used ,  namely:  Vero cel l s  (African green 
monkey k idney ) , HEp-2 cel l s  ( Human Epidermo i d ) , HEF cel l s  ( primary Hamster 
Embryo F i brob last) , and transformed hamster embryo cel l s  ( 333-8-9 , 12F#1 , 
or 12F#2 ) .  Vero cel l s  were used for PFU assays of vi rus pool s .  HEp-2 
cel l s  were used to grow v i rus  poo l s and a s  contro l s  for immunoperoxi dase 
sta i ns and � s i tu hybri d i zations . HEF cel l s  were used for UV inacti vated 
HSV transformation experiments and as contro l s  for immunoperoxi dase stains  
and  cel l sorter anal ysi s .  333-8-9 cel l s  were obta i ned from Bayl or Col l e ge 
of Med i c i ne.  They were in i ti al l y  transformed by UV i nacti vated 333 in  
Dr.  F .  Rapp ' s  l aboratory . These ce l l s  were used a s  control s in immuno-
peroxidase sta i ns and � s itu hydrib i zati ons . 333-8-9 cel l s  were a l so 
grown under various concentrati ons of TPA for analys i s  by cel l sorti ng 
techniques and two-dimensi onal gel el ectrophoresi s .  12F#1 a nd 12F#2 cel l s  
were obtai ned from Dr. B .  K. Murray . They were i n i ti al l y trans formed 
by UV i nacti vated 333 in hi s l aboratory . These cel l s  were eval uated by 
immunoperoxidase sta ins .  
Cel l s  were cul tured i n  Eagl e ' s mini mum essenti al medi um ( EMEM) sup­
pl emented w ith 10% fetal bov i ne serum , gentamyci n  ( 50 ug/ml ) and 0 . 15% 
NaHCO (for cel l s  in stopoered vesse l s )  or 0 . 22% NaHCO (for cel l s  in a 
3 . 3 
CO
2 
atmosphere ) .  Cel l s  were mai n tai ned at 370 C and passed every thi rd day . 
At the time of passage ,  cel l monolayers recei ved a 5 mi nute r inse wi th 
0 . 02% ethyl ened iami netetraaceti c ac i d  (EDTA ) fol l owed by a 2 mi nute treat­
ment wi th 0 . 25% tryps i n  in EDTA . Cel l s  were di spersed by pi petti ng and 
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seeded i nto two cul ture flasks . 
Primary expl ants were obta i ned from l i p tumors , i ncl uding  Dr1BA in-
duced , HSV  + TPA i nduced , UV  + TPA i nduced and  HSV  + UV + TPA i nduced 
tumors . Tumor expl ants ( 1  mm3 ) vlere i nd iv idual l y  l ayered betl�een one drop 
of ch icken embryo extract and one drop of chi cken pl asma . Duri ng the out­
growth phase , exp lants were incubated in  l'laymouth ' s  medi um contai n i ng 10% 
fetal bov i ne serum, gentamyc i n , pen ic i l l i n and NaHC03 . The cel l u lar out­
growths �Iere eva 1 ua ted by immunoperoxi dase sta i ns . 
ULTRAV IOLET IRRAD IATION 
UV exposure was del i vered to the ventral s urface of mice and to i n -
activate v i rus  pool s .  Two UV bu lbs (General El ectri c G 15T8 , 15 watt )  de­
l i vered 42  ergs/mm2/ s  of exposure when he l d  21 cm above the surface to be 
i rrad iated . 
CHE� 1ICALS AND SOLUTIONS 
Scopol am i n e  was used to inh i b i t  sal i vary secretions when chemical 
carc i nogens were appl i ed to the l i ps.  It was d i l uted wi th steri l e  sal i ne 
to a concentrat ion of 0 . 02 mg/ 0 . 1  ml . M i ce were injected i ntraperi toneal ly  
wi th 0 . 1  ml ( approximately 1 mg/kg of body wei ght)  • .  Thi s produced xerosto-
mia wi th i n  15 m i nutes . vJater bottl es were removed from the cages for the 
four hours fol l o�li ng i njection so that the mouth rema i ned dry . 
3-methyl cho 1 anthrene (3-MC ) and di methyl benzathracene ( or-1BA) were 
d i ssol ved in d i methyl s u l foxi de ( or-1S0)  and used to induce tumors on mouse 
l i ps . Concen trati ons of 3-MC used were 5 ng/appl i cati on and 15 ng/appl i ca­
t ion .  Concentrati ons of OJ·1BA used were 15  ng/appl i cati on and  25 ng/appl i ca-
tion .  
The  tumor promoting agen t ,  12-0-Tetradecanoyl -Phorbol -1 3-Acetate ( TPA) 
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was used i n  both .ill v ivo and � vi tro stud ies .  In  the .ill v ivo studi es , 
10 mg of TPA was d i s sol ved i n  7 ml of DMSO . Ten ul app l i cati ons ( 0 . 02 
umol e )  were del i vered to the r i ght maxi l l ary l i p three times a week (Mon . , 
l�ed . ,  Fr i . ) .  Dur i ng � vi tro exper iments , TPA was used at concentrati ons 
of 1 ug/ml , 0 . 1  ug/ml , 0 . 0 1  ug/ml and 0 .001 ug/ml of medi a .  
Nembu tal and Metophane were used as anes the ti c agents . Nembutal , 
a short acti ng barbi turate , was d i l uted 1 : 10 in steri l e  sal i ne and 0 . 1 ml 
i nj ected i n tra peri toneal l y .  E i ght to ten mi nutes of ane s thesi a resul ted . 
Metophane , an i nhal ati on agen t ,  was del i vered to animal s in a cl osed cham­
ber and prov i ded 3-5 mi nutes of anesthes i a .  
LABIAL I NOCULATION OF t�I CE 
M ice were anestheti zed i n  a cl osed chamber i n  wh i ch the atmosphere 
was satura ted wi th Metophane fumes . Anesthesi a �Ias obtai ned after 5 mi n­
utes i n  thi s envi ronment .  The ri ght max i l l ary l i p of the anes theti zed 
mouse was l i ghtl y  abraded by a s l ow speed dental dri l l  wi th  a stee l brush  
attachment. L i g ht  pressure on the mucosa wi th the dental brush produced 
erythema , but  acti ve b leedi ng was not produced. The abraded l i p  was 
pa i nted w ith  ( i )  a cotton ti pped sti ck moi stened in a v i rus sol uti on 
(approximately 100 ul ) ,  ( i i )  10 ul of chemi cal carci nogen so l ut ion ( 3-MC 
or DMBA ) , or ( i i i )  10 ul  of DI�SO control sol uti on according  to the i nd i ­
v idual exper imental protocol . L i ps were exami ned weekly under 2X magn if i­
cation for herpe t i c  and/or neopl asti c l es i ons . 
TISSUE REMOVAL AND EVALUATION 
At the termination  of the � v ivo experiments , mice were sacri fi ced 
by chl oroform i nh al at ion and cardi ac exsangu i nat i on . Sera were saved for 
neutral i z i ng antibody assays . External macroscopi c eval uat i on was care-
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fu l ly performed to document the presence of l i p  or s k i n  tumors . Autopsy 
was performed whenever lymphadenopathy or organomegaly were present and 
s poradi cal ly  on normal a ppearing mi ce . Photographs of tumors at 1 : 1  magni ­
fication were obtained.  Ster i l e  forceps and sci s sors \'iere used to remove 
l i p tumors . Large l i p  tumors were tri sected and porti ons were treated 
as fol l ows : 
A .  P l aced i n  a ti ssue embeddi ng bag , iden ti fi e d  by mouse 
number , fixed in 10% neutral buffered forma l i n ,  and 
submi tted for h i s to logi c eval uati on wi th hematoxyl i n  
and eos i n  (H&E) sta i n i ng ( see Append ix  I I  for deta i l s ) ;  
B .  Identi fied by mouse numbe r ,  embedded in  frozen secti on 
embeddi ng compound (OTC ) , and '!val uated by i rranuno­
peroxi dase stai ni ng ;  
C .  Expl anted onto a coversl i p  i n  a 60 mm pe tri d ish , 
embedded i n  a p l asma cl o t ,  and cul tured under 
Haymouth ' s  medi a .  
L IGHT M ICROSCOPIC EVALUATION 
Specimens were obtai ned from bi ops ied  l i p  tumors at the ti me the 
mice were sacrif iced . The ti ssue was fi xed i n  10% neutral buffered 
forma l i n  and b l ocked i n  paraffi n  for secti oni ng at 6 mi cron i nterval s .  
Sec ti ons were H&E stai ned and observed for the fo l l owi ng : 
A .  Evidence of v iral  i nfecti on ( bal l ooni ng degenerati on , 
mul tinucl eated g i ant cel l s ,  eosi noph i l i c  nucl ear 
i ncl us i ons ) ;  
B .  Evidence of anapl asi a ( hyperchromatici ty ,  nucl ear or 
cel l u l ar pleomorph i sm ,  i nverse nuc l ear-cytop l asmic 
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rat i o ,  abnormal mi totic f i gures , loss  of pol ar ity or  
an i socytosi s )  ; 
C .  Tumor type ( pap i l l oma , epi thel i a l  dyspl a s i a , squamous 
cel l carci noma ) .  
Other specimens for immunoperoxi dase sta i n i ng were also obtai ned 
from bi ops ied 1 ip tumors . The tissue was embedded i n  OTC and secti oned 
on a cryostat at 6 mi cron i nterval s .  Secti ons were fi xed in acetone for 
10 minutes at room temperature and ai r dried.  Secti ons were i mmunoperoxi ­
dase sta i ned and eval uated for the presence of HSV anti gens . 
L ight  mi croscopy was performed on a Ni kon mi croscope . Photomi cro­
graphs were taken wi th a 35 mm camera uti l i zi ng Ecktachrome f i lm  (ASA 64) . 
PREPARATION OF HYPERH1tlUNE ANTISERA 
Anti sera for the immunoperoxi dase stai n were produced i n  mice , 
hamsters and rabbi ts . For hamster o<;-333 anti sera , each of fi ve adu lt  
hamsters recei ved 1 ml  of an i nocul um containi ng 0 . 5 ml  of compl ete 
Freund ' s  adjuvant and 0 . 5 ml of UV i nacti vated 333.  Fourteen and 28 days 
l ater , the hamsters recei ved 1 ml i nj ecti ons of i nfecti ous 333.  Al l i n­
jecti ons were bi l ateral and gi ven subcutaneously near the popl i teal l ymph 
nodes . Hamster �-tumor anti sera were obtai ned from those hamsters who 
devel oped tumors fol l owi ng injecti on of the transformed hamster cel l 
l i ne 12F# 2 .  Anti sera rai sed i n  rabbi ts i ncl uded �-333 , �-HSV-2 stra i n  
NS , o<.-VP 143 o f  333 , and 0(.-4 hour anti gen of 333 .  Rabbi t 0<.-333 anti sera 
were prepared in  a manner s imi l ar to that used for the hamster �-333 .  
The 333  early four hour anti gen was prepared by infecti ng HEp-2 cel l s  
wi th 333 and harvesti ng the sol ub l e  prote i n  four hours posti nocul ati on . 
Two ml of thi s prepara tion �Ias  injected i n to each of two rabbi ts on days 
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0, 14, 28 and 42 . The i njections were g iVen subcutaneously near the 
popl i teal , axi l l ary and submandi bul ar lymph nodes . Rabbi t  cx.-HSV-2 s tra i n  
M S  anti serum was obtai ned from the Center for D i sease Control . Rabbi t 
cx.-VP 143 anti serum was obtained from Dr.  Guy Cabral . Mouse �-tumor 
anti sera were obtai ned from those ·mice wh ich  devel oped tumors fol lowi ng 
HSV + UV + TPA treatment , and whose neutral i z ing  anti body ti ter was equal 
to or greater than 1 :40 . 
Bl ood was drawn from these ani mal s by cardi ac puncture 14 days after 
the l as t  i mmuni zati on . Serum was separated by centri fugation and stored 
at -20oC .  Optimal  d i l uti ons of anti s era ( 1 : 2  to 1 : 10 )  were determi ned by 
mi croochterolony deoub l e  immunodi ffus ion .  Anti sera were absorbed by i n­
cUbation wi th 108 HEp-2 cel l s /ml of anti serum and/or 103 HEF cel l s/ml for 
one hour at 37oC .  F o  1 1  owi n g  overni g h t  storage i n  the refri gerator , the 
absorpti on wa s  repeated . The supernatant fl u id  col l ected after centri fu­
gation was passed through a 0 .45 mi l l i pore fi l ter. Thi s was the pri mary 
ant i serum for the immunoperoxi dase sta i n .  
mMUNOPEROX IDASE STA I NI NG PROCEDURE 
Demons tration of vi ra l  anti gens i n  cul tured cel l s  or cl i ni cal s pec i-
mens was accompl i shed us ing  the i mmunoperoxi dase stai n a s  descri bed by 
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Delel l i s .  Cover sl i p s , upon wh i ch cel l s  were grown , I'Jere fi xed by : 
( i )  three sal i ne ri nses of 5 min . each , ( i i ) a i r  dryi ng for 30 mi n . , and 
( i i i )  fixa tion  in acetone for 5 mi n .  at room temperature . Biops i ed 
t i s sue specimens were e i ther embedded i n  OTC (for l ater secti oni ng and 
acetone fixa ti on)  or exp l anted for cel l ul ar outgrowth � vi tro on gl ass  
covers l i ps ( for l ater acetone fi xati on ) . 
The s ta i n i ng procedure began wi th a rehydration of the fi xed speci -
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men for 10 m i n .  in 0 . 1 H PBS , pH 7 . 6 . Prima ry anti serum from hamsters , 
rabb its  or mice was fl ooded onto the t i ssue  and i ncubated for 45 m i n .  at 
370C in a humid if ied chamber . Endogenous peroxidase was b locked by a 30 




, and a 30 mi n .  r inse  i n  
a 10% egg a l bumi n .  Al l b l ock ing procedures were performed a t  room temper­
ature. The s pecimens were washed in PBS for 10 m i n .  A second l ayer of 
anti serum , consi sti ng o! a di fferent species ' anti serum aga i ns t  the 
primary antibody , ( e . g .  goat o<.-rabbi t anti body ) vias di l uted 1 :4 in PBS 
and fl ooded onto the gl ass s l i de or cover s l i p .  A 30 mi n .  peri od at 370C 
i n  a hum id if ied env i ronment fol l owed .  I f  the techni que used was two l ayered , 
the anti body for the second l ayer was purchased conj ugated to peroxidase 
(Cappe l l  Incorporated ) ;  if the three l ayer techn ique was used , a thi rd 
anti serum was added after the second incubati on . Thi s thi rd l ayer ( same 
species  as the primary )  cons i s ted of anti-horserad i s h  perox i dase serum 
bound to i ts anti gen (Cappel l I ncorporated ) .  Thi s anti serum was di l uted 
o 
1 : 100 i n  PBS and a pp l i ed for a 30 min . i ncubati on peri od at 37 C .  The 
specimen wa s washed in  PBS for 30 sec. Fol l owi ng the peroxi dase conta i n­
i ng l ayer , the materi al was i ncubated i n  the dark for 10 m i n .  i n  Tr i s  
buffered sal i ne ( pH 7 . 6 ) conta i n i ng 0 . 05% d i ami noben zi di ne a nd 0 . 01% hydro­
gen peroxide .  The  ti ssues were ri nsed i n  d i s ti l l ed water,  dehydrated 
through a series of ethanol s and xylene , and mounted in Permount for obser-
vat i on wi th l ight mi croscopy . 
Necessary control s that \�ere run i n  paral l el i ncl uded known-pos i t i ve 
HSV infected HEp- 2 ,  HEF and Vero cel l s  as we l l  as uninfected HEp-2 and 
HEF cel l s .  Addi tional control s cons i s ted of rep l acing i ndi vidual  anti -
serum l ayers wi th PBS ,  usi ng non-HSV-speci fi c  serum as the primary anti-
serum, and absorbi ng the primary anti serum w ith hi gh ti ter HSV . 
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tl ICRO-TITER ASSAY OF SERUr1 NEUTRAL I Z I NG ANTIBODY 
Sera were obtai ned by card i ac puncture or retroorb i tal p l exus b l eedi ng .  
Fol l owi ng retroorbi tal b l eedi ng , 100 u l  of  bl ood was added to 0 . 45 m l  of  
GLB  (a  1 : 10 d i l u tion  of  serum assumi ng a hematocri t of 50%) . Fol l owing  
c l ot forma ti on , the sera were separated by  cen tri fugati on at 1000 x G for 
10 mi n .  Sera were drawn off and stored at -300C .  Sera were heat i nacti­
vated at  560C for 30 min . and two-fo l d  seri al d i l uti ons ( 1 : 10 to 1 : 320) 
were made in a 96 we l l  p l ate ( Costar , Cambri dge , Mass . ) .  A suspensi on of 
333 conta i n i ng 100 TC I D50 was added to each we l l  and i ncubated at 36
0C for 
one hour. Then , 4 . 0  x 105 Vero cel l s  were added to each we l l  and i ncubated 
for 2-3 days . Necessary control s i ncl uded a h i gh ti ter rabbi t 0<-333 anti -
serum , a normal mouse serum and ce l ls wi thout serum. Hhen 50% of the normal 
mouse serum control we l l s  devel oped cytopath i c  e ffects ( CPE) , the rema i n i ng 
we 11 s were graded for the presence or absence of CPE . The neutral i zi ng 
anti body ti ter of the experimental serum was expressed a s  the reci procal 
of the h i ghest d i l uti on of serum whi ch prevented v i ral  CPE . 
I N  V I TRO TRANSFORr�ATI ON BY UV I NACTIVATED HSV 
A 333 v i rus  i nocul um was exposed to 42  ergs/mm2/ s  of UV l i ght for 
var i ou s  per i ods of time , rang i ng from 0 to 10 mi n .  Al i quoted HEF cel l 
pe l l ets were i nfected wi th the UV i nacti vated 333 at an MOl of 3 and i n­
cubated at 37
0C on a rotary shaker for 1 hour .  Control cel l s  were mixed 
wi th GLB in p lace of v i rus . The cel l s  were then suspended i n  EMEt1 and 
6 
seeded 1 . 1  x 10 cel l s /T-75 fl a s k .  The medi a were changed weekly for two 
weeks . On day 21  postinocu l ati on ,  the experi ment was terminated by ( i )  
p i ck i ng sel ected foci  for subcul turi n g ,  ( i i ) f i xation  i n  acetone and analy­
s i s  by immunoperoxi dase sta i n i n g ,  or ( i i i )  f i xation  i n  10% formal i n ,  sta i n-
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i ng with 0 . 2% Tol ui d ine b l ue and counti ng the number of transformed foc i 
per fl ask . Cel l s  from pi cked foci were analyzed by immunoperoxi dase sta i n-
i ng ,  cel l sorti ng techniques and inocul ation into newborn hamsters .  I n  
l a ter experiments , TPA ( 0 . 1  ug/ml ) was added t o  the media  a t  various 
times , rang i ng from 0 to 96 hours post inocul ati on .  
ONCOGEN I C ITY OF TRANSFORMED HEF 
5 
For oncogen i c i ty testi ng , 5 x 10 cel l s  suspended i n  50 ul of HBSS 
were injected subcutaneous ly  in the interscapu l ar area of newborn hamsters . 
These an imal s were examined weekly for tumor growths . The tumors that 
devel oped were surgi cal l y  removed a nd porti ons expl anted to cel l cul ture 
or fi xed i n  10% forma l i n .  The fi xed ti ssue was exami ned by l i gh t  mi cro­
scopy uti l i z i ng H&E sta i n i ng .  The cel l l i ne gro�m from expl ants was 
analyzed by immunoperoxidase sta in ing .  
PUR IF ICATION AND RAD IOLABELI NG OF  CELL  AND HSV DNA 
In prel iminary studi es , rad i ol abe l ed HEp-2 DNA was prepared by � 
vi tro l abel ing of the cel l s  wi th 3H-Thymid ine ( 10 uc/ml ) for 24 hours . 
The 1 abe 1 ed HEp-2 ce 11 s \'Iere washed , tryps i ni zed , co 1 1  ected in med i um , 
and pel l eted by centrifugati on ( 1500 x G for 10 mi n . ) .  The cel l s  were 
l ysed \�i th 1% SDS and treated wi th Prote i nase K (1 mg/ml ) .  The nucl eic  
acids  "ere extracted three times wi th an equal vol ume of chl oroform : i soamyl ­
al cohol ( 24 : 1 )  and prec i pi tated in 90% ethanol. Fol l O\� i ng treatment wi th 
RNAase , the DNA was extracted aga i n  w ith chl oroform : i soamyl al cohol , pre­
c i p i tated in ice co l d  90% ethanol and resuspended in 0 . 5  ml 1X SSC .  Thi s 
5 - r 
HEp-2 DNA had a n  acti v i ty of 7 . 8  x 10 cpm/ml . In l ater studies , radio-
l abel ed HSV DNA was prepared by ni ck  trans l ati on of  puri fied 333 DNA .  
The 333  DNA was obta i ned by the " H i rt" extraction method descri bed by 
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Rapp. The supernate fracti on was banded twi ce in  an eth i di um bromide-
ces ium chlor ide grad i ant (den s i ty = 1 . 566 g/cm3 ) .  The v i ral DNA band was 
co l l ected and exhausti vely d i alysed agai nst  TNE buffer for 48 hours . DNA 
was prec i pi tated i n  2 vol umes of 90% ethanol and resuspended in IX SSC . 
For ni ck  trans l ati o n ,  100 u l  of 333 DNA was mi xed wi th 25 uc of each of 
the four H3-dNTP i n  100 u l  of 50 mM Tri s-HC1 , pH 7 . 8 ,  5 mM MgC1 2 , 10  mM 
2-mercaptoethanol ( i-1E ) , 50 ug/ml of bovine serum al bumi n .  The reaction , 
154  -8  as  descri bed by Mani ati s ,  was  s tarted by the addi ti on of 10 ug of 
DNAase I and 1 2  uni ts of Dr�A po lymerase 1,  was i ncuba ted at 150C for 1 hour , 
and \�as termi nated by chl oroform : i soamyl al cohol extracti on . The radio-
l abeled 333 DNA was preci pated wi th i ce col d ethanol and resuspended i n  
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0 . 5  ml SSC . I ts acti vi ty was 5 . 8  x 10 cpm/m1 . 
I N  S ITU HYBR I D I ZATI ON 
The methods used to l ocal i ze v i ral  transcri pts by � s i tu hybri d i za-
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t ion  were s i m i l ar to those descri bed by Bra h i c .  Un infected H Ep-2 , 333 
infected HEp-2 , and 333-8-9 cel l s  were grown on aci d cl eaned microscope 
sl ides and prepared for hybrid i zat i on as control s .  The sl ides were rehy-. 
drated i n  PBS and fi xed for 20 mi n .  i n  ethanol /aceti c ac i d  ( 3 : 1 ) .  They 
were treated wi th 0 . 2  M HCl  for 20 mi n . , 300 nt·l NaC l /30 rrM Na-ci trate ' for 
30 mi n .  at  700 C and 10 mM Tri s HC 1/2  mM CaC12/ 1  ug Protei nase K/ml for 
15  m i n .  at 370C .  These treatments were i n terspersed wi th d i s ti l l ed water 
ri nses and termi nated by dehydration  in a series of 70% and 95% ethanol 
ri nses . 
The hybridi zat ion  med i um contai ned the rad i ol abe l ed DNA i n  a sol u­
ti on of 40% formami de , 10  rrM Tri s  HC1 , 1 nN EDTA , 600 rn/>1 NaC l , 0 . 02% 
(wt/vol ) Ficol l ,  0 .02% pol yv i nyl pyrrol i done and 1 mg of bovi ne serum 
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a l bumin/ml . Thi s hybridi zati on mi xture was heated to 1000C for 20 sec.  
and immediately cool ed to OOC .  F ifty u l  were used to cover each cyto­
l og i cal  preparation wh i ch was then covered wi th a gl ass cover s l i p .  The 
hybr i d i zation chamber cons i s ted of a 150 mm petri di sh  whose bottom was 
covered wi th 2X SSC .  The hybri d i zi ng s l i des were on a stage above th i s  
sol uti on and mai ntai ned a t  280C for 6 0  hours . Fol l owing  hybri di zati on , 
the s l i des were washed twi ce i n  chl oroform and bti ce i n  50% formamide/10 
rrM Tri s  HC1/l ml-1 EDTA/ and 600 mM NaCl for 5 min . .  eac h .  Extensi ve 
wash i ng for the next 24 hours uti l i zi ng  the same buffer preceded two 
5 mi n .  ri nses in  300 nt·1 NaCl /30 rrM r�a-ci trate . Thi s 11as fol l o�led by de­
hydration i n  70% and 90% ethano l . The s l i des were then d ipped i n  a 450C 
sol u ti on of 1 part Koda k  NTB-3 nucl ear track emul s ion  and 3 parts of 
400 m�1 ammoni um acetate . The s l i des were al l owed to dry i n  the upri ght 
po si tion and were transferred to a desi ccator for storage in the dark at 
40 C .  After the appropri ate exposure time ( 6-8 days ) ,  the s l i des were 
deve l oped in Dektol devel oper for 2 mi n . , ri nsed i n  d i s ti l l ed water and 
fi xed in 30% sod ium th iosul fate , After wash i ng i n  water , the s l i des 
were counters tai ned wi th Tol u id ine  b l ue ( 0 .2% i n  60% ethanol ) for 1 hou r .  
The sl i des were dehydrated in  9 5 %  ethanol and a coversl i p  was a ppl i ed 
wi th Permount.  The s l i des were then exami ned and photographed us i ng a 
N i kon l i ght mi croscope . 
TWO-D IMENSI ONAL GEL ELECTROPHORESIS 
Radi ol abe l ed sol ub le  cel l protei ns were anal yzed by two 6 imensi onal 
( 2-D ) gel el ectrophores i s .  333-8-9 cel l s  under variou s  concentrati ons of 
TPA ( 0 . 0  ug/ml , 1 . 0  ug/ml , 0 . 1  ug/ml , 0 . 0 1  ug/ml , 0 . 001  ug/ml ) a nd HEF 
cel l s  were cul tured i n  60 mm petri di shes wi th S35 meth ion i ne ( 20 uc/ml ) .  
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Fol l owi ng i ncubation for 48 hours , the ce l l s  were ri nsed wi th di s ti l l ed 
water and - treated wi th 100 ul of lysi s buffer ( 9 . 5  M urea , 5% ME , 2% NP-40 , 
2% amphol i nes pH 3-10) . The protei n concentrati on �/as approximately 100 , 000 
cpm/ug of protei n as  determi ned by the recently descri bed Bern l ohr method . 156 
The rad iol abe l ed protei ns i n  l ys i s  buffer were co l l ected and stored at -70oe .  
The 2-D gel e l ectrophoreti c procedure used was s i mi l ar to that de-
1 57 scri bed by O ' Farrel l .  For the fi rst dimens i on ,  i soel ectri c focusi n g  
( rEF )  gel s were prepared i n  gl ass tubes wi th a n  overal l l ength o f  1 3  cm 
and an i n ternal di ameter of 2 . 5  mm. The gel mi xture cons i s ted of 5 . 5 gm 
urea , 1 . 33 ml of acrylamide stock ( 29 . 2% acrylamide , 0 .8% bi s in 100 ml 
of dei oni zed water ) , 2 . 0  ml of NP-40 , 1 . 95 ml of water and 0 . 5  ml of 
amphol i nes ( 0 . 4  ml of pH 5-7 , 0 . 1  ml of pH 3-10 for equ i l ibri um condi ti ons ) 
( 0 . 5  ml of pH 3-10 for nonequi l i bri um condi tions ) . The mi xture was swi rl ed 
in a 370 water bath and degased under negati ve pressure .  TEt-1ED and ammoni um 
persul fate (5 ul and 10 ul , respecti vely)  �!ere added . The ge l mi xture 
was poured i n to each glass tube and polymeri zed for one hour. The gl ass 
tubes were then loaded i nto an e lectrophoreti c chamber wi th the l ower 
chamber ( pos i ti ve termi nal ) f i l l ed wi th 10 �� H3P04 and the upper chamber 
( negative termi nal ) wi th 20 mM NaO H .  The gel s  were prerun for 15 mi n .  
a t  100 V ,  3 0  mi n .  at 300 V ,  and 3 0  mi n .  at 400 V .  For nonequi l i bri um 
cond i ti ons , the termi nal s and buffers were reversed and the gel s  were 
not prerun .  Three sets o f  2-D ge l s  were performed o n  e ach protei n samp l e , 
namely : ( i )  25 ul of samp l e  per gel under equi l i bri um cond i ti ons , ( i i ) 
145 ,960 cpm of sampl e per gel under equi l i bri um condi ti ons , and ( i i i )  
145 ,960 cpm of sampl e  per gel under noneq ui l i bri um condi ti ons . rEF was 
performed for 18 hours at 300 V for equi l i bri um cond i ti ons and 3 hours 
at 400 V for nonequi l i bri um conditi ons . Fol l owi ng thi s ,  each gl ass tube 
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was removed and the gel extruded by ai r pressure . Each ge l was pl aced 
in a 15 ml tube and covered wi th 5 ml of SOS samp l e  buffer { 2 . 3% SOS , 
5% ME , 10% glycerol and 62 . 5  mM Tr i s-HC1 , pH 6 . 8 } . rEF  gel s were stored 
at -70
oC unti l the - 2-D gel s  were run . 
The 2-D protein  separation was performed by e l ecrophores i s  i n  an ex­
ponenti al 7% to 20% 50S-polyacryl ami de gradient { 5 0S-PAGE } . The gradient  
was made wi th a gradient ma ker contain i ng 5 m l  of dense gel  sol uti on i n  
the contant s ide a n d  1 6  m l  o f  l i ght g e l  sol uti on i n  the i nconstant s i de . 
The dense gel sol uti on { 20%} contai ned 2 . 0  ml l ower gel buffer ,  5 . 3  ml 
acry l am ide stock , 0 . 7  ml 75% glycerol , 15 ul ammoni um persul fate and 4 u l  
TEMEO . The l i ght gel sol ution { 7% }  contai ned 4 . 0  m l  lower gel buffe r ,  
3 . 73 m l  acryl ami de stoc k , 8. 27 m l  dei oni zed wate r ,  25  u l  of ammoni um per­
sul fate and 8 ul TEMEO .  Fl u ids  �,ere pumped from the gradient maker by an 
automati c pumpi ng devi ce at a fl ow rate of 3 ml/mi n .  i nto a s l ab gel appa­
ratus { 0 . 75 mm x 15 cm x 14 cm} . After overni gh t  polymeri zati on , a stack­
i ng gel was l ayered on top .  The s tacki ng gel sol ution contai ned 1 . 25 ml 
stacki ng gel buffer { 0 . 4% 505 , 0 . 5  M Tr i s -HC1 , pH 6 .8 } , 0 . 7 5  ml acryl ami de 
stoc k , 3 ml water , 15 ul ammoni um persul fate and 5 u l  TEMEO.  The stack ing  
ge l  polymerized for one h our . 11eanwhi l e ,  the cyl i ndri ca l rEF  ge l  was 
equ i l ibrated in fresh 505 sampl e buffer for one hour. Mel ted 1% agarose 
was added to the top of the stacking  ge l and the rEF gel pl aced hor i zontal ­
ly i n  i t . The a pparatus was then connected to the power source . Each gel 
was run at 20 rnA constant current for approxi mately 2 � hours at 200 C unti l 
the track i ng dye reached the bottom of the s lab  gel . The ge l s  were sepa­
rated from the apparatu s ,  fi xed , stai ned , dryed and autoradi ographed on 
Kodak XR- l f i l m .  The autoradi ographs from the indi vi dual samp les were 
then compared wi th one another for quanti tati ve and qual i tati ve di fferences . 
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CELL SORTER ANALYSIS 
6 
For cel l sorter analys i s ,  10 cel l s/sampl e were harvested and washed 
i n  Ca Mg free PBS . The cel l s  were pe l l eted by centri fugation and resus­
pended i n  3 ml of  PBS .  Whi l e  vortexi ng , 7 m l  of 100% ethanol was added.  
Thi s 10 ml cel l suspens ion  was used for cel l sorter analys i s .  
The analys i s  i nvol ved quanti tati ve fl uorescent sta i ni ng of the cel l u ­
l ar DNA a nd rapi d analys i s o f  the fl uorescence emi s s i on s i gnal obtai ned 
as each ce l l  traversed a l aser beam. Thi s techn i que has been presented i n  
158 
deta i l  by Cri ssma n .  The cel l suspension  was centri fuged , washed i n  
PBS a n d  resuspended i n  4 . 5  m l  P B S  conta i n i ng 1 0  ug/ml of RNAase . I ncuba­
o 
tion at 37 C progressed for 30 m i n .  The cel l s  I'Jere then centri fuged , 
- 5  
washed i n  5 ml PBS and i ncubated for 30 min . i n  5 m l  of 6 . 9 x 1 0  M pro-
p id ium i odi de/3 . 8  x 10
-2 
t·, Na-ci trate . The cel l s  were then centri fuged , 
washed , resuspended i n  PBS , f i l tered through a 74 um fi l ter and i ntroduced 
i nto the cel l sorter. The fl ow chamber al l owed cel l s  to proceed at a rate 
of 1000 cel l s/ s  past el ectrical and opti cal sensors that measured the 
cel l vol ume and fl uorescence . Passage through a 75 um d i ameter ori fi ce 
produced an e 1 ectri c s i gnal wh i ch was proporti ona 1 to the cel l vol ume . 
Passage through a l aser beam exci ted the propi d i um i od i de s tained DM and 
the emi tted fl uorescence was measured , ampl i fied  and d i sp l ayed as h i s tograms 
uti l i z i ng a mul ti channel pu l se he i ght analyzer. The h i stograms were bi ­
modal : the peak on the l eft represented cel l s  i n  G1 phase , the peak wi th 
twi ce the DNA content of G1cel l s  represented cel l s  i n  G2 + M phase , and 
d i str ibuted between the two peaks �Jere cel l s  i n  S phase wi th varyi ng  degrees 
of DNA repl i cation compl eted . The number of cel l s  i n  G2 + �1 phase for each 
of the submi tted samp les were compared wi th one another for s i gn i fi cant 
di fference s . 
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STATISTICAL EVALUATI ON OF DATA 
Chi -square test wi th Yate ' s  correction factor and Student ' s  t tes t 
were empl oyed where appl i cab le  to analyze the data . Serum neutral i zi ng  
anti body ti ters from control , tumor beari ng and  non-tumor bearing  mi ce 




I NDUCTION OF LAB IAL HERPETI C LESI ONS 
S i nce i nfecti ous HSV has been i dent ified  i n  some h uman tumors and 
i nd irect ev idence has i nferred an etiol og i c  ro l e  for HSV in the devel op-
ment of squamous ce l l  carc i n omas , the i ni ti al phases of th i s  project were 
desi gned to devel op a sui tab l e  ani mal  model for i nduc i ng herpeti c l e s i ons . 
The max i l l ary l i p of a mouse was chosen as the s i te for i nfecti on due to 
i ts anal ogy to h uman herpes l ab i al i s ,  i ts access to top i cal app l i cati on 
of UV l i gh t  or chemi cal s ,  and i ts prior use by K itce s ,  et al . ,  in th i s  
27  
l aboratory . Abraded ri ght max i l l ary l i ps of mal e  BALB/c mi ce were i n -
fected wi th the 333 strai n o f  HSV-2 ( 333) . Vesi c les  devel oped a t  the 
inocul ati on s i te 2-3 days l ater. These ves i cl es soon ruptured and 
formed ul cers ( Fi g .  Ia ) .  By the tenth to s i xteenth day , these les i ons 
had heal ed and rega i ned normal macroscop i c  and mi croscopi c appearance.  
H i s topathol ogi c features of herpeti c l i p l es i ons i ncl ude fl u id  
fi l l ed ves i cl es surrounded by mul ti nucleated gi ant cel l s  and  an  i n tense 
i nfl ammatory i nfi l trate ( F i g .  Ib ) .  M icroscopi c exami nati on wi th h i gher 
magni fi ca ti on reveal ed bal l ooni ng degenerati on wi th i n  many of the Tzanck 
cel l s .  The presence of HSV anti gens \�i thi n  the herpeti c l i p l es i ons was 
shown by i mmunoperox idase sta in i ng of cryostat secti ons u s i ng rabb i t  �-333 
antiserum as the primary serum ( F i g .  Ic ) .  The major i ty of the HSV anti gens 
were l ocated wi thi n  the surface epi thel ia l  cel l s ;  h owever , pos i ti ve stai n-
i ng �Ias often ev ident al ong the hai r shaft epi the l i um and wi thi n  the seba­
ceous g l ands . Al so ,  when vari ous groups of mi ce between 5 and 8 wks of age 
( 16 to 100 mi ce/group )  were i nocul ated wi th HSV , the i nci dence of herpet ic  
1 esi  ons  var ied wi th the t i ter of the i nocul um , rangi ng  from 60% to  100% as  
ti ters i ncreased from 1 x 106 PFU/ml to  1 .  3 x  107 PFU/ml ( Tab 1 e 1 ) .  Th ; s 
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ti ter-related fi ndi ng i s  not due to an age rel ated factor si nce i t  has 
prev iou�ly been shown in this l aboratory that 5 wk. old mice devel op a 
h i gher inc idence of l es i ons than 8 wk.  o l d  m ice  when i noculated wi th 
identi cal vi rus preparati ons.  
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FI GURE 1 
Macroscopi c and mi croscopi c pathol ogy of HSV-2 i nduced l i p l es i ons .  The 
r ight  maxi l l ary l i p  of a 5 week ol d mal e BALBlc mouse was i nocul ated wi th 
HSV-2 as described in Tab l e  1 .  
( a )  W ith i n  5 days , a vesi cular u l cerati ve l es ion  appeared on 
the l i p .  
( b )  M icroscopi c exami nati on o f  hematoxyl i n  and eos i n  stai ned 
paraffi n embedded sections reveal ed an i n traepi the l i al 
ves i c l e  surrounded by i nfl ammatory cel l s  (40X magn i f ication ) . 
( c )  Microscopi c exami nation of immunoperoxi dase stai ned cryostat 
secti ons showed the presence of HSV anti gens wi thi n the 
epi thel i um and al ong the hai r shafts (40X magni fi cati on ) .  
.. -· 1 
• F ] G I IRE  1 
a .  
b .  
c .  
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F IGURE 1 ( conti nued) 









. c HSV T l ter ( PFU/ml ) 
6 
1 . 0  x 10 
6 
3 . 9  x 10 
6 
5 . 0 x 10 
6 
5 .0 x 10 
7 
1. 3 x 10 
Mi ce wi th 
Herpetic L i p  Lea ions/ 
Total M ice 
12/20 ( 60 )  
99/100 ( 99 )  
16/ 16 ( 100) 
74/75 ( 99 )  
36/37 (97 )  
a .  �1al e BALB/c mice were i nfected o n  the abraded ri ght maxi l l ary l i p wi th approxi amtely  100 ul  o f  a 
HSV-2 stra i n  333 sol ution .  
b .  Age of the mice when i nfected wi th HSV . 
c .  Titer of virus pool used to i nocul ate the mouse . 
d .  Each animal was eval uated 5 days postinocul ation wi th a 2x scope for the presence of  herpetic l i p 





S ince recurrent herpes l abi al i s  has  been associ ated wi th the onset 
of squamous ce l l  carci noma of the l i p  i n  humans , attempts were made to 
reinfect mouse l i ps wi th HSV . Repeated rei nfecti on was desi gned to 
mimi c recurrent HSV i nfection  i n  humans s i n ce no recurrent HSV model i n  
m i ce exi sts . Repeated appl i cati ons of i nfecti ous v i rus to the same 
si te on the mouse ' s  l i p  fa i l ed to i nduce tumors ( Tab l e  2 ) . In fact , 
when mice were rei nfected wi th HSV-l or HSV-2 , the i nci dence of herpeti c 
l i p l es i ons decreased wi th subsequen t  i nocul ati ons . Al so , the sever i ty 
of l es i ons and the duration  before heal i ng decreased .  The apparent 
immunol og i c  protecti on fol l owi ng pri mary i n fecti on was further shown by 
the fa i l ure to devel op herpe ti c  l i p  l esi ons on the l eft maxi l l ary l i p  
after three i nfecti ons on the ri gh t  maxi l l ary l i p ( Tab l e  2 ) . 
CHEM ICAL CARC I NOGENS AND ULTRAV IOLET I RRADIATION AS TUMOR INDUCERS 
S i ng l e  or mul tipl e l ab i al i nfecti ons of mi ce wi th HSV fai l ed to 
i nduce 1 i p  tumors in our model . Howeve r ,  the poss i bi l i ty exi sts that 
HSV may act as a cocarci nogen in concert wi th known chemi cal or envi ron­
mental agents . In the next seri e s  of experi ments , model s for the i nduc­
tion of l ab i al tumors by chemi cal carci nogens or u l trav i o l et i rradi ati on 
were i nves ti gated. These model s were desi gned for eventual use wi th 
concomi tant HSV infect ion  i n  order to dete rmi ne i f  HSV pl us carci nogen 
cou l d  ( i )  act synerg i s ti cal l y  to i n crease tumor y ie l d ,  or ( i i )  effect 
the l atent peri od of tumor emergence . Thus , dosages and exposure proto­
col s for carc i nogen appl i cat ion were varied  i n  order to determine whi ch 
protocol woul d al l ow HSV superi mposed i n fecti on to express i ts e ffect .  
I n  one ser i es of exper iments , 3-r·lethyl chol anthrene ( 3-MC ) , a pol y­
cycl i c  hydrocarbon ,  was appl i ed to abraded mouse  l i ps i n  two d i fferent 
TABLE 2 EFFECT OF REPEATED INOCULATIONS WITH HSV ON THE INCIDENCE OF LABIAL HERPETIC LES IONS 
% Mice Wi th Herpetic Lip Les ionsa 
Viru s  
Inocu l um 
1st 2nd 3rd 4th % Mice Iji th 








3 x 10 
7 
3 x 10 
6 














a .  Each an imal was eval uated 5 days posti nocul ati on wi th a 2 x  scope for the presence o f  herpeti c l i p 
l esi ons on the most recent i nocul ation si te .  
b .  Ten mal e  BALB/c mi ce ( 6  wks . of age) were i nfected on the abraded ri ght maxi l l ary l i p  wi th approxi­
mately 100 ul of a v irus sol ution on each of the fi rst three occasi ons . The fourth i nocul ation was 
del ivered to the abraded l eft maxi l l ary l i p .  The consecuti ve treatments were 4 ,  6 and 4 wks .  apart 
respectively .  
c .  Same protocol as  " b" above . The fourth i noculation was del i vered to the abraded r ight  maxi l l ary 
l ip .  
d .  Twenty mal e BALB/c mi ce ( 5  wks . of  age) were i nfected on  the abraded right maxi l l ary l i p  wi th 
approximately 100 u l  of a vi rus sol ution on both occas i ons . The second i nocul ati on fo l l owed 
the first by 23 wks .  
e .  Each animal was eval uated wi th a 2 x  scope for the presence o f  tumors 34-40 wks . after the first 





concentrations for one to si x app l i cati ons ( Tab l e  3 ) . Twenty-fi ve weeks 
after 3-MC appl i cati on ,  tumors had fa i led to appear.  Apparently,  these 
concentrati ons and/or appl i cation frequencies were not enough to act as 
i n i ti ators and promoters . Consequently , a more potent carcinogen , dimethyl � 
benzanthracene (DMBA) , was used i n  the next seri es of experi ments . DMBA , 
al so a pol ycycl i c  hydrocarbon , was appl ied  to abraded mouse l i ps i n  two 
different  concentrations for one to thi rty app l i cati ons ( Tabl e  4) . The 
lower concentration of DNBA ( 15 ng/app l i cation)  fa i l ed to i nduce tumors 
when appl ied from 1 to 10 times . However ,  at a h i gher concentrati on and 
wi th more frequent app l i cations , tumors began to emerge 5 weeks after 
cessati on of DMBA appl i cati o n .  Subsequently , these tumors grew t o  gro­
tesque s i zes ( F i g .  2 ) .  The inc idence of tumors i ncreased as the number 
of a ppl i cati ons increased . From these data , i t  was determi ned that DMBA 
appl i cati on for 3 ,  4 or 5 weeks woul d res u l t  i n  a tumor yi el d ( 1 1 . 75 , 
18 . 8 ,  40 . 0% respecti vely) that �!ould permi t the effect of concomi tant  HSV 
i nfection  to be effectively measured. Thus , these regimens were used i n  
l a ter studies comb i n i ng HSV i nfecti on pri or to and during  DMBA app l i cati on . 
U l trav i ol et ( UV )  i rradi ation , often associ ated wi th cl in i cal reacti va-
tion of herpes l abi al i s  and the deve l opment of l i p cancer i n  humans , was 
investi gated in another series of experiments . A group of 10 BALB/c ma l e  
mice ( 6  wks . of age ) were anestheti zed , abraded on the right maxi l l ary 
l i p ,  and exposed on thei r ventral surface to s i x  mi nutes of UV- i rrad i ati on 
2 
at 42 ergs/mm I s .  S ix  weeks l ater the procedure was once aga i n  repeated . 
Another group of 19 BALB/c mal e mice ( 5  wks .  of age) were then exposed to 
the UV- irrad i ation da i ly for 7 days . Dai ly exposure ( 6  mi nutes at 42 ergs/ 
mm
2/ s )  for 7 days was once aga i n  repeated 23  weeks l a ter. I n  both experi -
ments , tumors fa i l ed to devel op and the l i ps retai ned thei r normal appearance . 
a 
TABLE 3 RESPONSE OF '·1ICE TO SUBCARC INOGENIC  DOSAGES OF 3-METHYLCHOLANTHRENE 
CONCENTRATION ANIMALS 
OF 3-MC/ IN NUMBER OF b LATENTc MICE WITH TUMORS/ % MICE WIJH 
APPLICATION GROUP APPLICATIONS PERIOD SURVIV ING MICE TUt10RS 
5 ng 7 0/7 0 
15 ng 10 0/ 10 0 
15 ng 10 2 0/9 0 
15 ng 10 3 0/10 0 
15 ng . 10 6 0/8 0 
Dt-1S0 sham 10 6 0/9 0 
a .  Five wk. old mal e  ICR mi ce were used i n  al l groups except the fi rs t ( 5  ng ) ,  where BALB/c mice 
were used. Each anestheti zed mouse recei ved 10 u l  of 3-Methychol anthrene ( 3-MC ) i n  DMSO on 
the l i ghtly abraded right maxi l l ary l i p .  
b .  Frequency of appl i cati on a s  fol l ows : 2 (days 0 ,  12 ) ;  3 (days 0 ,  7 ,  14) ; 6 (days 0 ,  2 , 4 , 7 ,  
9 ,  1 1 ) .  
c . Average time span unti l emergence of cl i ni ca l l y  evident tumors . 
d .  Each animal was eva l uated weekly with a 2X scope and then graded for the presence o f  tumors 




TABLE 4 INDUCTION OF L I P  TUNORS I N  MI CE FOLLOWING DIMETHYLBENZANTHRACENE APPLICATIOl 
CONCENTRATION 
OF DMBA/ ANHIALS Nut·mER OF b LATENTc HI CE WITH TUM�S % MICE WITH 
APPL ICATION IN GROUP APPL I CATIONS PERIOD SURVIV ING MIC TUMORSe 
15 ng 10 1 0/ 10 0 
15 ng 10 2 0/10 0 
15 ng 10 3 0/ 10 0 
15 ng 10 6 0/ 10 0 
15 ng 10 10 0/8 0 
25 ng 18 15  7 wks 2/16 ( 1 ) ( 1 )  1 2 . 5  I U1 ...... 
I 
25 ng 24 15  6 wks 2/ 18 ( 0 ) ( 2) 1 1 . 0  
2 5  ng 18 20 6 wks 3/16 ( 1 ) ( 2 )  18 . 8  
2 5  ng 18 25 5 wks 4/10 ( 1 ) ( 3 )  40 . 0  
2 5  ng 100 25 6 wks 32/80 ( 10 ) ( 22 )  40 . 0  
2 5  ng 18 30 7 \�ks 7/14 ( 2 ) ( 5 )  50 . 0  
DMSO SHM1 18 30 0/ 16 0 
SAL INE CONTROL 10 12 0/ 10 0 
a .  Five wk. ol d BALBlc mi ce were used i n  al l groups except the 15 ngldose studies where 
ICR mice were used.  Each anestheti zed ani mal recei ved 10 ul  of di methyl benzanthracene 
(DMBA) in OI"SO on the l i ghtly abraded ri ght maxi l l ary l i p .  
b .  Frequency o f  appl i cati on a s  fol l ows : 2 ( days 0 ,  12) ; 3 ( days 0 ,  7 ,  14) ; 6 (days 0 ,  2 ,  
4 , 7 , 9 , 1 1 ) ;  10 (Mon . -Fri . for 2 I'Iks . ) ;  1 2  (Mon . ,  Wed . , Fri . for 4 wks . ) ;  1 5  (Mon . -Fri . 
for 3 wks . ) ;  20 (Mori .  -Fri . for 4 wks . ) ; 25 ( �lon . -Fri . .  for 5 wks . ) ;  30 U'lon .  -Fri . for 
6 wks . ) .  
c .  Average time span unti l emergence of  cl ini ca l l y  evi dent tumors . 
d .  Hi stol og i c  determi nation o f  tumor type : number \'Ii thi n fi rst parentheses represents 
# of papi l l omas ; number wi thi n  second parentheses represents # of squamous cel l  
carci nomas . 
e.  Each animal was eva l uated weekly wi th a 2X scope and then graded for the presence 






Hacroscopi c and m icroscopi c pathol ogy of Dr1BA induced l i p l es i ons . The 
right  maxi l l ary l i ps of 5 week old mal e BALB/c mi ce were repeatedly 
i nocu l ated ( 25 times ) wi th DHBA as descri bed in Tab l e  4. 
( a )  \�i th i n  7 weeks an exophyti c tumor appeared on the l i p .  
( b )  By the termi nation of the experiment ,  20 weeks after D�IBA 
appl i cation , many of the tumors had grown to appreci ab l e  
s ize .  
( c )  Mi croscopi c exami nation o f  hematoxy l i n  and eos i n  s ta i ned 
paraffin embedded secti ons reveal ed mal i gnant i nvasi ve 
squamous epi the l i al cel l s  ( 20X magni fi cation ) .  
D i agnos i s :  Squamous  Cel l Carc i noma 
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FIGURE 2 
a .  
b .  
c .  
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F IGURE 2 ( conti nued) 
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CONCOMITANT HSV INFECTION AND DMBA APPLI CATION 
Due to the l ack of tumor emergence when HSV was used al one and i n  
order to i nvesti gate poss i bl e  synerg ism ,  the effect of HSV infecti on 
accompany ing DMBA appl i cation was i n vesti gated i n  several groups of mi ce . 
I n  two d ifferent experiments , HSV was i nocul a ted prior to DMSA appl i cation .  
When HSV i nfecti on �/as i n i ti ated two days before the appl i cati on of a 2 . 5% 
DMBA sol uti on fi ve days a week for four weeks , 6% of the animal s devel oped 
tumors by the termi nati on of the experiment at 22 weeks (Tabl e 5 ) . Al ­
though from d i fferent stud i es ,  a compari son  of these data to that of a four  
week appl i cation of DMBA al one (Tab l e  4 )  ( 6%  and  18 . 8% ,  respecti vely ) shows 
that HSV i nfection did not cause an i ncrease in tumor inc idence .  I n  another 
experiment , when a 2 . 5% m1BA sol uti on was appl ied  to the l i ps of mi ce da i ly 
for a per i od of fi ve weeks , the i nc idence of tumors at 20 weeks was no 
di fferent ( p = . 06 )  between that group vlhi ch was i nfected wi th HSV on the 
1 ip two days pr i or to the ini ti ati on of Di'lBA appl i cations and the other 
group that recei ved no vi rus i nocu l ati on ( Tab l e  6 ) . The percentages of 
an imal s wi th papillomas as compared to those wi th squamous ce l l  carci nomas 
vari ed a l i tt l e  but not s ign if icantly ( p = J) . 
Si nce HSV infection pri or to DMBA appl i cati on fa i l ed to i ncrease 
the tumor yi e l d ,  HSV infecti on during the actual DMBA appl i cation peri od 
was i nvesti gated. A decrease in tumor inci dence was seen when HSV i nfec­
tion was superimposed on  day 5 , 1 2 ,  and  19 after the i n i tiati on of  the 2 1  
day Di1BA appl i cation period (Tab l e  7 ) , ho�/ever i t  was not stati stical ly  
s i gn ifi cant (p = . 14 ) . El even percent of the mi ce recei ving DMBIl. devel ­
oped squamous cel l carcinomas ; whereas , those mi ce \·li th superimposed HSV 
i nfecti ons fa i l ed to show tumors . It was impossi b l e  to eval uate for the 
presence typi cal ves i cul ar-ul cerat i ve herpeti c l es i ons after inocu l ati on 
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TABLE 5 INDUCTION OF L I P  TUt�ORS I N  MICE  FOLLOH I NG HSV INFECTION PRIOR 
TO THE APPLICATI ON OF DMBA FOR 4 WEEKsa 
GROUP 
% MICE WITH HE�PETI C 
LESIONS 
t1I CE \HTH TUMORS/ 
M ICE  SURVIV I NGc 






0/16 ( 0 )  ( 0 )  




a .  Both groups rece i ved 100 ul of a 5 x 10 PFU/ml 333 sol uti on to the 
r ight  maxi l l ary l i p . Two days l a ter , 10 ul of 2 . 5% DI�BA or DI�SO was 
appl i ed to the right maxi l l ary l i p of 7 wk . o l d  BALB/c ma l e  mi ce 
( 16 i n  control group ; 75 in experimental group) 5 days wk . for 4 wks .  
b .  Each an imal  was eval uated 5 days posti nocul ati on wi th a 2 X  scope . 
c .  H i stol ogi c determi nati on of tumor type : number wi thi n first parenthe­
ses ' represents # of papi l l omas ; number wi thi n second parentheses re­
presents # of squamous cel l carc i noma s . 
d .  Each an i mal was eval uated Itleekly wi th a 2X scope a n d  then graded for 
the presence of tumors 22 wks . after DMBA appl i cati on . 
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TABLE 6 I NDUCTION OF L IP  TUr�ORS I N  mCE  FOLLOIH NG HSV I NFECTION PRIOR TO 
THE APPLICATION OF DMBA FOR 5 HEEKSd 
HSV I NOCULA­
TION GROU P 
Uni nfected 
Infected 




MI CE  14I TH TUr�ORS/ 
M ICE  SURVIV IN(JC 
32/80 ( 10 ) ( 2 2 )  
29/7 1 (8 ) ( 21 )  





a .  The i nfected group recei ved 100 ul of 3 . 9  x 10 PFU/ml 333 sol uti on to 
the r i ght maxi l l ary l i p .  Two days l ater , both groups recei ved 1 0  u l  of 
2 . 5% DMBA appl i cation to the right maxi l l ary l i p of 8 wk . o ld  BALB/c 
mal e  mi ce ( 100 mi ce per group ) . 
b .  Each animal  was eval uated 5 days postinocul ati on wi th a 2 X  scope . 
c .  H i s tol ogi c determi nati on o f  tumor type : number wi thi n  fi rst parenthe­
ses represents # of papi l l omas ;  number \�i thi n the second parentheses 
represents # of squamous cel l carci nomas . 
d.  Each animal was eva l uated week ly  wi th a 2X scope and then graded for 
the presence of tumors 15 wks . after Df.1BA app l i cation.  
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TABLE 7 I NDUCTI ON OF TUMORS , I N  NICE  FOLLOH I NG APPL I CAT ION OF DMBA AND 
SU PERI I4POSED HSV I NFECTI ONd 
HSV I NOCULA- M I CE \�I TH TU�10RS/ % �lI C E  WITH 
n ON GROUP SURV I V I NG 14I CEb TUMORSc . 
No Inocu l a t i on 2/ 18 ( 2 )  1 1% 
Day 5 I nocul ati on 0/ 19 0% 
Day 12 I nocul ation 0/16 0% 
Day 19 I nocu l at i on 0/ 15 0% 
a . All grou ps recei ved 10 u 1 of 2 . 5 % m·1BA , 5 days /wk . for 3 wks . to the 
abraded ri ght  maxi l l ary l i p of 6 -wk . ol d mal e  BALB/c mi ce �24 mi ce per 
group) . I n  add i ti on , 3 groups recei ved 100 u l  of a I - x 10 PFU/ml 333 
sol ut ion to the same s i te on the i ndi cated day after carci nogen appl i ­
cati on i ni ti ati on .  
b .  H i s tol og i c  determi nati on of  tumor type : number wi th i n  parenthesi s 
represents # of squamous cel l carc inomas . 
c .  Each anima l  was eval uated weekly wi th a 2X scope and then graded for 
the presence of tumors 20 �ks . after DNBA appl i cati on . 
-66-
because the l i ps had al ready been made erythematous , ha irl ess , swol l en a nd 
ul cerated by repeated DMBA appl i cations . However , a t  the termi nati on of 
th i s  study , serum was obta ined from HSV i nfected animal s and shown to con­
tai n  neutra l i z ing anti bodies  di rected agai nst HSV . Thus , HSV i nfecti on  
i ni ti ated prior to  or during the m'IBA appl i cati on peri od d id  not  i ncrease 
the tumor yi e ld , shorten the l a tent peri od , or c hange the papi l l oma to 
squamous ce l l  carci noma ratio . 
CONCOM ITANT HSV I NFECTION AND PHYSI CAL I RRITATION 
Phys i cal i rri tati on is often l i sted as a contri b uti ng factor to the 
in i ti ati on of the neop l asti c  process . In addi ti on , trauma often precedes 
the l es i ons of herpes l abi al i s  i n  humans . Thu s ,  abrasi on was i n vesti gated 
in conjuncti on wi th HSV infecti on . 
Fou r  weeks after HSV infecti on , the ri ght maxi l l ary l i ps of mi ce 
were l i ghtl y abraded by a s l ow speed dental handpi ece wi th a steel brush 
attachment.  Thi s abrasi on was once aga i n  repeated six weeks l ater. Hhen 
the experiment was terminated 34 weeks posti nfecti o n ,  none of the anima l s  
had devel oped l i p  tumors ( Tab l e  8 ,  Groups 3 & 4) . I n  a paral le l  exper i -
ment,  an  equal number of  animal s recei ved the same treatment except for 
the add i ti on of s ix  mi nutes of UV- i rrad i ati on at 42 ergs/mm
2
/ s  immedi ately 
fol l owing the l i ght abras i o n .  The  resu l ts ,  however , "Jere s imi l ar i n  that 
none of the mi ce devel oped tumors and the l ips retai ned normal appearance 
(Tab l e  8 ,  Groups 5 & 6 ) .  
CONCOMITANT HSV I NFECTION AND UV-IRRADIATION 
As prev i ous ly  poi nted ou t ,  the del i very of UV exposure al one or the 
inocu l at ion of HSV by i tsel f d id  not i nduce l i p tumors . Therefore , a 
series of experiments were desi gned to i nvesti gate the effect of UV- i rra-
TABLE 8 
GROUP 
F IRST a 
TREATMENT 
1 HSV right 
2 HSV ri ght 
3 HSV right 
4 HSV right 
5 HSV right 
6 HSV right 
7 1·1ed ia  right 
8 Abrasion 
RESPONSE OF BALB/c tHCE TO REPEATED UV , HSV , OR ABRASION TREATMENTS 







L IP b 
LESIONS 
100% HSV ri ght 0% 
100% HSV right 10% 
100% Abrasion  0% 
100% Abrasi on 0% 
100% Abras i on 0% 
& UV 
100% Abrasi on 0% 
& UV 
0% Abras ion  0% 
& UV 




THI RD d 
TREAH1ENT 
L IP b 
LESIONS 
HSV right 20% 
HSV right 10% 
Abrasi on 0% 
Abrasi on 0% 
Abras i on 0% 
& UV 
Abrasi on 0% 
& lJV 
Abrasi on 0% 
& UV 




FOURTH L IP  b 
TREATMENTe LESIONS 
HSV l eft 0% 
HSV ri ght 0% 
HSV l eft 25% 
HSV ri ght 22% 
HSV l eft 78% 
& UV 
HSV ri ght 80% 
& UV 
HSV r i ght 100% 
& UV 
Abrasi on 0% 
% MICE 
WITH 
L IP f TUMORS 
0% 
0% 











Each group of 10 males ( 6  wks. of age) were anesthetized, abr9ded on the maxillary right lip and the 
first six groups received 100 ul of HSV- 1 inoculation (3 x 10 PFU/ml) . The seventh group received 
a "media only" inoculation, whereas the eighth group received only abrasion. 
Each animal was evaluated 5 days postinoculation with a 2X scope for lesions on the most recent 
inoculation site. 
Each animal was anesthetized, abraded on the maxillary right lip and the first two groups received 
100 ul of HSV inoculation ( 3  x �0
7 PFU/ml). The fifth, sixth and seventh groups received six minutes 
of UV irradiation at 42 ergs/mm Is. The second treatment followed the first by four weeks. 
d. Same protocol as "c" above. The third treatment followed the second by six wks. 
e. Each animal was anesthetized, abraded on the maxillary right or left lip ( as indicated) and the 
first seven groups received 100 ul of HSV-1 inoculation {3 x 107 PFU/ml) In addition, groups 
five, six and seven received six minutes of UV-irradiation at 42 ergs/mm2/s. The fourth treatment 
followed the third by four weeks. 
f. Each animal was evaluated weekly with a 2X scope and then graded for the presence of tumors 20 wks. 
after the fourth treatment. In addition, histopathologic evaluation of  representative lips from 






d iation i n  conjunction w ith HSV i nocu l ati on i n  our mouse model . 
S i nce Rapp has reported � vi tro transformation of hamster cel l s  by 
i nfecti on w i th HSV-2 i rrad i ated for s i x  mi nutes at 42 ergs/mm2/ s .  an 
anal ogous protocol was attempted � v i vo . In one experiment . a vi rus 
i nocul um was i rrad iated pri or to i ts appl i cati on onto abraded l i ps of 
mice. F ifteen mal e  BALB/c mi ce ( 5  wks . of age ) were anestheti zed . l i ghtly 
abraded on the ri ght maxi l l ary l i p .  and swabbed wi th approximately 100 u l  
6 -
of a 333 sol ution ( 1  x 10 PFU/ml ) that had just  been UV- i rradi ated for 
6 minutes at 42 ergs/mm2/ s .  F ive days l ater ,  when HSV i nduced l i p  l es i on s  
woul d norma 1 1y be presen t ,  n o  1 e s  i ons were see n .  D a  i ly eva 1 uati o n  of the 
1 ips  conti nued to show the 1 ack of herpeti c 1 esi ons ; whereas i n a group 
of m ice i nocul ated �/i th the same vi rus pool . but not i rradiated prior to 
appl i cation , 60% of the animal s deve l oped herpeti c  l es i ons by the fi fth 
day (Tabl e 9) ( p  = . 02 ) .  Apparently , the UV exposure had destroyed the 
i nfecti ous properties of the HSV-2 inocul um . Twenty-three vleeks late r ,  the 
l i ps appeared normal and no tumors were ev i dent .  The procedure of i nocu­
l ation wi th a UV- i rradi ated vi rus poo l was repeated.  Once aga in , herpetic  
l esi ons fa i led to -develop by the fi fth day and tumors were not 'evident 
seventeen weeks l ater. Mi croscopi c exami nati on of these l i ps at that t ime 
reveal ed normal strati fied squamous epi the l i um and fibrous connecti ve 
ti ssue . Consequently ,  another series of experiments were des igned to 
i nvestigate the effect of UV exposure del i vered to mouse l i ps infected wi th 
norma l uni rradi ated HSV-2 . Three di fferent combi nati ons of HSV i nocu l at ion 
on day 0 fol l owed by UV-i rradi ati on (6 minutes da i ly a t  42 ergs/mm2/ s )  on  
days 0 through 6 ,  2 through 6 or 4 through 6 i n  three groups of 15  BALB/c 
mi ce each were i nvesti gated. The i nci dences of herpeti c l i p l es i ons for 
the three groups were 64% ,  86% and 87% respecti vely  and are depi cted i n  
TABLE 9 INDUCTION OF DYSPLAS IA I N  tH CE BY UV EXPOSURE TO HSV I NOCULATED LIPS 
% t�ICE % MICE MICE 
b WITH WITH WITH % �lICE 
HSV INOCU- UV EX POSU RE ON HERPETIC HSV I NOCU- UV EXPOSURE ON HERPETIC TUMORS/ WITH 
LATION ON DAY DAY DAY LIP  LATION 8N DAY DAY DAY L I P  MICE SUR- L I P  
DAY if 0-6 2-6 4-6 LES IONSc DAY 162 162-168 164-168 166-168 LESIONSc V IV ING TUMORSe 
Yes 0% Yes 0% 0/15 0% 
Yes 60% Yes 47% 0/ 16 0% 
Yes Yes 87% Yes Yes 38% 0/12 0%* 
I 
..... 
Yes Yes 86% Yes Yes 50% 0/ 11  0%* 0 I 
Yes Yes 64% Yes Yes 20% 0/ 10 0% 
f f 
Yes 0% Yes 0% 0/ 15  0% 
Yes Yes 80% 0/20 0% 
Yes Yes 74% 0/20 0% 
Yes Yes 59% 0/25 0% 
*I-l istopatho-logic- eXam-inatlon of bi opsied l i ps reveal ed hyperkeratosi s ,  acanthosi s and epi the l i al dysplasia  
in  4 of  the 23  animal s ( p  < 0 .0 1  I'lhen compared to  rema i n i ng 75 UV + HSV treated ani mal s ) .  
a .  BALB/c mal e mice , approxi mately 5 wks . of age , were anestheti zed , abraded on  the ri ght maxi l l ary l i p ,  
and swabbed wi th 100 u l  of a 1 x 106 PFU/ml sol ution o f  333. At the begi nni ng o f  the exper iment ,  the 
number of animal s/group,  readi ng from the top to the bottom , were 19 , 20 , 1 5 ,  15 , 1 5 ,  1 5 ,  30 , 30 and 
30 respectively .  
b .  Animal s were anestheti zed and the ir  l i ps exposed to 6 mi nutes of UV-i rradi ati on at 42 ergs/mm2/s  on 
each day. 
c .  Each animal was eval uated 5 days posti nocul ation wi th a 2 X  scope . Heekly eval uati ons o f  heal i ng 
l es ions are shown in F ig .  3 .  
d .  Same as "a " except 333 i nocul um had a ti ter of 6 . 1  x 106 PFU/ml . 
e .  Each animal was eval uated weekly wi th a 2X  scope and  then graded for the presence of tumors on  day 283 . 
f.  This  v irus i nocul um was i rrad i ated wi th 6 mi nutes UV l i ght at 42 ergs/mm
2





Tabl e 9 .  Apparently ,  s i nce the U V  del i very on  days 0 and 162 was g i ven 
wi thi n minutes after the HSV inocul um was appl i ed , much of the i nfecti ous 
behavior of the vi rus was inh ib i ted. \�eek ly  exami nation of the heal i n g  
l i ps demonstrated a n  increase i n  herpetic  l es i on i nc idence a n d  severi ty 
wi th pro longed heal i ng peri ods ( F i g .  3a ) .  \�hen the di fferent subgroups 
of UV adm i n i s tration were exami ned separately , del i very on days 4 through 
6 and 2 through 6 increased the inci dence and sever i ty of the herpeti c 
l es i ons to a greater extent than del i very on days 0 through 6 ( Fi g .  3b ) .  
After 23 weeks , del ayed heal i ng was wel l  documented , but tumors had fa i l ed 
to emerge . Consequentl y ,  the procedures were repeated . I n  add i ti on , 
three other groups of mi ce were subjected to s imi l ar vi ral i nfecti ons and 
UV exposures (Tab l e  9 ) .  Once agai n ,  that group of anima l s  rece iv ing  UV 
exposure on  days 0 through 6 had l es s  severe and a smal l er i nci dence of 
herpetic  l esi ons as compared to those recei v i ng UV exposure on days 2 
through 6 or 4 through 6 posti nfecti on ( 20% , 50% , 38% , respecti ve ly ) .  
At the time of sacrifi ce on day 283 , macroscopi c  evi dence of tumors was 
l acki ng . However , several an imal s of the group that recei ved HSV i n fecti on 
and UV exposure on days 2 through 6 or 4 through 6 posti nfecti on demon­
strated hi stol ogi c ev i dence of hyperkeratosi s ,  acanthos i s ,  and epi the l i al 
dyspl asi a (Tab l e  9 ,  F ig .  4a & b ) .  Al though many of the experimental an ima l s 
died secondary to anesthesi a dur ing HSV inocul ation and UV expos ure , the 
hi stol og i c  evi dence was encouragi ng and l ed to an expansi on of the experi ­
ments i nvestigating concomi tant U V  ex�osure and HSV infecti on . 
CONCOMITANT HSV INFECTION AND UV I RRADIATION \'!ITH PROMOTION BY TPA 
Because epi the l i al dyspl as i as devel oped fol l owi ng UV- i rradi ation of 
herpeti C  l i p l esi ons , it  was fe l t  that the add i ti on of a tumor promoti ng 
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FIGURE 3 
Del ayed heal i ng of HSV-2 i nduced l i p  l es i ons fol l ,Owi ng UV i rradi ati on . 
The right  maxi l l ary l i ps of 5 week ol d mal e  BALB/c m ice were ( i )  i nocul ated 
wi th HSV-2 ( HSV only ) , ( i i ) UV- i rradi ated on days 0-6 ( UV only) , or ( i i i )  
i nocu l a ted wi th HSV-2 and UV- i rradi ated on days 0 -6 ,  2-6 , or 4-6 posti nocu­
l ation  ( HSV + UV ) as  descri bed i n  Tab le  9 .  Fi gure 3a represents the pre­
sence of l i p  l esi ons over the heal i ng period .  I n  add i t i on ,  the HSV + UV  
group was  d iv i ded i n to i ts three subgroups ( UV- i rradi ation de l i vered on 
days 0-6 , 2-6 , or 4-6 pos ti nocul ation)  and the presence of l i p  l esi ons 
duri ng the heal i ng peri od i s  presented i n  F i gure 3b . 
:r: 
1- .  
1 0 0  
75 
- , I \ 







\ , \ 
-74-
F I G U RE 3 0.  
.: . . . . . . . . .  . U V only  
HSV + UV 














I , I , 
I \
, I 










' "  
..... ..... ..... ..... 
. . . � . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
.
. . .  
. o _ · . .  · . . . .  · . .  
· . .  · . .  · . . . .  · .. ·r . .  · . .  · · · . .  
2 3 4 
T I M E  ( m ont h s )  
100 
en z 7 5  0 





I-Z W U 0::: 25 w D-
-75-
F I G U R E  3 b  





HSV + uv : dOY 4 - 6 
H SV + U V :  doy 2 - 6 
HSV + U V :  doy 0 - 6 








. . . . 
�'" ',-----I :  - - - _ I I 
I ff I E  













T I M E  ( m o n t h s )  
-76-
FIGURE 4 
Macroscopi c and mi croscopi c pathol ogy of HSV-2 i nfected , UV-i rrad i ated l i p 
l es i on s .  The right maxi l l ary l i p o f  a 5 \�eek o l d  mal e BALB/c mouse was 
i nocul ated �Ii th HSV-2 and UV-i rradi ated on days 2-6 and 164-168 posti nocu­
l ation  as descri bed i n  Tabl e  9 .  
( a )  A t  autopsy o n  day 283 postinocul ation , the l i p was erythematous 
but 1 acked macroscopi c tumors . 
( b )  However , mi croscopi c exami nation of hematoxy l i n  and eos i n  
sta i ned paraffi n embedded secti ons reveal ed hyperkeratos i s ,  
acanthos i s  and ep i thel i al dyspl as i a  ( 40X magni fi cat ion ) . 
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FIGURE 4 
a .  
b .  
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agent to the regimen m ight i ncrease cel l u l ar rep l i cation rates and promote 
tumor formati on .  Tetradecanoyl -phorbol -acetate ( TPJl.) has  been wi de ly  
uti l i zed as a promoter of  the neopl asti c process whi l e  i nvesti gati ng 
possi b l e  carc i nogen i c  agents and consequently vIas chosen for use in  thi s 
study . One hundred eighty-two mi ce were subjected to HSV l i p i nocul ati on , 
UV exposures on days 3 ,  4 ,  5 ,  6 ,  and TPA app l i cations three times a week 
beg i nni ng on day 9 for the duration of the experiment ( Table  10) . N i nety­
s ix  percent  of these animal s devel oped typi cal  herpeti c l i p  l esi ons by 
five days postinocu l ation .  Wi thi n thi s  group , 32 mi ce devel oped l i p tumors 
at the s i te of HSV infecti on . The average peri od of time for these tumors 
to emerge was 10 . 8  weeks . At the termi nati on of the experiment 193 days 
after HSV i nocu l ation , h i stol og i c  exami nati on of these tumors revealed 
24 beni gn papi l l omas , 2 epi the l i al dyspl as i as , and 6 squamous cel l carc i ­
nomas ( Fi g .  5 & 6 ) .  The vari ous control groups of ani mal s  are l i sted i n  
Tab l e  10 .  O f  statistical  s i gn if i cance , the appl i cation of TP.l\ al one three 
times a week produced no tumors as  compared to the group receivi ng HSV + 
UV + TPA (p  . 013) . However , HSV i nocul ati on pl us the appl i cati on of TPA 
three times a week produced two papi l l omas , whereas UV exposure pl us TPA 
three times a wee.k yiel ded three papi l l omas ( F i g .  7 ) .  S i nce the TPA was 
di ssol ved i n  DMSO ,  one control group recei ved HSV i nocul ati on , UV expo-
sure and DNSO appl i ed three ti mes a week . Thi s group devel oped one papi l ­
l oma . A compari son of the experimental group w ith the rema i n i ng 152 contro l 
anima l s  reveal ed that squamous cel l carcinomas devel oped only i n  the group 
recei v i ng HSV , UV , and TPA (Tabl e 10) (p = . 04 ) . Al so ,  papi l l omas deve l oped 
more frequentl y  in the experimental group (p = . 001 ) . In addi ti on , tumors 
arose earl i er in this  group ( 10 . 8  wks . )  as compared to the control groups 
( 13-24 wks . ) 
TABLE 10 INDUCTION OF LIP  TUt�ORS IN MICE FOLLOHING HSV INFE(;TIOIh 
UV EXPOSURE . AND TPA REPEATED APPL ICATION 
ANIMALS % MICE WI TH 
IN  HERPETIC LATENTi MICE IHTH TUr�ORS5 % t1ICE GROUpa TREAn.1ENT L IP LESIONSh PERIOD SURVIVING NICE WITH TUf10RSk 
30 • TPA onlyb 0% 0/30 0% 
37 HSV & TPA
c 
97% 13 wks . 2/33 ( 2 )  6% 
d 
40 UV & TPA 0% 13 I'lks . 3/34 ( 3 )  9% 
I 
..... 
40 UV & TPA e 0% 0/36 0% \D I 
& Abrasion 
20 HSV & VV 100% 24 I'lks . 1/19 ( 1 ) 5% 
& DMSO 
182 HSV & UV 96% 10 .8  wks . 32/156 ( 24) ( 2 ) ( 6 )  21% 
& TPAg 
a .  BALB/c mal e  mice were approximately 7 wks . o f  age when fi rst treated. 
b .  Each animal  was anestheti zed and abraded o n  the maxi l l ary right l i p o n  day 0 and then recei ved 0 . 02 umol e  
TPA/10  u l  of DMSO o n  the s i te three times every wk . 
c .  Each animal was anestheti zed , abraded on the maxi l l ary ri ght l i p  and  swabbed wi th 100 ul  of  a 1 . 3  x 10 
PFU/ml sol uti on of 333 on day 0 and then recei ved TPA as i n  "b "  above . 
d .  Each animal was anestheti zed and abraded o n  the maxi l l ary ri ght l i p  on day 0 ,  exposed to 6 mi n .  of UV­
irradi ation at 42 ergs/mm /s da i ly on days 3 ,  4 ,  5 "& 6 ,  and then recei ved TPA as  in "b" above . 
e .  Each animal was treated as i n  "d" above and then 1 i ghtly abraded on the maxi 1 1  ary ri ght 1 i p on day 2 5 .  
f. Each animal  �Ias anestheti zed , abraded on the maxi l l ary r ight l i p and swabbed wi th �OO 
PFU/ml sol ution of 333 on day 0 ,  exposed to 6 mi n .  of UV-irradi ation at 42 ergs/mm /s  
3 ,  4 ,  5 & 6 ,  and then recei ved 10  ul of m�so on the s i te three times every wk . 
g.  Same as "f" above except that each 10 ul of DMSO contai ned 0 . 02 umol e  TPA. 
h.  Each animal was eval uated 5 days posti nocul ati on wi th a 2X scope . 
i .  Average time span unti l emergence of cl i n i cal ly evi dent tumors . 
u 1 of 1 .  3 x 107 
da i ly on days 
7 
j . Hi stol ogic determi nation of tumor type : number �Ii thi n fi rst parenthes i s  represents # of papi l l omas ; 
number wi thi n second parenthes i s  represents # of epi the l i al dyapl asi as ; number wi thi n thi rd parenthesi s  
represents # of squamous cel l carci nomas . 





F IGURE 5 
Pap i l l oma i nduction by HSV i nfecti on , UV- i rradi ati on and repeated TPA 
appl i cati on .  The right maxi l l ary l i ps of 7 week o ld  mal e  BALBlc mi ce 
were i nocu lated wi th HSV-2 , UV-irradi ated on days 3-6 posti nocul ation 
and exposed to repeated TPA appl i cati ons as  descri bed in Tab l e  10 ( HSV & 
UV & TPA ) .  
( a )  At autopsy , 28 weeks posti nfectio n ,  24 mi ce had devel oped 
papi l l omas at the ori gi nal herpeti c l es ion  s i te .  
( b )  t licroscopi c exami nati on o f  hematoxyl i n  and eosi n stai ned 
paraffi n embedded secti ons reveal ed ben i gn strati fi ed 
squamous epi the l i um arranged i n  fi nger- l i ke projecti ons over 
a fi brous connecti ve ti ssue core ( 20X magn i fi cati on ) .  
D i agnosi s :  papi l l oma . 
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a .  
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FIGURE 6 
Squamous cel l carc i noma i nducti on by HSV i nfect i o n ,  UV- i rradi ation  and 
repeated TPA appl i cation . Refer to the l egend of Fi gure 5 for detai l s .  
( a ) At autopsy , 28 week s  posti nfecti on , 6 mi ce had devel oped 
squamous cel l carci nomas at the ori ginal herpeti c l es i on s i te .  
( b ) Mi croscopi c exami nati on as descri bed  for F i gure 5 reveal ed 
i nvas ive i s l ands , of mal i gnant squamous epi thel i um. P l eomorp h i s m ,  
i nverse nucl ear : cytop l asmi c ratios and kerati n pearl formati on 
are evi dent ( 40X magnifi cati on ) . Di agnos i s : squamous cel l 
carci noma . 
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F IGURE 6 
a .  
b .  
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FIGURE 7 
Tumor i nduction wi th vari ous combi nati ons of HSV i nfection . UV- i rradi ati on , 
and TPA appl i cati on .  The right maxi l l ary l i ps of 7 week o ld  male BALB/c 
mi ce were e i ther i nocul ated wi th HSV-2 , UV i rradiated on days 3-6 pos ti noc­
ulation , exposed to repeated TPA app l i cati ons , or treated with combi nati ons 
of these agents as described i n  Tab l e  10 . The homogram depi cts the tumor 
i nc i de{lce fol l o�li ng each of these treatments . 
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F IGURE 7 
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At the termination of th i s  experiment ,  a total of 38 l i p  tumors that 
had devel oped in the experimental as we l l  as control groups were s urgi cal l y  
removed . Many o f  the tumors were not l arge enough t o  trisect for :  ( i )  
formal i n  fi xation and paraffi n embeddi ng , ( i i ) cryostat secti on i n g ,  and 
( i i i ) exp l antati on to ti s sue cul ture.  Therefore , pri orities for eval ua­
tions were set.  The fi rs t pri ori ty was to obta i n  a hi s tol ogi c di agnos i s  
uti l i zi ng  H&E stai ned paraffi n. embedded ti ssues . The di agnoses are de­
pi cted i n  Tab le  10. The next pri ori ty was to exami ne the tumor cel l s  for 
the presence of HSV antigens uti l i zi ng  the i mmunoperoxidase s tai n .  Pre­
l imi nary s tud ies , sta i n i ng HSV infected mouse l i ps , i ndi cated that formal i n  
'--fixation a nd paraffi n embeddi ng often yiel ded fal se negati ve res u l ts . 
Best resu l ts were obtai ned i n  these prel imi nary s tudies uti l i z ing  cryos tat 
sections  of frozen s pecimens . Consequentl y ,  the search for HSV anti gen s  
i n  experimental ti ssue was performed upon cryos tat secti ons o r  explanted 
ti ssue i n  cul ture . Twenty-two of the 38 l i p  tumors were l arge enough to 
hemi sect and freeze one porti on for cryostat secti oni ng .  El even of the 
tumors were even l arger and were tri sected ; one porti on exp l anted to 
ti ssue cul ture � vi tro . Five of these attempted expl ants successfu l ly  
grew out  onto cover s 1 ips . I n both i nstances , cel l s  were eventual ly 
fi xed and s ta i ned uti l i zi ng the immunoperoxi dase s ta i n .  Resul ts are 
l i sted i n  Tab le  1 1 .  When the primary anti serum of the immunoperoxidase 
sta i n  was rabb it  �-HSV-2 stra i n  MS , four ti ssue specimens s tai ned for 
HSV antigen s .  These specimens were from three animal  s of the HSV + U V  + 
TPA group.  Hhen hamster 0<.-333 anti serum was used as  the pri mary anti serum , 
s ix  specimens s ta i ned pos i tive ( Fi g .  8 ) .  Once aga i n ,  these speci mens came 
from animal s of the HSV + UV + TPA group .  I n  addi ti on , these s ix  speci ­
mens sta i ned posi tive when mouse �-333 or mouse �-HSV + UV + TPA tumor 
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TA8LE 11  PRESENCE OF HSV ANTI GENS I N  MOUSE LIP  TW�ORS AS DETERMINED BY  
H1MUNOPEROXI DASE STAINING UTI L I Z ING VAR IOUS ANTISERAS 
ANIMAL TREATME�T H I STOPATHOLO� IC  TISSUE 
NU[�BER GROUP DIAGNOS I S  TYPEc 
82 UV + TPA Papi !
,
l oma C 
91  C 
91  E 
132 HSV + TPA C 





217  Squamous Cel l Ca .  C 
225  Papi  11  oma C 
235 Squamous ·Cel l -Ca . C 
236 Epi the l i al Dyspl asi a - C 
250 Papi l l oma C 
251  Squamous Ce 11 Ca . - C 
255  Papi l l oma C 
256 " C 
256 E 
257 Squamous Cel l Ca . C 
265 " E 
272 C 
272 E 
273 Papi 11 oma C 
275 " C 
278 C 
285 C 
297 HSV + UV + DMSO C 















b .  L ight mi croscop ic  exami nati on o f  H&E stai ned 6 mi cron secti ons of the 
formal i n-fi xed paraffi n embedded porti ons of b i ops ied tumor. 
c .  "c "  represents 6 mi cron cryos tat sections of portions of b i opsi ed tumor . 
" E "  represents outgrowths from expl anted tumor ti ssue cul tured i n  vi tro 
on cover s l i p s .  
d .  Thi s anti serum was used as  the primary serum i n  the i mmunoperoxi dase 
s ta i n i  ng . 
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F IGURE 8 
Presence of HSV anti gens i n  HSV + UV + TPA i nduced tumors as determi ned 
by i mmunoperoxi dase s ta i n i n g .  Deta i l s  of the tumor i nducti on procedure 
are descri bed i n  Tab l es 10 and 1 1 .  
(a ) Pos i ti ve i mmunoperoxi dase s ta i n i ng for HSV anti gens i n  a cel l  
grown out from the exp l anted papi l l oma removed from an i ma l  #155  
(400X magnifi cati on ) . 
( b ) Posi tive immunoperoxi dase s ta i n i ng for HSV anti gens wi thi n fi ve 
or s i x  basal epi thel i al cel l s  from the papi l l oma removed from 
an imal #256 ( lOOX magn i f i cati on ) . 
(c ) Negati ve immunoperoxi dase s tai n i ng for HSV anti gens wi thi n 
normal uni nfected mouse l i p  ep i thel i um ( 100X magni fi cati on ) . 
Refer to Figure lc for an exampl e  of posi t ive s tai n i ng wi thi n 
HSV-2 s tra i n  333 i nfected mouse l i p epi the l i um. 
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F IGURE 8 
a .  
b .  
c .  
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anti serum was used as  the primary anti serum. S i nce only tumors from the 
HSV + UV + TPA group showed the presence of HSV anti gens as  determi ned by 
immunoperoxi dase sta i n i ng wi th these four anti sera , these resu l ts suggest 
that HSV may p l ay a rol e in the devel opment of these tumors .  
cor�PARIsorl OF HSV-ANTI BODY TITERS 
At the termination of each of the aforementi oned � v i vo carc i nogene­
s i s  experiments , the anima l s  were sacri fi ced by card i ac exsangui nation . 
The serum was analyzed by mi cro-ti ter assay for neutral i zi ng anti bodi es . 
The mean serum HSV neutra l i zing  anti body ti ter for each of the groups i s  
l i sted i n  Tab le  12 .  Anti bod i es to HSV were not found i n  mi ce whi ch had 
not been infected \�i th HSV . Of those groups that had been i noculated on 
the l i p w i th HSV , the mean anti body ti ter ranged from 12 to 18 . 4 .  Statis­
tical anal ys i s  of  these ti ters uti l i zi ng  Studen t ' s  t Test reveal ed no 
si gni fi cant di fferences between the groups . However ,  wi thi n one group 
(HSV + UV + TPA ) , when the ti ters from the tumor beari ng anima l s  were 
compared to those of non-tumor bear i ng animal s ,  a h i ghly si gni fi cant 
d ifference �merged ( p <O. OOl ) . Those animal s wh i ch devel oped pap i l l omas 
and carc i nomas had an increased anti body ti ter aga i ns t  HSV ( 28 . 6 )  as com­
pared to those animal s wi thout tumors ( 16 . 3 ) .  Further subdi v i s i on and 
compari son of ti ters from papi l l oma bear i ng ( 2 7 . 6 )  versus carcinoma bear­
i ng ( 30 . 0 )  an imal s fa i l ed to yi e l d  s i gni fi cant di fferences ,  a l though the 
carci noma group had sl ightly greater ti ters . Al though there was a s i gn i ­
f icant di fference between tumor beari ng and  non-tumor beari ng i n  the H SV + 
UV + TPA group , the same was not true for the tumor beari ng ( 17 . 2 )  a nd 
non-tumor beari ng ( 14 . 0 ) subd i v i s i ons of the HSV + DMBA group . Thus , the 
tumor beari ng characteri stic  al one cannot be he l d  respons ib le  for the 
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s ignifi cant i ncrease i n  HSV anti body response seen i n  the HSV + UV + TPA 
tumor bearing animal s .  
TRAtlSFORMATION I N  V ITRO BY UV-I NACTIVATED HSV 
The i nduction of mal i gnant tumors in BALB/c mi ce fol l owing  i n fecti on 
wi th HSV-2 , exposure to UV- i rradi at ion and topi cal appl i cation of TPA 
rei nforced the concept that HSV may act as a cocarci nogen . However , the 
mol ecul ar mechani sms of these vari ab l es (HSV , UV a nd TPA ) and the i r  
functions i n  the transforming events were i mpossi b l e  to deduce from the 
..!.!!. vivo data . Consequently ,  a ser"i es  of ..!.!!. vi tro experi ments �Iere de­
signed to i nvesti gate some of the mo l ecul ar events and i nteracti ons of 
.'--
HSV , UV and TPA duri ng cel l  transformation . 
The effect of i nfecti on wi th HSV on cel l ul a r  metabol i sm and macro-
mol ecul ar biosynthes i s  has been we l l  documented . H ithi n hours after HSV 
i nfecti on the cel l ' s macromol ecular bi osyntheti c machi nery is shut down 
in favor of viral transcri pti on , transl ation and vi rus assemb ly .  V i ral  
repl i cation genera l l y  l eads to cel l death by cytolys i s .  For examp l e ,  
one ml of the HSV-2 poo l s  used i n  these s tudies can cause as many as 10 
mi l l ion  p l aques (areas of cel l  destructi on ) to form in a monol ayer of 
Vero cel l s  wi th in  48 hours after i nfecti on . I t  has been cl early demon-
strated , however , that v iral  i nfecti v i ty i s  optimal at specifi c pHs and 
temperatures and can be i nh"i bi ted by vari ous agents , i nc l udi ng UV-i rradia­
tion .  
I n  the f irst  series of  experiments , the effect of  UV-i rradi ation on 
HSV-2 i nfecti v i ty was i nvesti gated . Petri p l ates conta i n i ng HSV-2 were 
2 subjected to var ious exposure times of UV- i rradi at ion at 42 ergs/mm / s .  
A t  i n termi ttent peri ods , rangi ng from 0 mi nutes to 10 mi nutes , samp les  
- 93-
TABLE 12 COMPARI SON OF HSV-ANTI BODY TITERS 
a 
TREATMENT GROUP �lEAN SERU�1 NEUTRALI ZING ANTIBODY T ITER + S . D .
b 
3-MC (3 ) 0 . 0  
DMBA ( 4 )  0 . 0 
DMBA + HSV ( 7 )  1 2 . 0  ± 12 
HSV + DMBA ( 5 )  1 5 . 0  ± 10 
HSV + DMBA ( 6 )  15 .6  ± 9 
( i ) Tumor beari ng 17 . 2  ± 9 
( i i ) Non-Tumor beari ng 14 . 0  ± 9 
TPA on ly ( 10 )  0 . 0  
HSV + TPA ( 10 )  16 . 7  ± 13 
UV + TPA ( 10 )  0 . 0  
UV + TPA + Abrasi on ( 10 )  0 . 0  
HSV + UV + D�1SC ( 10 )  14 . 7  ± 5 
HSV + UV + TPA ( 10 )  18 . 4  ± 1 3  
( i ) Non-Tumor beari ng 16 . 3  ± 10* 
( i i ) Tumor beari ng 28 . 6  ± 18* 
a .  PaDi 1 1  oma 27 . 6  ± 20 
b .  Squamous Cel l Carci noma 30 .0  ± 11  
*Anal ys i s  by Student ' s t Test reveal s p < 0 . 00 1 .  Al l other combi nati ons 
of compari sons were not s ign if icant ( p >  . 22 ) .  
a .  The number i n  parentheses represents the tab l e  number where detai l s  
of treatment are found.  
b .  Serum neutra l i zi ng antibody ti ters for each mouse were determi ned by 
mi croti ter analysi s as des cri bed i n  Materi al s and Methods . 
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�Iere removed and assayed for i nfect iv ity ( PFU/ml ) on Vero cel l s .  The 
effect of UV- i rradiation is depicted i n  F igure 9 .  Genera l l y  for each 
minute of UV exposure , the vi ral ti ter decreased one l og .  After s i x  
mi nutes o f  U V  exposure , l i ttl e o r  no i nfecti ous vi rus remai ned . Rapp  
had prev i ous ly  suggested that the vi ral i nfecti v i ty of HSV  needed to  be 
inh ib i ted before the oncogeni c  potenti al cou l d  be expressed in transfor­
mati on experiments and he used 6 and 8 mi nutes of UV exposure i n  h i s  
71  
stud i es .  I n  cogni zance of Rapp ' s  data and the  data presented i n  F i gure 9 ,  
a n  endeavor was made to transform HEF cel l s  � vi tro usi ng HSV-2 i rra­
diated for 6 ,  7 and 8 mi nutes . 
In numerous pre l imi nary transformi ng experiments , the cri ti ca l  
nature o f  the pH o f  the medi um duri ng the vi rus adsorption phase and 
during attachment of the i nfected HEF cel l s  was evi dent.  Extreme acid i c 
or basic  condi tions duri ng vi rus adsorpti on or duri ng cel l attachment 
severely dimi ni shed the number of cel l s  that grew after bei n g  seeded 
in T-75 fl asks . If a sub threshol d number of cel l s  were seeded ( e . g .  5 . 5  
5 
x 10 cel l s/T-75 fl ask )  few , i f  any , cel l s  survi ved a nd they fa i 1 ed to 
d iv ide.  Thus , the number of cel l s  seeded pe r flask  proved to be cruc i al 
6 
and 1 . 1 x 10 H EF/fl ask  appeared to be optimal . In addi t ion , constant 
surve i l l ance was necess ary in order to mai ntai n a pH of 7 . 0-7 . 2  through­
out the duration of the experiments . 
The amount of UV- i rradi ation recei ved by the vi rus was very i mpor-
tant in  determi n i ng the effi ci ency of transformation (Tab le  13) . S ix  
mi nutes and  e ight  mi nutes of  UV exposure yi e l ded an  average of 0 . 9 5  and 
1 . 30 foci per T-75 fl ask , respe cti vely .  Seven minutes o f  U V  exposure 
generated an average of 3 . 27 foci per fl ask  ( F ig . 10 ) .  Thi s represents 
-7 6 
9 . 9  x 10 focus for�ing uni ts (FFU ) per PFU or , conversely , 1 x 10 PFU/FFU . 
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F IGURE 9 
Effect of UV- irradi ati on on HSV i nfectiv i ty .  Two ml vol umes of HSV-2 s tra i n  
7 2 333 ( 1 . 0  x 10 PFU/ml ) i n  35 mm Petri di shes were exposed to 42 ergs/mm / s  
of UV- i rradi ation.  A t  var ious times during UV exposure , samp l es were re­
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a .  Each fl ask was seeded wi th 1 . 1 x 1 0  hamster embryo fi brobl asts (HEF) after a one hour i n cubation 
at 370C wi th ei ther GLB or UV-i rradi ated 333 (MOI=3 ) . 
b .  Assayed on Vero cel l s  pri or to UV i rradi ati on for the i ndi cated number of mi nutes at 42 ergs/mm
2
/s .  
c .  Fl asks were fi xed i n  10% formal i n  and stai ned wi th 0 . 2% To l ui d i ne b l ue on  day 2 1  posti nocul ation . 
Uti l i z ing a 2X scope , foci were counted based upon s i ze ,  morphol ogy and sta i n i ng characteri sti c s .  
6 
d. Focus Forming U? its (FFU ) per Plaque Forming Un it  ( PFU ) of vi ral i nocul um (eg .  3 . 27 foc i / 3 . 3  x 10 
PFU = 9.9 x 10- FFU/PFU ) .  







Effic i ency of transformi ng HEF cel l s  by i nfecti on wi th HSV-2 stra i n  333 
UV- irradi a ted for vari ous periods of ti me . A vi rus i nocul um was UV-i rra­
diated for 6 ,  7 or 8 mi nutes prior to i nfecti ng HEF as  des cri bed i n  
Tabl e  1 3 .  The effic iency o f  transformati on , i n  terms o f  average number 
6 
of transformed foci per 1 . 1 x 10 cel l s ,  was maxi ma l  at 7 minutes of 
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6 
In add i t i o n ,  th i s  represents 3 . 0  FFU per 10 cel l s .  Transformation 
effic i enc i es of th i s  magni tude have not prev iously been reported ; gener­
a l i y ,  the transformation effi c i encies reported for HSV are 1 . 5- 2 5 . 0  t imes 
l ess eff ic ient in terms of foc i  per ce l l .  However ,  only 6 and 3 minute 
UV exposure times have been reported and , therefore , the 7 mi nute UV expo­
sure is one expl anation for the h i gh effi ciencies noted in  these exper i­
ments . Sl i ght variation  i n  v i rus  preparati ons i s  another poss i bl e  expl ana­
tion .  
PROPERTI ES OF  UV- INACTIVATED HSV TRANSFORMED HAMSTER EMBRYO CELLS 
Fol l owi ng the demonstrati on that UV-i nacti vated HSV was capabl e of 
transformi ng HEF cel l s  i nto foc i  that had an i ncreased rate of ce l l  
d i v i s ion  and had the abi l i ty to prol i ferate wi thout the addi tion of new 
growth med i a  every 2-3 days , i t  \�as necessary to further characteri ze 
these foci . Foci general l y  coul d be v i sual i zed 10-14 days posti nfecti on 
as smal l areas of i ncreased cel l densi ty per uni t area surrounded by a 
monol ayer of degenerating HEF  cel l s .  H0\1eve r ,  not al l foci appeared 
morphol ogi cal ly  i denti cal by 21  days posti nfecti on , when the exper iment 
was termi nated by ei ther fi xati on in  10% formal i n  and stai ni ng wi th Tol u i ­
d i ne b l ue o r  by pi cki ng and subcul turing i nd iv i dual foc i . Many of the 
foci appeared fi broblastic  \�i th l ong s l ender cytop lasmi c processes that 
i ntertwined , overl apped and p i l e d  up i n  a haphazard fash ion ( Fi g .  1 1a ) .  
Other foci appeared epi the l i o i d  wi th p l eomorph i sm and angul ar cytop l asmi c 
boundaries  ( F i g .  l Ib ) .  Rapp has  previ ously reported that two major morpho­
l og ica l  var iants of foci exi s t ,  name l y :  fi brob l asti c and epi the l i o i d . 60 
In an  effort to characteri ze transformed cel l s  i n  more deta i l ,  a 
focus p icked from a fl ask and pa ssaged to establ i s h  a stable  cel l l i ne 
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FIGURE 1 1  
Morphol ogical vari ants of  HEF cel l s  transformed by UV-i nacti vated HSV-2 . 
H EF cel l s  were i nfected wi th HSV-i rradi ated for 7 minutes as described i n  
Tab l e  13 .  
( a )  A fibrobl asti c type foci demonstrati ng i ntertwi ned fus i form cel l s  
wi th a tendency to overl ap and p i l e  u p  on one another ( 20X mangi ­
fication . 
( b )  An epi the l i o id  type foci demonstrati n g  pl eomorph i c  cel l s  wi th 
angu lar cytopl asmi c boundaries ( 20X magni fi cation ) .  
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F IGURE 1 1  
a .  
b .  
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was studi ed .  The fibrob l asti c cel l l i ne that resul ted was desi gnated 
3-26-7#1 representi ng the foci  from fl ask #1 of the tranformati on experi ­
ment performed o n  3-26-79 uti l i zi ng 7 mi nutes o f  U V  exposure to i nacti vate 
the HSV inocu l um .  The cel l l i ne was eval uated ( i )  for oncogeni ci ty ,  ( i i )  
by immunoperoxi dase sta i n i ng and ( i i i )  by cel l sorter analys i s .  
In order to exami ne the oncogeni c  nature o f  3-26-7 #1  cel l s , S x 10
5 
cel l s  i n  50 ul of HBSS were i njected subcutaneous ly  i n  the interscapu l ar 
area i nto each of 16 newborn ( 5- 14 days o ld )  hamsters . S ix  weeks l ater ,  
4 of 16 hamsters had devel oped l a rge tumors ( 2  cm x 1 cm x 1 cm) a t  the 
s i te of i njecti on ( F i g .  12a ) .  Al though the skin was freely moveab le  over 
the tumors , surg i cal expl oration showed them to be f i xed to the underly ing 
musc l e  l ayers . H i stol og i c  exami nati on of H&E stai ned ti ssue secti ons 
revea l ed that al l the tumors were fi brosarcomas ( F i g .  12b ) .  At autopsy , 
no ev i dence of metastas i s  �/as found i n  tumor beari ng animal s and the re-
mai n i ng 12 hamsters demonstrated no evi dence of tumors . Sera were obta i ned 
from the tumor beari ng animal s .  By mi croti ter techni ques , the poo l ed sera 
were found to have a HSV neutral i zi ng anti body t iter of 10 wh i ch i nd i ca ted 
that the hamsters had devel oped anti bodies capab l e  of recogni z i ng HSV v i ­
rion envel ope anti gens . In add i ti on , these sera ( termed hamster O(,4;umor)  
was capab le  of detecting HSV speci fi c anti gens in  ( i )  cel l s  producti ve ly  
i nfected wi th HSV-2 (HEF , HEp-2 or  Vero ce l l s ) , ( i  i )  parental transformed 
( 3-26-7#1 )  cel l s ,  ( i i i ) other transformed HEF cel l s  ( 12F#1 & 12F#2 )  and 
( i v )  cel l s  deri ved from outgrowths of hamster tumor t i ssue expl anted 
� vi tro onto gl ass cover s l i p s  (Tabl e 14) . Apparentl y ,  the 3-26-7# 1 
cel l s  express HSV glycoprote i n  anti gens i n  the cytopl asmi c membrane that 
are anti gen i cal l y  rel ated to the HSV envel ope glycoprote i ns . I t  has prev­
iously been reported that HSV transformed cel l s  express severa l HSV vi rus 
- 104-
FIGURE 12 
Oncogeni c i ty of 3-26-7#1 cel l s . The UV-i nacti vated HSV transformed cel l 
l i ne  3-26-7#1 was tested for oncogeni ci ty by injecti ng 5 x 10
5 
cel l s  i n  
50 u l  of HBSS i nto the i nterscapu l ar area of newborn hamsters ( 5- 14 days 
ol d ) .  
( a )  Six  weeks l ater , 4 of 16 hamsters devel oped tumors at the  s i te 
of i njectio n .  These tumors were fi xed t o  the underlyi ng muscl e 
l ayers . 
( b )  H i stopatho l og i c  exami nation o f  H&E sta i ned paraffi n embedded 
sections reveal ed mal i gnant spi ndl e cel l s  demonstrati ng p l eo­
morph i sm and anisocytosi s ( 100X magni fi cat i on ) .  D i agnosi s :  
fibrosarcoma . 
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F IGURE 12 
a .  
b .  
TABLE 14 PRESENCE OF HSV ANTIGENS I N  CULTURED CELLS AS DETERMINED 
BY m��UNOPEROXIDASE STAINING UTIL IZ ING VARIOUS ANTISERASa 
RABBIT RABBITC/.- MOUSE ex-
b RABB IT 0(.- RABBIT 0<.,- 333 EARLY VP 143 HAMSTER HAMSTER HSV+UV+TPA 
CELLS HSV-2/MS <*333 4 HR .  ANTIGEN (333) 0<.- 333 o<.-TUMOR TUMOR 
HEF Uni nfected 
HEF Infected +( 35 )  + ( 30 )  + ( 30 )  + ( 25 )  + (40) + (  3) + ( 1 5 )  
wi th 333 ;. 
HEp-2 Uni nfected I 
+ ( 50 ) ( C )
c c ..... 
+ ( 70 )  + (60 )  + (70 ) 
0 HEp-2 Infected +( 50 ) ( C )  + (  2 )  + ( 30 )  m 
wi th 333 
I 
Vero Infected + ( 50 )  + ( 30)  + ( 50 )  +(  2 )  
wi th 333 
3-26-7# 1 +( 5 )  +(  1 )  +(  1 )  + (  . 5 )  + (  . 5 ) + ( . 5 )  
12F#1 +(  . 5 )  + (  1 )  +(  2 )  + (  2 )  + (  3 )  
12F#2 +( 2 )  +(  1 )  + (  1 )  + (  2 )  + (  2 )  
Hamster Tumor +( 1 )  +( 2 )  + (  2 )  +( 10 ) 
Expl ant 
Mouse DMBA Tumor 
Explant 
a .  Rabb it ,  hamster and mouse sera were used as the pri mary anti sera in the immunoperoxi dase stai n .  The 
stai ning technique and devel opment of anti sera are descri bed i n  Materi al s and Methods . The number 
in parentheses after the "+" represents the percentage of cel l s  showi ng presence of posi tive stai ning.  
b .  HEF , HEp-2 and Vero cel l s  were i nfected wi th 333 (MO l=l ) and i ncubated for 15 hrs .  at 3f c .  UV-i nacti­
vated HSV transformed ce l l  l i nes were 3-26-7# 1 ,  12F#1 and 12F#2 . A hamster tumor , created by the 
subcutaneous i njection of 12F#2 cel l s  was expl anted and the i n " vi tro outgrowths analyzed . A mouse 
squamous cel l carci noma , i nduced by DMBA, was exp lanted and the in vi tro outgrowths analyzed . 
c. Genera l l y ,  the l ocati on of posi tive stai n ing \�as nucl ear or peri nucl ear ; however " (C ) "  represents 






polypepti des and glycoprote ins .  I n  order to  test thi s hypothes i s ,  3-26-7#1 
cel l s  were sta i ned by the immunoperoxidase method uti l i zi ng various primary 
�-HSV sera (Tabl e  14) . 
HSV antigens present i n  3-26-7#1 cel l s  were determi ned wi th anti sera 
speci f ic  for different HSV protei ns . The presence of HSV-2 stra i n  333 
( 333 )  v i ra l  protei n VP 143 (an early nonstructural protei n wi th a mol ecul ar 
wei ght of 143 ,000) was demonstrated i n  0 . 5% of the 3�26-7#1 cel l s  by stai n­
ing  wi th primary rabbi t �·VP 143 anti serum . The presence of one or more 
of the early 4 hour protei ns of 333 was demonstrated in 1% of the 3-26-7#1  
cel l s  by sta in ing  wi th rabbi t �earl y 4 hour antigen of  333 anti serum 
( F i g .  13 ) .  The presence of some of the protei ns of the 333 vi rion was 
demonstrated i n  1% and 5% of the 3-26-7#1 cel l s  by s tai ni ng wi th rabbi t 
0(·333 and hamster od33 anti serum , respecti ve l y .  As previously menti one d ,  
3-26-7#1 cel l s  �Iere capab l e  of i nducing  f ibrosarcomas when injected i n to 
hamsters and the sera from these animal s ( hamster �tumor) proved capab l e  
of sta i n i ng 3-26-7#1 cel l s .  Thus , these 3-26-7# 1 cel l s  expressed tumor 
spec ifi c anti gens ; some of wh i ch coul d  be 333 VP 143 , early 4 hour proteins  
of  333  or 333  envel ope proteins . Before l eavi ng thi s topi c ,  men ti on must  
be  made of  the immunoperoxi dase s tai n i ng  of the control and other HSV 
transformed cel l s  (Tab l e  14) . T\1o other UV- i nacti vated HSV trans formed 
cel l  l i nes , 12F#1 and 12F#2 ,  were eval uated.  General l y ,  the stai ni ng of 
these cel l s  was s imi lar  to 3-26-7#1 cel l s .  The cel l l i ne s ,  12F#1 and 
12F#2 had prev i ously been shown by another researcher i n  our l aboratory to 
possess HSV antigens as measured by immunofl uorescence stai ni ng .  However , 
si nce those resul ts were not quanti tati vely eval uated , the putati ve greater 
sens i ti v i ty of immunoperoxi dase stai n i ng as compared to i mmunofl uorescence 
sta i n i ng coul d not be tested. The negati ve control cel l s ,  uni nfected HEp-2 
-109-
FIGURE 13 
Presence of early 4 hour antigens of HSV-2 stra i n  333 in 3-26-7#1 cel l s .  
The UV- i nacti vated HSV transformed ce l l  l i ne 3-26-7#1 was sta ined wi th the 
immunoperoxi dase method ut i l i zi ng rabbi t anti serum to the early 4 hour 
antigens of 333 as descri bed in Tab l e  14 .  Cel l s  demonstrati ng pos i tive 
sta i n i ng are shown ( 400X magn ifi cation . ) .  
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F IGURE 13 
- 1 1 1 -
and HEF cel l s  consi stently stai ned negative for HSV a ntigens i rrespective 
of the primary anti sera uti l i zed ( F i g .  14a ) .  Thi s  i ndi cated the absence 
of HSV antigens as  wel l  as  adequate absorpti on of the antisera . 333 i n­
fected HEp- 2 ,  HEF and V ero cel l s  con s i s tently s tai ned posi ti ve for HSV 
antigens ( F i g .  14b ) .  DI'�BA i nduced mouse l i p  tumors expl anted to ce l l  cul ­
ture fa i l ed to show the presence of HSV anti gens . Outgrowths from ex­
pl anted hamster tumors , created by subcutaneous i nj ection of UV- i nacti­
vated HSV transformed cel l s  i nto hams ters , sta i ned pos i ti ve for HSV 
anti gens wi th four di fferent primary anti sera . F inal l y ,  the antiserum 
from mi ce beari ng HSV + UV + TPA i nduced tumors s tai ned only 333 i nfected 
H EF and HEp-2 cel l s ,  i nd icating  that i f  tumor speci fic  anti gens exi s t  on 
the surface of HSV + UV + TPA i nduced mouse tumors they are di fferent from 
( i ) HSV anti gens on the surface of UV- i nacti vated HSV transformed cel l s  or 
the i r  � vivo  induced hamster tumors or ( i i ) tumor speci fi c  anti gens o n  
t h e  surface of Dr1BA i nduced mouse squamous ce l l  carci nomas . 
After demonstrati ng that the cel l l i ne , 3-26-7#1 , was oncogeni c and 
expressed HSV spec i fi c anti gens , attenti on was turned to i nvesli gati ng  the 
cel l DNA content by cel l sorti ng  analys i s  and compari ng  i t  to the DilA con­
tent of norma l hams ter embryo cel l s .  The computer generated homograms 
p lotting DNA content per cel l vs . number of cel l s  are presented i n  Fi gures 
15  and 16 .  Surpr i s i ngly , consi deri ng  the  fact that the  3-26-7#1 cel l s  
were oncogen ic  i n  hamsters , the homogram analys i s  of 3-26-7#1 cel l s  was 
nearly identi cal  to that of norma l  hamster cel l s .  �1ost of both cel l types 
were i n  Go - G1 phase at channel number 4-0 and few ce 1 1  s were i n S ,  G2 or 
tl phase . These data and the fact that 12  of the 16 newborn hams ters i n­
jected \�i th 3-26-7#1 cel l s  fa i l ed to devel op fi bros arcomas suggested that 
the cel l l i ne  was a mi xture of transformed and nontransformed cel l s  and 
-112-
FIGURE 14  
Immunoperoxidase sta i ned control cel l s . HSV posi tive and negati ve control 
cel l s  were sta ined wi th the immunoperoxidase method as descri bed i n  
Tab l e  14 .  
(a )  Uninfected HEp-2 cel l s  stai ned wi th rabb i t  �-333 as  the  primary 
anti serum demonstrate the absence of HSV anti gens (400X magn i­
fication ) .  
( b )  HSV-2 stra i n  333 i nfected Vero cel l s  sta i ned wi th rabb i t  c(-VP 143 
as  the pr imary anti serum demonstrate the presence of HSV antigens 
(400X magnif i cati on ) .  
- 1 13-
F IGURE 14 




Cel l sorter analysi s of hamster embryo cel l s .  The computer generated 
homogram , pl otti ng DNA content per cel l vs . number of cel l s ,  reveal s 
t hat the majori ty of cel l s  are d i p l o i d  and i n  Go - G1 p hase . 
r .. � .� . .  
: HAMSTER EMBRYO FIBROBLAST CONTROL , 654/20, P I C  9/20/79 NUN = 354 1 5  
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F IGURE 16 
Cel l sorter analysis  of 3-26-7#1 cel l s . The computer generated homogram , 
p lotting DNA content per cel l vs . number of cel l s ,  reveal s that the maj­
ority of cel l s  are d i p l o i d  and in Go - G1 phas e .  
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not homogenous .  Consequently , 3-26-7#1 cel l s  were serial ly d i l uted and 
sampl es seeded onto a 96 wel l pl ate for the purpose of subcloning  the cel l 
l i ne .  Three di fferent subcl oned ce l l  l i nes ori gi nati ng from s i ng le  cel l s  
of the parental 3-26-7#1 were successfu l l y  i n i ti ated : 3-26-7#la , 3-26-7 
# lb , 3-26-7# lc . These three cel l l i nes were then eval uated by cel l sort­
i ng ana l ys i s .  The homograms for these three subcl oned cel l  l i nes are pre­
sented in F igures 17 , 18 and 19 , respective l y .  These analyses showed that 
the parental cel l l i ne was , i ndeed , heterogenous in ce l l  type . Al though 
3-26-7#la a nd 3-26-7#lb cel l s  were s imi l ar to the parental 3-26-7#1 cel l s  
wi th the majority of the cel l s  i n  Go - G1 phase , many of the 3-26-7#lc 
cel l s  had twi ce as much DNA per cel l .  Two poss i b l e  exp l anations exi s ted : 
( i )  rap i d  cel l u l ar rep l i cation p l aced these cel l s  i n  the tetrapl o id  G
2
-t1 
phase , or ( i i ) these Go aneupl o id  cel l s  had approximately twi ce the chromo­
some number as the other cel l l i nes.  However , the poi nt was made that 
th i s  transformed focus was not a homogenous cel l popul ation .  Unfortunately ,  
these cel l l i nes were l ost  to further study due to bacteri al contami nati on . 
EFFECT OF TPA ON TRANSFORt1ATI ON IN VITRO BY UV- I NACTIVATED HSV 
S i nce the addi tion of TPA app l i cation to the HSV + UV � vi vo regimen 
was so successful in promoting the emergence of tumors on mouse 1 i ps , a 
seri es of experiments was desi gned to i nves tigate the acti vi ty of TPA JJl 
v i tro. Parti cul ar attenti on  was pa i d  to the effect that TPA mi ght have on  
UV-i nac ti vated HSV transformation of hamster cel l s .  However , pri or to 
i nvesti gati ng that , prel imi nary experiments were necess ary to eval uate the 
effect of TPA itsel f upon cel l s  and to arri ve at proper dosages for i ncor-
poration i n to growth med i a .  
The first series of experiments were desi gned to i nvesti gate the l ong-
- 1 19-
FIGURE 17 
Cel l sorter analys i s  of 3-26-7#1a . The computer generated homogram , 
pl otting Dt� content per cel l vs . number of ce l l s ,  reveal s that the 
major i ty of cel l s  are dipl o i d  and i n  Go - G1 phase . 
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Cel l sorter analys i s  of 3-26- 7#lb cel l s .  The computer generated homo­
gram , p l otting DNA content per ce l l  vs . number of cel l s ,  revea l s  that the 
majori ty of cel l s  are d i p l o i d  and in Go - G1 phase .  
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Cel l sorter ana lys i s  of 3-26-7#lc cel l s .  The computer generated homo­
gram, pl otting DNA content per ce l l  vs . number of cel l s ,  reveal s that the 
majori ty of cel l s  have twi ce the DNA content per cel l as Go - G1 cel l s .  
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term effect (one month or more )  of various  concentra ti ons of TPA i n  the 
growth med ia  on the express i on of HSV genome and on prote i n  synthes i s  i n  
the transformed cel l s  333-8-9 . Thi s knowl edge was essenti al for i ts use 
in l a ter 2 1  day transformat ion experi ments . The concentrations of TPA 
tested were 0 . 0  ug/ml , 1 . 0  ug/ml , 0 . 1  ug/ml , 0 . 01 ug /ml and 0 . 001 ug/ml 
of med i a .  Three separate parameters in 333-8-9 cel l s  were i nves ti gated , 
name ly :  ( i )  quanti tative or qual i tative var iations  i n  so l ub l e  protei n 
production as measured by two-dimensi onal gel el ectrophores i s , ( i i )  changes 
in DNA content per cel l as analyzed by the cel l sorter and ( i i i )  variati ons 
i n  HSV anti gen express i on as determi ned by i mmunoperox idase stai n i n g .  
For two-d imensi onal ( 2 - 0 )  g e l  el ectrophoresi s ,  samp l es of H E F  cel l s  
and the five sampl es of 333-8-9 cel l s  grown under var i ou s  concentrati ons 
of TPA �/ere seeded in equal numbers (1 x 104 cel l s )  onto separate Petri 
di shes . The cel l s  were i ncubated at  370C in the presence of 20 uc of 
S35  methi on ine/ml of medi a .  After 4 8  hours , the cel l s  were harves ted i n  
lys i s  buffer and 5 u l  o f  thi s sampl e was TCA preci p i  tated and coun ts per 
mi nute (cpm )  determi ned in a sci nti l l ati on counter. An equal number of 
cpm was not obta i ned for the d i fferent sampl es ( Tab,l e  15 ) .  ,Apparently ,  
max imal  protei n synthes i s  occurred when TPA was present  at a concentrati on 
of 0 . 1 ug/ml of med i a .  S i nce th i s  i n crease cou l d  b e  i nduction o f  new pro­
teins  or s i mply an i ncrease i n  normal protei ns , other al i quots of the same 
s i x  sampl es were subjected to 2-0 gel e l ectrophoresi s .  .lI.utoradi ographs 
from equ i l i br i um ( 25 ul / samp l e  and 145 ,960 cpm/samp l e )  as  wel l  a s  non­
equ i l i br ium ( 145 , 960 cpm/sampl e )  2-D gel s were scrut i n i zed for qual i ta ti ve 
or quant itative  changes i n  rad i o l abe led protei n conten t .  Compari sons of 
the autoradi ographs  from the 2-D ge l s  performed on HEF and 333-8-9 cel l s  
reveal ed most  of the l abel ed protei ns to be s i mi l ar i n  the i r  p I  poi nts and 
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TABLE 15 EFFECT OF TPA IN THE MED IA OF CULTURED 333-8-9 C ELLS 
HEF 
333-8-9 
333-8-9 wi th TPA l/ug/ml 
333-8-9 wi th TPA 0 . 1 ug/ml 
333-8-9 wi th TPA 0 . 01 ug/ml 
333-8-9 wi th TPA 0 . 00 1  ug/ml 
b 
T . C . A .  PREC I P I TABLE cpm/25 u l  
218 .260 
279 , 640 
274 . 145 
736 ,670 
435 , 200 
145 ,960 
a .  Each cel l sampl e ( I  x 104 cel l s/60 mm Petri d i s h )  was i ncubated for 
48 hours at 370C i n  the presence of 20 uc of $35 meth ion i ne per ml 
of medi a .  
b .  The cel l s  were harvested i n  100 u l  of lysi s buffer and 5 u l  o f  thi s  
sampl e was eval uated for cpm fol l owi ng TCA precip i tati on . 
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mol ecu l ar wei g hts . However , consi stently there appeared two protei ns  i n  
the HEF cel l s  that were not present i n  the 333-8-9 cel l s  ( F ig .  20a , b ,  c ,  
d ) .  These proteins  had mol ecular  wei ghts o f  68 ,000 and 43 ,000 . In con­
trast ,  compari sons of the autoradi ographs of the gel s performed on 333-8-9 
cel l s  ma inta i ned under various concentrati ons of TPA in the med i a  reveal ed 
no qual i tative d i fferences . However , there appeared to be an i ncrease i n  
the amount of one protei n  i n  the sampl es grown under TPA concentrations of 
0 . 1 ug/ml a nd 0 . 0 1  ug/ml (Fig .  20b , c ,  d ) .  Thi s protei n had a mol ecular 
wei ght of 50 ,000 . A s imi l ar quanti tati ve i ncrease was not seen in  those 
sampl es grown under TPA concentrati ons of 1 . 0  ug/ml or 0 .001 ug/ml . Thus , 
the i ncrease in TCA precip i table counts among 333-8-9 cel l s  grown under 
TPA at concentrations of 0 . 1  ug/ml or 0 .0 1  ug/ml was not a qual i tati ve 
i nduction of new protei n but rather a quanti tati ve i ncrease of at l east 
one major prote i n .  
Interest i n  TPA a t  a concentration o f  0 . 1  ug/ml o f  medi a  for future 
� vi tro transformation studies began duri ng the 2-D gel experiments . 
That i nterest was i ncreased by the cel l sorter analys i s  of 333-8-9 cel l s  
cul tured under the same fi ve concentrations of TPA as  used i n  the prev ious 
exper iment.  The DNA homograms are presented in F i gures 21a-e representi ng 
the five increasi ng concentrations of TPA , respecti vely . By summi ng the 
percentages of cel l s  in S, G
2 
and M phases , it i s  possi bl e to get a n  i n­
d icati on of the repl i cative acti v i ty of each of the fi ve cel l samp l es . 
In order of i ncreasi ng concentrati ons of TPA from 0 .0 ug/ml to 1 . 0  ug/ml , 
these repl i cative i ndexes are 54 . 8 ,  54 . 7 ,  59 .6 , 62 . 2  and 53 . 9 ,  respectively.  
The repl i cati ve activ i ty of 333-8-9 cel l s  was , therefore , maxima l  at a 
TPA concentration of 0 . 1  ug/ml of medi a .  
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FIGURE 20 
Autoradiographs from the 2-D gel s  of HEF and 333-8-9 cel l s .  HEF cel l s  and 
333-8-9 cel l s  were radi ol abel ed in cul ture and subjected to 2-D gel el ectro­
phores i s  as  described in Tabl e  15  and in i ts secti on of Materi al s  a nd 
11ethods .  
( a )  The autoradiographs o f  normal HEF cel l s  demonstrate the presence 
of two proteins  not seen in any of the 333-8-9 protein  ge l s  
(arrows ) .  
( b ,c ,d . ) The autoradi ographs of 333-8-9 cel l s  grown under TPA at con­
centrations of 0 . 0  ug/ml , 0 . 1  ug/ml and 0 .0 1  ug/ml , respecti vel y .  
The qual i tati ve i ncrease i n  one parti cul ar protei n i s  demo n­
strated in the l ater two ge l s  (arrows ) .  
Each IEF gel was l oaded �lith 145 ,960 cpm/ sampl e and run under 
equi l i br ium condi tions (approxima tely 100 ,000 cpm/ug of protei n ) . 
The upper r ight corner of each fi gure represents the top ( ba s i c  end , 
pH7 )  of the 1st dimension gel and the upper l eft corner was the 
bottom (acid ic  end , PH5 ) .  The i soel ectric  focus i ng was from right  
to  l eft . The  SOS-PAGE separation was from top  to  bottom through an 
exponenti al grad i ent of 7% to 20% acryl ami de.  
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F IGURE 20 
a .  
b .  
--
-
c .  
d .  
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F IGURE 20 ( conti nued ) 
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FIGURE 21  
Cel l sorter analys i s  of  333-8-9 cel l s  cul tured wi th various concentrati ons 
of TPA .  The computer generated homograms . a-e .  represent 333-8-9 cel l s  
cul tured wi th TPA i n  the med i a  at concentrati ons of 0 .0 ug/ml . 0 . 001 ug/ml . 
0 . 01 ug/ml . 0 . 1  ug/ml or 1 . 0  ug/ml . respecti vely . The rep l i cative activ­
it ies ( 5  percent + G
2
M percent)  are 54 . 8 . 54 . 7 . 59 . 6 . 62 . 2  and 53 . 9 .  
respecti vel y. 
- 132-
F IGURE 21a 
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CRUDE STRIPPING 
IIIIIfILE = 6 TAPE = . 
G8-G 1 PERCENT = . . . . .  .42.2 
S PERCENT = . . . . . . . . . . . 4.2 
G2-11 PERCENT = . . . . . . . 58.6 
CV = . . . . . . . . . . . . . . . . . 8.89 
G8-G1 IG>E = . . . . . . . . . 41 .35 
G2-11 I«X>E = . . . . . . . . .  78.93 
G8-G I so = . . . . . . . . . . .  3.68 
G2-11 so = . . . . . . . . . . . 1 1 .88 
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F IGURE 21b 
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ttttfll..E = 7 TAPE = JlC I I  
G6-G1 PERCENT = . . . . .  . 45.3 
S PERCENT = . . . . . . . . . . .  2 . 7  
G2-11 PERCENT = . . . . . . . 52 
CV = . . . . . . . . . . . . . . . . .  1 I .49 
Ge-GI mDE = . . . . . . . . . 38.94 
G2-11 HODE = . . . . . . . . . 66.34 
Ge-GI SO = . . . . . . . . . . .4 .47 
G2-11 SO = . . . . . . . . . . .  1 1 . 74 
1 20 i ! 
------ --------------- ----- -� 
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F IGURE 21c 
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IIIIfIl.E = 8 TAPE = JIC 1 1  
GHI PERCENT = _ . . . . .  48.4 
S PERCENT = . . . . . . . . . . . 5 
G2-11 PERCENT = . . . . . . . 54.6 
tv = . . . . . . . . . . . . . . . . . 9.89 
GHI IGlE = . . . . . . . . .  39. 13 
G2-11 !WE = . . . . . . . . .  66. 6S 
Ge-Gl SI) = . . . . . . . . . . . 3 .87 
G2-11 SI) = . . . . . . . . . . .  1 1 .56 
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F IGURE 21d 
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.1f.: . .  Jt_.l .LEILLS_. _________ __ __ . _ _____ _ _ _ _____ _ _ __ -l 
2j3e IIIFILE = 9 TAPE = Jt I I  
' 1  , !!HI PERCENT = . . . . . .  37.8 f i S PERCENT = . . . . . . . . . . .  5.6 
L G2-ft PERCENT = . . . . . . .  56.6 
, 
I 








tv = . . . . . . . . . . . . . . . . .  18.32 
!!HI IQ)E = . . . • . . . .  .48.97 
G2� IQ)E = . . . . . . . . . 66.87 
!!HI $ = . . . . . . . . . . . 4.23 
G2� $ = . . . . . . . . . . .  1 1 .72 
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F IGURE 21e 
333-8-9CELLS/ l .eJlGlIfL TPA/6t8/29 7116/19 tlf1 = (7.98.! 










IIIflI.£ = 18 TAPE = Jt I I  
6IIHI PBI:f.NT = . • • . . •  48. 1 
S PERmIT = . . . • • . . • . . .  8.8 
G2-fI PERmIT = . . . • • . .  «i. 1 
tv = • . • • • • . • • • . . . • . . .  9.9 
6IIHI m: = . . . . . . • . .  1.21 
1i2-f1 III( = . . . . . . . . .  67.92 
6IIH1 SO = . . . . . . . . . . .  3.91 
, G2-fI SO = . . . • . . • . . .  . 1 1 .  63 
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Fol l owi ng i nvesti gations of the effect of TPA upon cul tured 333-8-9 
cel l s  by f-D gel el ectrophoresi s and ce l l  sorter analysi s .  the thi rd and 
fi nal sets of experiments were performed.  These were desi gned to eval uate 
any variations in HSV express i on i n  333-8-9 cel l s  cul tured wi th TPA at the 
same fi ve concentrations as i n  the previ ous two studies . The presence of 
HSV anti gens was determi ned by i mmunoperoxi dase sta i n i ng using  seven 
di fferent antisera (Table  16 ) .  Al l but one of the anti sera . sta i ned every 
sampl e ( F i g .  22) ; however . trends were not obv ious . Apparently . any quan­
t i ta tive or qual i tative di fferences i n  HSV anti gen expres si on among these 
cel l s  were not detectab l e  by immunoperoxidase stai n i ng or . converse ly .  the 
presence or absence of TPA in  the growth medi  a had 1 i ttl e effe.ct on HSV 
antigen express i on by 333-8-9 cel l s .  S i nce HSV antigens were present i n  
333-8-9 cel l s .  i t  was al so poss i bl e  to detect HSV mRNA wi thi n these cel l s  
by .i!! si tu hybridization ( Fi g .  23 ) .  
At the termi nation of these three series of experiments i n vesti gat i ng 
the effect of TPA by i tse l f  on transformed cel l s . i t  was cl ear that the 
agent caused i ncreased protei n  synthes i s  and cel l ul ar rep l i cati on . Thi s  
effect was maximal a t  TPA concentration of 0 . 1  ug/ml o f  med i a .  T h i s  con-
centration of TPA had been used i n  prev i ous � v i tro studi es for unexpl a i ned 
reasons and was chosen for use i n  UV- i nacti vated HSV trans formati on e xperi-
160 
ments \�i th i n  thi s di ssertation because of data just  presented . 
I n  those experiments des i gned to measure the effect of TPA on UV­
i nacti vated HSV transformation of hamster cel l s .  a protocol was fol l owed 
exactl y as descri bed earl ier for transformation experi ments � vi tro except 
for the add i ti on of TPA at a concentration of 0 . 1  ug/ml to the medi a .  The 
var iab le  then became the l apsed time posti nfecti on that the TPA was added 





TPA 1 ug/ml 
333-8-9 wi th 
TPA 0 . 1  ug/ml 
333-8-9 wi th 
TPA 0 . 01 ug/ml 
222-8-9 wi th 
TPA 0 . 001  ug/ml 
TABLE 16 PRESENCE OF HSV ANTIGENS I N CELLS CULTURED WITH TPA AS DETERtlI NED 
BY IMflUNOPEROXIDASE STAINING UTI L IZ ING VARIOUS ANTISERAd 
RABBIT RABB IT cx-
RABBIToc.- RABBIT 0(-333 EARLY VP 143 HN1STER HAMSTER 
HSV-2/MS ""-333 4 HR.  ANTI GEN (333) cx·333 \X-TUMOR 
+( 1 )  +( 4 )  + ( 3 )  + ( 6 )  +( 4 )  +( 2 )  
+( 2 )  +( 3 )  +( 2)  ( 1 )  + ( 6 )  +(  2 )  
+( 2 )  +( 3 )  +( 2 )  + (  4 )  +( 6) + ( 4) 
+( 3) +( 5) + ( 1 )  +( 7 )  +( 5 )  +( 2 )  
+( 2 )  +( 3 )  + ( 3 )  +( 3 )  +( 4 )  +( 1 )  




b.  The UV- i nactivated HSV transformed cel l 1 ine , 333-8-9 , was cul tured under var i.ous concentrations of 






Presence of HSV anti gens i n  333-8-9 cel l s . The transformed 333-8-9 cel l s  
were sta i ned wi th the immunoperoxi da se method uti l i zi ng hamster �tumor 
anti serum as descri bed i n  Tab l e  16 . One cel l demonstrati ng posi ti ve s ta in­
i ng adjacent to two negatively sta i ned cel l s  are shown (400X magn i fi cati on) . 
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F IGURE 22 
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FIGURE 23 
Presence of HSV spec if ic  mRNA in  333-8-9 cel l s .  The trans formed 333-8-9 
cel l s ,  a l ong wi th HSV posi tive and negati ve control s ,  were subjected to 
1!:!. s i tu hybri d i zation w i th radio l abe l ed HSV DNA as  descri bed i n  i ts sec­
tion of Material s and Methods . 
( a )  Uni nfected HEp-2 cel l s  were used as negati ve control cel l s  and 
l acked HSV mRNA i n  the cytopl asm. 
( b )  HSV-2 stra in  333 i nfected HEp-2 cel l s  were used a s  pos i ti ve 
control cel l s  and showed the presence of mRNA in the cytop l asm.  
( c )  Transformed 333-8-9 cel l s  al so  showed the presence of mRNA i n  
the cytopl asm. 
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F IGURE 23 
a .  
b .  
.. 
c .  
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F IGURE 23 (conti nued) 
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a .  See footnotes of Tab le  13  for detai l s .  
HOURS POSTINOCU- # OF TRANS- TRANSFORMATION 
LATION TPA ADDED FORI4ED F�C I /  EFF IC I ENCY 
TO MEDIA 1. 1 x 10 CELLS FFU/PFU 
1 0 . 00 
24 0 .07 
0 . 60 1 .  8 x 10 
-7 
24 2 . 10 
-7 
6 . 4  x 10 
-6 
48 5 . 62 1 .  7 x 10 
-6 
72 3 . 80 1 .  2 x 10 
-7 
96 2 . 9 1  8 . 8  x 1 0  
1 0 . 30 
-8 
9 . 0  x 10 






The effect of TPA ' s  addi tion to the medi a  was dependent upon the time of 
i ts adm i n i s tration (F i g .  24 ) . When the TPA was added i mmedi ately after 
the 1 hour v iral attachment peri od as  the cel l s  were seeded onto the T-75 
fl asks , the number of foci that emerged was smal l er than the number de­
rived from non-TPA conta i n ing experiments (Tabl e  13 ) . However , as the 
addi tion  of the TPA to the medi a  was del ayed , i ncreas i ngly greater numbers 
of foc i  per fl ask emerged . The effect peaked 48 hours posti nocul ation and 
then began to decrease . The maximum average number of foci per fl ask  i n  
these experiments uti l i zi ng TPA i n  the med i a  was 5 . 6 2  ( Fig .  25 ) . Thi s re­
presented a lmost a two-fo l d  i ncrease as  compared to non-TPA conta in i ng 
flasks (Tab l e  13 ) .  Thus , TPA not only promoted tumor i nducti on � v i vo wi th 
concom i tant HSV infecti on and UV exposure , but al so i ncreased transformati on 
effi c iency � v i tro wi th UV- i nacti vated HSV . 
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FIGURE 24 
Eff ic i ency of transforming  HEF cel l s  wi th the presence of TPA i n  the medi a .  
HSV-2 stra i n  333 was UV- i rradi ated for 7 mi nutes and used to i nfect HEF 
cel l s  as  desri bed in Tab l e  17 .  The effi ciency of trans formati on , in  terms 
of average number of transformed foc i  per 1 . 1 x 10
6 
cel l s ,  was maximal when 
the TPA ( 0 . 1 ug/ml ) was added 48 hours posti nocul ation .  
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FIGURE 25 
Compari son of fl asks from UV- i nacti vated HSV transformation experiments . 
On the l eft i s  a fl ask  that was seeded wi th uninfected HEF cel l s  and ma i n ­
tai ned i n  cul ture for 21  days . No foci were evi dent and mi croscopi c exami ­
nati on reveal ed only degenerated cel l ul ar debri s .  The mi ddl e fl ask was 
seeded wi th HEF cel l s  i nfected wi th UV-i nactivated (7 mi n . ) HSV . Foci 
were evident that mi croscopi cal l y  appeared fibrob l ast ic  or epi thel i oi d .  
On the right i s  a fl ask  that was seeded wi th HEF cel l s  i nfected wi th UV­
i nactivated ( 7  mi n . ) HSV and ma i n tai ned in medi a  contain i ng TPA ( 0 . 1  ug/ml ) . 
An i ncreased number of foci were evident .  
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F IGURE 25 
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O ISCUSSI ON 
I N  V IVO TRANSFORr-lATION 
Certai n  Herpesviruses have long been associ ated wi th several human 
neoplas i as  (uteri ne cervica l  carc i noma , Burk itt ' s  l ymphoma , and naso pharyn­
geal carc i noma )43 , but the rol e of HSV in the deve l opment of human cancer 
has been very diffi cul t to demonstrate . The neop l astic  transforming pro­
cess is a very compl ex seri es of events and HSV may act in  concert w ith 
other factors to induce cancer. Therefore , an � v i vo model was desi gned 
combi ning  HSV infection wi th exposure to certai n  envi ronmental cofactors 
(a chemi cal carc i nogen or UV-i rradi ation w ith or wi thout a tumor promoti ng 
agent) . Pri or to th i s  model , the only i n  v ivo  evi dence for HSV ' s  di rect 
ro l e  in oncogenes i s  was the subcutaneous i njecti on of cel l s  .transformed 
� v i tro . Thus , an appropriate model was des igned and ,  i n  addi tion , many 
i nteresti ng observati ons rel ating to peri pheral topi cs were made duri ng  
the process .  For exampl e ,  Tabl e 1 impl i es that the i nci dence of macro-
scopi cal ly  observab l e  herpeti c  l i p l esi ons in m i ce was rel ated to the 
ti ter of the v i ral  i nocu l um as  l ong as one accepts the fact that younger 
mice general l y  devel op a h igher i nc i dence of l es ions than ol der mice when 
i nocul ated wi th i denti cal v iru s  preparati ons . 27 Th i s  ti ter-dependent re­
sponse m i g ht exp l a i n  how 40-90% of the human popul ation have serol ogi c evi ­
dence o f  prior HSV-1 i nfection i n  the apparent absence o f  a primary HSV-1  
i nduced g i ng i vo stomatitis  by theor i z i ng that the ti ter of the v irus duri ng 
8 
primary exposure was l ow and the subsequent i nfection  was subcl i n i cal . 
Another exampl e  of an i n teresting observation rel ates to the fact that 
physical  trauma and/or UV exposure are common causes g iven by pati ents 
for the recrudescence of herpes l ab i al i s .  Hoo.�ever , i n  our mouse model 
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repeated abrasion  and UV exposure fol l owing  a herpetic  l i p  i nfecti on 
fa i l ed to acti vate recurrence of cl i n i ca l ly evi dent l es i ons (Tab l e  8) . 
Thus , a di fference may exi st between HSV l a tency i n  the mouse a s  compared 
to l atency in humans and is  in agreement wi th other reports on HSV l atency 
i n  that a good animal  model that mimi cs human l atency i s  not avai l ab l e .  
The rema i n i ng observati ons rel ate more di rectly t o  the fie l d  o f  i n terest 
i nves ti gated in thi s d i ssertatio n .  
Oncogeni c transformati on o f  a host cel l requi res the survi val and 
uncontro l l ed repl i cati on of that cel l .  Therefore , an al terati on i n  the 
normal cytolyti c course of HSV i nfecti on must occur i n  order for the host  
cel l to  survive .  Hhen an unal tered HSV i nfect i on was  i ni ti ated pri or to 
or dur i ng the app l i cati on of DMBA , a decrease i n  tumor yie l d  resul ted as 
compared to uni nfected D�1BA treated anima l s (Tab l e  5 ,  6 ,  7 ) . One pos s i bl e 
expl anation  i s  that the lyti c infecti on by HSV destroyed the cel l s  commi tted 
by DMBA to oncogenic  transformati on . In a si mi lar  vei n ,  repeated HSV i n­
fecti ons fa i l ed to i nduce tumor devel opment on mouse l i ps ( Tab le  2 ) , even 
though repeated exposure or pers i s tent i nfecti ons by HSV have been hypothe-
si zed as  a poss i ble  mechani sm for oncogeni c  transformati on .  The hypotheses 
state that HSV l atency , repeated reacti vati on or defective vi ral producti on 
mi ght produce al teration of the vi ra l  genome , thus i nh ib i ting the lyti c 
functi ons of HSV and al l ow i ng express ion  of the oncogeni c capabi l i ty .  I n  
the studies reported in  thi s  thesi s ,  it  was necess ary to  inhi b i t  the  lyti c 
functi ons of HSV by UV-i rradiati on .  The data presented i n  F i gure 9 demon-
strate that an optimal exposure time to UV radi ati on exi s ts i n  order to 
i nacti vate HSV i nfecti v i ty .  Rapp has previ ously presented s i mi l ar data 
and s hown that 6 to 8 mi n utes of UV exposure resu l ts i n  maxima l  trans forma­
tion .i!l v i tro .71  Hhen HSV was i rradi ated for 6 mi nutes pri or to i nocul ati on 
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on the l i ps of mice , no herpeti c l esi ons or tumors arose ( Tab l e  9 ) . Thus , 
a gene function necessary for HSV infecti vi ty was i nacti vated by exposure 
to UV rad i ation .  I n  addi ti on ,  repeated HSV  i nfecti ons with superimposed 
UV exposure on days 3 ,  4 ,  5 and 6 when v i ral ti ters were maxi mal in the 
tissue fa i l ed to induce tumor devel opment (Tabl e 9 ) . These data , however , 
do not rul e out the poss i bi l i ty that HSV may be oncogeni c  for at l east  
two reasons : ( i )  the duration of observati on may have been too s hort and 
( i i )  kno�m carci nogens a pp l i ed to abraded mouse l i ps al so fa i l ed to i nduce 
tumors under certa i n  c i rcumstances . M i ce that were subj ected to ( i )  UV­
i rradi ati on da i ly for 7 days on two separate occasi ons (Tab l e  9 ) , ( i i )  
var i ous  concentrati ons of 3-MC for as many as si x appl i cati ons ( Tab le  3 )  
a n d  ( i i i )  15 n g  o f  DMBA per app l i cati on for a s  many as 1 0  appl i cati ons 
(Tab l e  4 )  did not deve l op tumors . With D�BA as the carc i nogen , tumors 
emerged only when h i gher concentrations and more frequent app l i cati ons 
were used (Tabl e  4 ) . Thi s dose dependent response is anal ogous to human 
data wi th ci garette smoki ng wh i ch shows an i ncreased i nc i dence of l ung 
cancer as  the comsumpti o n  of tobacco i ncreases . S ince DrtBA and c i garette 
smoke have been shown capab l e  of i n i t iation  and promotion , it i s  reasonab l e  
that l ower dosages and l ess frequent exposures o f  DMBA are subcarci nogeni c .  
A simi l ar si tuation may exi st i n  the studies o f  HSV + U V  induced neop l asi a 
i n  the mouse model . At l ower frequencies of exposure and wi thout adequate 
promoti o n ,  HSV + UV treatments i!! v i vo were subcarci nogen i c  (Tabl e  9 ) . Al ­
though the combi nation of HSV + UV resul ted i n  mi croscop i c  dyspl as i a ,  mal ig­
nant tumors devel o ped on ly  when the repeated appl i cati on of TPA was added 
to the HSV + UV protocol . Thi s emphasi zes the pos s i b l e  mul ti stepped a nd 
mul tifactorial nature of carci nogenes i s, as wel l, as the common requi rement 
for i n i tiation  and promotion del i vered i n  a parti cul ar sequence. 
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The resul ts obta i ned  in these s tudies  show that squamous ce l l  carc i ­
nomas d o  devel o p  after HSV + UV + TPA exposure (Tab l e  10 ) .  Thi s represents 
the fi rst data impl i ca ti ng HSV as a cocarcinogen in an animal  model . Anal o­
gous to the cl assi cal two stage chemi cal carc i nogenes i s  model , the combi na­
tion of HSV infection and UV- i rradi ati on on the days of maximum ti s sue ti ter 
was consi dered the i ni ti ator and TPA the promoter. HO�iever , di fferent 1 a­
tent periods before tumor emergence exi sted i n  the two model s :  35-49 days 
for D�1BA (Tab l e  4) and 76 days for HSV + UV + TPA ( Tab l e  10) . In add i ti on ,  
the ratio  of papi l l oma devel opment to squamous ce l l  carc i noma devel opment 
varied between the two model s :  15 to 35 ( 70% cancers ) for DI'IBA (Tab l e  4 )  
and  24 to  6 ( 20% cancers ) for HSV  + UV  + TPA ( Tabl e  10) . Thus , compari son 
of the two model s i ndicates tha t ,  under the condi ti ons of thi s study , Dr1BA 
wa s capab le  of i nduc ing a h igher inc idence of squamous cel l carci nomas with  
a shorter l atent peri od than  HSV + UV + TPA treatments ( p<.OOI ) . In agree-
119 
ment wi th prev i ous studi es , these studies showed that DMBA represents 
a potent carc i nogen . 
Important theoreti cal exp l anati ons emerge when HSV + UV is cons i dered 
the i n i ti ating agent si nce most stud i es currently view al terati ons of 
cel l ul ar DNA as the most  attractive mechani sm for the i ni tiati on of the 
carc i n ogen i c  process . One exp l anation wou l d  be that UV- i rradi ati on acts 
136 
as  a mutagen i nduci ng DNA al terati ons . as  descri bed by Parri sh and that 
HSV acts a s  an i nh ib i tor of DNA repa i r  by d i sru ption of host DNA as de-
74 
scri bed by Aure l i an .  However , another expl anat i on coul d be that UV-
i rradiation  s imply  destroys the cytolyti c capabi l i ties  of HSV ( Fig . 9 )  
and al l ows the v irus to express i ts i nherent oncogeni c capabi l i ty .  The 
author prefers the l ater expl anation for several reasons . In these 
studies , UV exposure on those days i mmedi ately fol l o�!i ng HSV i nfecti on 
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increased the severi ty and del ayed the heal ing  of l i p l es i ons (F i g .  3 ) . 
Furthermore , analysi s of the serum neutral i zi ng an�i body ti ters from the 
mi ce i n  the HSV + UV + TPA group showed a si gni fi cant i ncrease among 
those anima l s  beari ng tumors (Tab l e  12) . I n  addi tion , four of these 
tumors ( 3  papi l l omas and 1 squamous cel l carci noma ) sta i ned pos i ti ve for 
the presence of HSV anti gens by immunoperoxi dase s ta i n i ng us i ng hamster 
C>(-33 3 ,  mouse 0<.-333 and mouse O<.-HSV + UV + TPA tumor anti sera . The i n-
creased antibody ti ters in  tumor beari ng mi ce and the presence of HSV 
antigens i n  these tumors impl ied a re l ationshi p between HSV and tumor 
devel opment.  However , HSV + TPA and UV + TPA treatments resul ted in devel ­
opment of a few papi l l omas but no squamous cel l carci nomas (Tabl e 10 ) . I n  
summary , these data suggest that HSV contri buted i n  a posi ti ve way to the 
deve lopment  of squamous cel l carci nomas fol l ow i ng HSV + UV + TPA treatment 
and , i n  that regard , may be consi dered a cocarc i n ogen . 
One fi nal hypothesi s of the mode of action  of HSV as a cocarci nogen 
is that HSV i nfection acti vates endogenous type C RNA tumor vi ruse s .  
Prov ing o r  d i s proving  thi s hypothes i s  was peri pheral to the studi es docu­
mented wi thi n thi s thesi s .  Type C RNA tumor vi ruses are rel eased from 
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mouse and  hamster ce l l s  after i nfecti on wi th UV-i nacti vated HSV . Proof 
that HSV i nfection or HSV transformati on acti vates Rr!A tumor vi ruses i s  
d iff i cul t t o  demonstrate si nce expressi on o f  the type C tumor vi ruses i s  
not requi red for transformation , and acti vation of the vi rus i s  not 
necessary for the cl i n i cal  i nducti on of  l eukemi a .  Research to date has 
al ways l i n ked these vi ruses to the i nducti on of l eukemi as and lymphomas 
and never to the devel opment of squamous c.el l carci nomas or s arcomas . 
I n  addi ti on , Hampar has suggested that the rel ease of type C RNA vi rus 
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may be the resul t of transformation and not the cause . 
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IN V ITRO TRANSFOR/'·1ATION 
Prev i ous  studi es have shown that hamster . mouse and human cel l s  are 
capabl e  of undergoing bi ochemi cal as  Vle l l  as  oncogeni c  transformation  
after i nfection with UV- i nactivated HSV . These s tudies have a lso  e l uc i -
dated that the optimal ti me for UV- i nacti vati on o f  HSV i s  s i x  or ei ght 
mi nutes at 42 ergs/mm2/ s .  The effi ciency of transformation fol l owi n g  
-7 41 
these exposures yiel ded a maxi mum of 4 x 10 FFU/PFU . I n  compari son , 
our stu d i es have shown the fol l owing  effi c iencies of transformation 
-7  -7  -7 
( FFU/ PFU ) :  2 . 9  x 10 , 9 . 9  x 10 and 3 . 9  x 10 for 6, 7 and 8 mi nutes 
of  UV exposure at 42 ergs/mm2/s  of the HSV i nocu l um ,  respectively (Tab l e  13 ) .  
6 
Th i s  represents 0 . 9 ,  3 . 0 ,  a nd 1 . 3  FFU/ 10 cel l s ,  respecti vely.  Furthermore , 
if TPA ( 0 . 1  ug/ml ) was added to the growth medi um 48 hours pos tinocu l ati on , 
-6 
a transformati on eff i c i ency (FFU/ PFU ) of 1 . 7  x 10 was obtai ned ( Tabl e 17 ) . 
6 
T h i s  represents 5 . 1 FFU/ 10 cel l s .  Thu s ,  wi th 7 minutes of UV exposure 
wh i ch has not previ ous ly  been reported , the transformation effi ciency was 
improved two and one-hal f times that reported previously as the maxi mum i n  
terms of FFU/PFU . If TPA was added 48 hours po sti nocul ati on to thi s 7 
mi nutes regimen , the transformation effic ien cy was nearly doub l ed agai n ,  
reachi ng fi ve times that previ ously reported .  Si nce other studies have 
6 
used MOI s  of 1-5 and Rapp has reported 1 FFU/5  x 10 cel l s ,  these trans-
formati on effic iencies represent a 1 . 5-25 fol d i ncrease i n  terms of FFU/ 
cel l .  Al though the reasons for th i s  increased effici ency was most  probably 
the cr i ti cal nature of the 7 mi nute UV exposure time and the addi tion of  
TPA to  the medi um ,  the importance of the stri ct ma i ntenance of neutra l pH 
and the number of cel l s  seeded per T-75 flask  cannot be understated . With­
out the knowl edge of the mi nute experimental protocol s fol l owed by others , 
compari son of tje many vari ables  i s  imposs i b l e .  
�/ 
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Foci  deri ved from the UV- i nacti vated HSV transformati on experi ments 
were subcul tured and shown to possess properti es s i mi l ar to other trans-
formed cel l l i nes . Rapp has  previ ously reported that fi brob l asti c  foc i 
and epi the l ia l  foci produce fi brosarcomas and adenocarci nomas , respecti vely , 
60 
when tested for oncogeni ci ty in newborn hamsters . The fi brob l asti c trans-
formed cel l l i ne , 3-26-7# 1 ,  was shown i n  these studies to  produce fi b ro­
sarcomas when i njected i n to hamsters , thus agreei ng wi th Rapp ' s  fi ndin gs . 
The poo l ed serum from these animal s contai ned anti bodies di rected aga i nst  
HSV and  was shown to  be capab l e  of  sta i n i n g  HSV  i nfected HEF , HEp-2  and  
Vero cel l s when used as the pri mary anti serum of the immunoperoxi dase  sta i n  
(Tab l e  14) . Furthermore , outgrowths from exp l anted hamster tumors a s  we l l  
a s  the 3-26-7#1 cel l s  demonstrated the presence of HSV anti gens �,hen stai ned 
wi th a variety of anti sera aga i nst  333 or i ts early prote i ns (Tab l e  14) . 
These resu l ts , agreei ng vli th previous studies ,
43  
demons trate that UV-i nact i­
va  ted HSV transformed cel l s  carry on thei r surface HSV anti gens that are 
numerous enough to be immunogeni c .  However , as  can be seen i n  Tab l e  1 4 ,  
not al l of the cel l s  at any gi ven time expressed HSV anti gens . T h i s  may 
be expl a i ned by the hypothesi s that anti gen express i on is cel l cycl e depen­
dent. Al though th i s  hypothesi s was not di rectly tes ted in these studi es , 
i t  was observed that most  of the cel l s  express i ng HSV antigens were rounded 
up as  if they were enteri ng G2 -M phase . Thi s observati on combi ned wi th 
cel l sorter data showi ng l ess than 34 . 6% of the cel l s  in  G2-�t phase at 
a g iven t ime ( F i g .  16 ) supports thi s hypothes i s .  In add i ti on ,  l ater studies 
( F i g s .  17 , 18 , 19 ) showed that the 3-26-7#1 cel l l i ne was heterogenous i n  
cel l type and may expl a i n , further , why so fel" of the cel l s  expres sed HSV 
antigen.  
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Another UV- inacti vated HSV transformed cel l l i ne , 333-8-9 , had many 
properti es  s imi l ar to 3-26-7#1 cel l s .  I t  had previ ously been shown to 
be oncogenic i n  hamsters and to express HSV anti gens on i ts surface . I n  
our studies , HSV anti gen expressi on by 333-8-9 cel l s  was rei terated 
(Tabl e  16 , F i g .  22) and the cel l s  were shown to possess HSV speci fi c mRNA 
in the i r  cytopl asm by � si tu hybri d i zation ( F i g .  23 ) . The presence of 
HSV spec i fi c  protein and mRNA imp l i es that at l east a fragment of HSV DNA 
i s  present , transcri bed and translated wi thi n these cel l s .  Furthermore , 
the 333-8-9 cel l s  were shown by 2-D gel el ectrophores i s  to l ack  two major 
protei ns that are possessed by normal hamster cel l s .  However , identifi  cati  on 
and characteri zation of these proteins  is necessary before thei r importance 
can be determined. 
Two final topi cs  deserve menti on . These are the mo l ecul ar acti ons 
of TPA and the p henomenon of " spontaneous " foci ari s i ng � vi tro . I t  was 
cl earl y  shown in these studies that TPA was capab l e  of i nducing  a qual i ta­
tive i ncrease in protei n synthesi s (Tab l e  15 , F i g .  20 ) and faci l i tati ng 
cel l u l ar rep l i cati on (Fig .  21 )  \�hen used at a certa in  concentrati on � 
vi tro ( 0 . 1  ug/ml ) .  Howeve r ,  at hi gher concentrati ons ( 1 . 0  ug/ml ) ,  these 
effects were not observed . TPA , noted for i ts i rri tati ng effect on ski n ,  
may have tox i c  acti v i ties at hi gher concentrati ons . The enhancement by TPA 
at optima l  concentrations of UV- i nacti vated HSV trans formati on of hamster 
cel l s  has a l ready been di scussed (Tab l e  17 ) .  In  this  action , TPA may 
ass i st i n  the i ncorporation of HSV genome into the host cel l or may dere-
160 
pres s a pers is ti ng HSV genome as  prev i ous ly  suggested .by Zur Hausen ; 
but certa i nly  TPA does not s imp ly  increase cel l ul ar rep l i cati on � v i tro . 
For exampl e ,  " spontaneous" foci , pos s i bly  representing  some form of smooth 
161 
surface tumori genesi s ,  arose i n  uni nfected fl asks but at the very l ow 
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6 i ncidence of 0 . 09 foci per 1 . 1.  x 10 cel l s  (Tab l e  13) ; thi s i nc idence de-
creased to 0 and 0 . 07 foc i  when TPA ( 0 . 1 ug/ml ) �/as add ed to the med i a  
1 hour and 2 4  hours pos ti nocul at ion , respecti vely ( Tabl e  17) . I n  summary , 
a 36 fo l d  i ncrease i n  the " spontaneous"  rate of foci  devel opment was seen 
when the hams ter cel l s  were infected wi th UV-i rradiated HSV-2 (7 mi n ) and 
a · 62 fol d  i ncrease emerged when TPA was added to the growth med i um at  
48  hours postinocul ati on (Tab l es 13 & 17 ) .  
CONCLUS I ONS 
The s i gn if icance of these resu l ts rests wi th the i r  abi l i ty to be 
appl i ed to the human s i tuati on .  Humans suffer from recurrent herpes 
l abial i s  and can rel ease i nfectious  HSV in the absence of cl i n i cal l es i ons . 
He are exposed to UV- i rrad i at i on i n  the forms of sunl i ght  and arti f ic i al 
i l l umi nati on .  We  are  i n  da i ly contact wi th envi ronmental chemi cal s that 
can act as  i ni ti ators as wel l as promoters . C i garette smoke and certai n 
d ietary subs tances , both capab l e  of i n i tiation and promotion ,  come i n  con-
tact wi th our 1 i p s  repeatedly .  Thu s ,  HSV ,  UV and promoter exposure to 
humans i s  not. rare ; to the contrary , the i nci dence of l i p  cancer re l ative  
to these ·expusures ' i s . However , it  i s  we l l  recogn i zed that after i n i t ia­
tion wi th a smal l dose of carc i nogen , i f  no promoter i s  appl i ed ,  no tumors 
deve lop .  Thus , combi nati ons of  many factors i nfl uence the l i kel i hood of  
neoplastic  development and actual tumori genes i s  i s  a rare phenome non . How­
ever rare , thi s  research has brought us one step cl oser to showi ng  an etio­
l og ical rol e  for HSV in the devel opment of squamous cel l carci nomas in man ; 
but important theoreti cal di fferences between associ ati on and eti ol ogy 
exi sts and deserve menti o n .  Assoc i ation o r  corre l at i on o f  H S V  wi th carc i -
noma devel opment cannot be i nterpreted as  cause and effect.  Al though these 
resu l ts showed HSV + UV + TPA treatments capab l e  of causi ng squamous cel l 
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carc i nomas i n  mouse l i ps , the possi bi l i ty exi sts that the UV-i rrad i ati o n  
was the i nducer and not the UV-i nacti vated HSV . Al though the tumor bear­
i ng mi ce had i ncreased HSV anti body ti ters as compared to non-tumor bear­
i ng mi ce , treated in a simi l ar fash i on , the pos si b i l i ty exi s ts that thi s  
may be acti vat ion of a l atent HSV i nfection by an immunosuppressi ve d i s­
ease ( squamous cel l carci noma ) .  Al though HSV anti gens were sho�m to be  
present i n  outgrowths from exp l anted tumors as  we l l  as  tumor b i ops i es , 
thi s  may represent a passenger rol e for HSV or preferenti al growth of HSV 
in tumor cel l s .  HSV anti gens were al so present i n  UV- i nacti vated HSV 
transformed cel l s  � vi tro and the s ame possi bi l i ty exists . The format ion  
of these transformed foc i , al though 36  to  62 t i mes more numerous wi th UV­
i nacti vated HSV infected cel l s  as compared to uni nfected control cel l s , 
may represent enhanced " spontaneous"  � vi tro transformati on . Local i zati on  
of HSV DNA wi thi n cancer cel l s  is  d i ffi cul t and may sti l l  not be ul t imate 
proof of the eti ol ogi cal  rol e  for HSV in the deve l opment of squamous cel l 
carc i noma . For exampl e ,  " hi t  and run" transformati on i s  poss i b l e  where 
the vi  ra 1 DNA sequences res pons i b 1 e for the mal i gnant convers i on are l os t 
after i n i ti ation .  Furthermore , if  the q uanti ty of HSV  DNA necessary for 
transformation  i s  s imi l ar to that requi red by SV 40 v i rus ( 1-2% ) , detect ion  
of  th i s  DNA  i n  a sea  of host DNA wi l l  be  di ffi cul t .  Problems exi s t  wi th 
b iops ied tumor ti ssue s i nce vari ation exi s ts between secti ons and nontumor­
ous t i ssue ( necrotic  and/or normal ) often pol l utes the bi opsy ' s  val ue .  
Outgrowths from tumor b i ops ies  may not  tru ly  represent the tumor s i nce 
some cel l u lar  subsets might show preferenti al growth � v i tro . In the 
future ,-t�e approach of us ing  those radi o l abel ed fragments of the HSV 
genome spec i f i c  for transformati o n ,  i n  conj unction wi th � si tu hybrid i za­
tion , may hol d the greatest promise  of detect ing  HSV nucl ei c ac i ds in 
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rna 1 i gnant cel l s .  
Ironi cal l y ,  the ul timate proof for the eti ol ogica l  l i nk  between HSV 
and carci nogenes i s  may come i n  the next 30 years from human prospecti ve 
studies . W ith the rapidly expanding  epi demi c of geni tal herpeti c i n fec­
tions that is presently ongoing  in the worl d ,  a para l l e l  ri se in the i nci ­
dence of cervi cal carci noma shoul d occur . Conversel y ,  numerous l aboratories 
have reported the devel opment of a vaccine to prevent HSV i nfecti ons and 
thi s preventi on  shoul d be fol l owed by a decrease in the i nci dence of car­
c i noma if a true l i nk  exi sts between HSV and carc inogenes i s . 
-161-
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APPENDIX  
Each  chemi cal  or reagent used in  th i s  study i s  1 i s ted be l ow i ts res pec­
tive  suppl  i er .  
Amersham Radiochemi cal Center , Eng l and 
S3 5  Meth ion i n e ,  4 . 56 �Ci/ml 
H3 dGTP , 6 . 3  Ci/m mol 
H� dTTP , 48 . 0  Ci/m mol 
H dATP , 16 . 6 C i/m mol 
H3 dCTP , 19 . 0  Ci/m mol 
Bake r ,  J. T . , Co . ,  Phi l l ipsburg , NJ 
acetone 
ammoni urn aceta te 
D�1S0 
H202 i soamyl al cohol 
sod i um bi carbonate 
sod i um ci trate 
sod i um hydroxide 
Beckman Instruments , Ful l erton , CA 
Protei nase K 
Sc i nti l l ati on tol uene 
Bethesda Research Lab . ,  Rockvi l l e ,  MD 
agarose 
DNA polymerase I 
B io-Rad Lab . ,  R ichmond , CA 
Acryl am ide 
Amphol i nes 
, Bi s 





Cal b i ochem , San Diego , CA 
2-ME 
ethid ium bromide 
F icol l 
polyv i nyl pyrrol i done 
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Conso l  i da ted Midl and Corp . , Brel1ster , NY 
TPA 
Difco , Detro i t ,  MI  
gel ati n . 
l acta l bumin  hydrolysate 
Freud ' s  compl ete adj uvant 




sod ium thi osul fate 
formami de 
F i s her Sc i en ti f i c  Co . , Fa i r  Lawn , NJ 
acetic acid  
ammoni um persu l fate 
cal cium chl oride 
egg al bumi n 
eosin 
hema toxyl i n 
methyl cel l ul ose 
Permount 
Tol ui d i ne bl ue 
Grand I s l and Biol og i cal  Co . ,  Grand I s l and , NY 
chick embryo extract 
chi cken pl asma heparini zed 
Eagl es mi n imal essenti al medi um 
. Waymou th ' s  med i um 
Kawecki  Berylco Industries , Inc . , C l evel and , OH 
cesium chl oride 
Lab-Tek Products , Napervi l l e . I L  
frozen t i s sue embeddi ng compound (OTC ) 
Mal l i nckrodt Chemi cal s .  McGraw Par k .  I L  
ch loroform 
glycerol 
. phosphoric  acid  
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Med i ca l  Col l ege of V irg i ni a ,  Ri chmond , VA . 
ethanol 
methanol 
neutral buffered formal i n  
nembutal 
scopol ami ne 
M i l  es Lab . , Kankakee , IL 
bov i ne serum al bumi n ,  fracti on V powder 
North American B i o l og i cal I nc . , t1 iami , FL 
fetal bov i ne serum 
g l utami ne 
goat serum 
HBSS 
tryp s i n  
P i tman-Moore I nc . , Hash ington Cross i n g ,  NJ 
methoxyfl uorane (Metophane ) 
Polysc ience , Bay Shore , NY 
DAB 
S i gma Chemi cal Co . ,  St . Loui s ,  MO 
EDTA 
gentamyci n  sul fate 
sod i um ch lor i de 
Tri s base i 
Hortli i ngton Chemical s ,  Freeho l d ,  NJ 
DNAase 
RNAase 
l .  
2 .  
3 .  
4.  
5 .  
6 .  
7 .  
B .  
9 .  
1 0 .  
I I .  
1 2 .  
1 3 .  
14.  
1 5 .  
16 . 




2 l .  
Xyl ene 
Xyl ene 
Abs . Al cohol 
Abs . Al cohol 
95% Al cohol 
95% Al cohol 
D i s t .  H2O 









Ammoni a  H ° 
2 
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APPENDIX  I I  
HEf-lATOXYLIN  AND EOS I N  STAIN  
(HARRIS HEMATOXYL I N )  
2 minutes 





D i p  
7 mi nutes 
D i p  
D i ps  
1 or 2 di ps 
D i p  
1 or 2 dips  
�lash under tap 10 minutes 
Eosi n 3 minutes 
95% Al cohol 2 to 3 dips  
95% Al cohol 2 to 3 dips  
Abs . Al cohol 5 m inutes 
Abs . Al cohol 5 mi nutes 
Xyl ene C l ear - 5 minutes 




























Aryl Hydrocarbon Hydroxyl ase 
Degrees Centi grade 
Cycl i c  Adenos ine  5 ' .  - Monophosphate 
Cycl i c  Guanos ine 5 ' .  Monophosphate 
Dimethyl benzanth racene 
Dimethyl sul foxi de 
Deoxyri bonuc l e i c  Aci d  
Ethyl enedi ami netetraacetate 
Epi dermal Growth Factor 
Eag l es ' M in imum Essenti al Med ia  
Gel ati n  Lactal bumi n Hydrolysate buffer 
Hypoxanthi ne ,  Ami nopteri n ,  Thymi dine  
med i um 
Hank ' s  Bal anced Sal t So l ution 
Hematoxy l i n  and Eos i n  
Hamster Embryo F ibrobl ast ( primary ) 
Cervi cal Carcinoma Cel l L i ne 
Human Epi dermo i d  Cel l L i ne 
Hour 
Herpes Simp l ex V i rus 
Herpes S impl ex V i rus Type 
Herpes S imp l ex V i rus Type 2 
Large External Transformation Sens i ti ve 
Protei n 
2-Mercaptoethanol 




























Mu l ti p l i c i ty of Infecti on 
�lol e  
Messenger Ri bonucl ei c Acid 
Orn i th i ne Decarboxyl ase 
Frozen Secti on Embedding Compound 
Polyacryl ami de Gel El ectrophoresi s 
Phosphate Buffered Sal i ne 
Posti nfecti on 
Pl aque-Formi ng Uni ts 
Phorbol Myri s tate Acetate 
Ri bonucl e i c  Aci d 
seconds 
Subcutaneous 
Standard Devi ati on 
Sodi um Dodecyl Sul fate 
Sod i um Lauryl Sul fate 
Three-Methyl chol anthrene 
HSV-2 Strai n 333 
Dr. Rapp ' s  UV i nacti vated HSV-2 Stra i n  
3 3 3  Transformed Cel l Line 
Dr.  Burns ' UV inacti vated HSV-2 Stra i n  
333 Transformed Cel l L ine 
Thymi d ine Kinase Negative Cel l s  
Thymi d i ne Kinase Pos i ti ve Cel l s  
Tetradecanoyl Phorbol Acetate 
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ABBREV IATIONS MEANING 
12F#1  Dr. Murray ' s  UV I nacti vated HSV-2 
Stra i n  333 Transformed Cel l L i ne 
12F#2 Dr.  Murray ' s  UV I nacti vated HSV-2 
Stra i n  333 Transformed Cel l L i ne  
UV  Ul travi o let  L i ght 
Vero Afr i can Green Monkey Kidney Cel l L i ne 
V Vol t 
wk week 
ABSTRACT 
ONCOGENIC  TRANSFORMATION BY HERPES S IMPLEX V I RUS 
James C. Burns , D . D . S . , M . S . ,  Ph . D .  
�ledi ca l  Col l ege o f  Vi rgi ni a - V i rg in ia  Commonweal th Univers i ty ,  1979 
Major Professor : Dr. B. K.  t·lurray 
Many l i nes of evi dence exi st  associati ng herpes simpl ex v i rus ( HSV ) 
w ith the devel opment of carc i noma . Data from human studies i ncl udes 
seroepidemi ol ogi c studies of carc i noma patients and the l oca l i zati on of 
v i ral  markers i n  human cancers . Experi mental  studies i ncl ude in v i tro 
transformation of cul tured cel l s  and vi ra l i nduced al terati ons of host 
DNA .  t�uch  of  th i  s ev i  dence i s  anecdotal or associ ati ve i n  nature and 
does not prove a cause and effect.  The purpose of thi s research was to 
i nvesti gate the oncogeni c potenti al of HSV type 2 ( HSV-2)  � vi vo and 
An in v ivo mouse model for l i p  carc i nogenes i s  was desi gned to com­
b ine  HSV-2 i nfecti on , ul travi o l et (UV )  exposure and tetradecanyl -phorbol ­
acetate (TPA) appl i cati
·
on .  Prel imi nary studies  showed that HSV-2 i nocul a-
ti on onto abraded mouse l i ps was capab l e  of causi ng ves i cu lar  u l cerati ve 
l esi on s .  These l es ions hea led compl etely after 10-14 days . Repeated 
herpetic l i p  i nfections fa i l ed to i nduce tumors . UV- irradi ati on del i vered 
2 
to the l es ion s i te da i l y  for 6 minutes at 42 ergslmm Is on days 3 through 6 
postinfecti on caused hyperkeratosi s ,  acanthosi s and dysp las i a  to deve lop  i n  
several  l i ps ;  wh i l e  the same UI! exposure del i vered by i tsel f fa i l ed to al ter 
the h i stol ogi c appearance . The add i t ion of repeated TPA appl i cation to the 
-2-
HSV + UV regimen promoted tumor emergence . Thi rty-two of 156 BALB/c mi ce 
devel oped tumors . Al though the majori ty were papi l l omas , si x were squamous 
cel l carc i nomas . These tumor beari ng mi ce had i ncreased HSV speci fi c ant i -
body ti ters . HSV anti gens were shown to be present i n  outgrowths from ex-
pl anted tumors as \"/el l as i n  tumor b i opsies  by i mmunoperoxi dase sta i n i n g  
wi th HSV speci f ic  anti seras . 
Another series of .:!.l!. v i vo studi es showed that HSV l i p i n fecti on 
i n i tiated prior to or during  repeated chemical carci nogen ( d imethyl benz­
anthracene/DMBA) appl i cation was capab l e  of reduci ng the i nci dence of 
tumors as  compared to D�1BA appl i cation wi thout s uperimposed HSV i nfecti on . 
Compari son of resu l ts from th i s  system and those from the HSV + UV + TPA 
system emphasi zed the fact that the lytic capabi l i ty of HSV must be i n ­
h i b i ted for the vi rus to express i ts oncogen ic  potenti a l . It was hypothe­
s i zed that the .:!.l!. vivo  UV-i rradi ated HSV acted as the i nducer and TPA as 
the promoter , analogous to the cl as s i ca l  two- state carc inogenes i s  model . 
S i nce nei ther the HSV i nfection  by i tsel f ,  the UV exposure by i tse l f ,  the 
TPA appl ication by i tsel f nor any combi nati on of two i nduced tile devel op-
ment of squamous cel l carci nomas , HSV was consi dered a cocarci nogen wi th 
UV -rad i a t i o n .  
An  analogous tri parti te system was devi sed .:!.l!. vi tro . Hams ter embryo 
cel l s  were i nfected w i th HSV-2 i rradi ated for 6 ,  7 or 8 minutes at 42 ergs/ 
mm2/s . Twenty-one days posti nocu l ation  transformed foci had devel oped 
-7 -7 -7 wi th frequenc ies (FFU/PFU ) of 2 . 9  x 10 , 9 . 9  x 10  , and 3 . 9  x 10  , respec-
6 
tively .  Thi s represents 0 . 9 ,  3 . 0  and 1 . 3  FFU/10 cel l s . The 7 mi nute trans-
-6 
forma ti on frequenci es v!ere further i ncreased to 1. 7 x 10 by the addi t i on  
of  TPA to the growth media  ( 0 . 1  ug/ml ) 48  hours posti nocul ati on . Th i s  re-
6 
presents 5 . 1 FFU/10 cel l s .  Thus , TPA Vias capab l e  o f  tumor promoti on .:!.l!. 
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v ivo and i ncreas ing transformation  effi c iency .:l..!! v i tro . Furthermore , TPA 
was s hown by two dimensi ona l  gel el ectrophore s i s  to i ncrease protei n  synthe­
s i s  in transformed cel l s  and by ce l l  sorter ana lys i s  to i ncrease cel l u l ar 
repl i cat ive act i v i ty .  
A transformed cel l l i ne , 3-26-7#1 ,  deri ved from a UV-i nacti vated 
HSV transformation experiment , was shown to possess HSV ant i gens by 
immunoperoxi dase sta i n i ng wi th specifi c anti sera and to be oncogeni c  when 
i njected i nto newborn hamsters . Sera from the tumor bearing  an i ma l s had 
HSV neutral i z i ng anti bodies and when used as the primary anti sera i n  the 
immunoperoxi dase sta i n  cou l d  detect antigens in HSV i nfected cel l s  and 
outgrowths from exp l anted hamster tumors . Another transformed ce l l  l i ne ,  
333-8-9 , was shown by .:l..!! s i tu hybridi zati on to have HSV speci fi c  mRNA i n  
i ts cytopl asm. 
These data reveal UV- i rrad i ated HSV capabl e of tumor i nducti on i n  
v i vo and of transform i ng hamster cel l � vi tro. In these systems , HSV 
can be consi dered a cocarc i nogen .  
